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Abstract
As genetic engineering technologies continue to advance and metabolic engineering
projects become more ambitious, the need for chromosome engineering tools is in-
creased. In this thesis, I have described the development of a ΦC31 phage integrase
based cassette exchange system. This system is called integrase mediated cassette
exchange (IMCE). IMCE allows for the integration of a ΦC31 attB flanked DNA cas-
sette, carried on a mobilizable donor vector, into a chromosomal landing pad locus.
The landing pad locus, consisting of ΦC31 attP sites flanking marker genes, was in-
tegrated into the chromosome of three members of the Rhizobiales, by homologous
recombination to create landing pad strains (LP-strains). The integration of the donor
cassette is catalyzed by ΦC31 integrase, expressed from a mobilizable vector. To ac-
complish IMCE, a tetraparental conjugative mating is carried out, including the attB
donor vector strain, the ΦC31 integrase expression plasmid strain, the LP-strain, and
the mobilizer strain. A variation on IMCE , reverse IMCE, was also accomplished with
the addition of a recombination directionality factor gene to the integrase expression
plasmid, and the use of attL and attR sites. Reverse IMCE was used to create a new
LP-strain containing the counter-selectable marker gene sacB.
A strategy to assemble overlapping DNA cassettes post-IMCE using genetic crosses
was developed. An application of this system was to assemble synthetic operons for
the metabolic engineering of Sinorhizobium meliloti to produce medium chain length
(mcl) polyhydroxyalkanoates (PHA). Two homologues each of phaC (PHA synthase
gene) and phaG (3-hydroxydecanoyl-[acyl-carrier-protein]:CoA transacylase gene) were
chosen. The genes were successfully combined in all four possible configurations on
the chromosome of S. meliloti. It was observed that the phaC construct did not in-
tegrate into the expected location, and therefore its expression was not guaranteed,
but promising preliminary results showing the detection of mcl-PHA were obtained.
v
The phaC genes described in this thesis have also been cloned into plasmids, for their
expression in strains carrying phaG within the landing pad. These strains will pro-
vide valuable tools for future work concerning PHA production. The chromosome
engineering tools developed in this thesis will be valuable for any future applications
requiring stable maintenance of a synthetic construct on the chromosome of these Rhi-
zobiales members.
vi
Acknowledgments
I would like to thank everyone around me that has encouraged me and kept me some-
what sane. I would like to thank my parents for their continued support and encour-
agement. I would like to thank Trevor Charles for taking me on, for affording me
the freedom to work independently, yet providing me with much needed guidance.
Thank you to my committee members: Marc Aucoin, Josh Neufeld, Bruce Reed for
their guidance through the years.
I would like to thank Paul Reginato for working on RIMCE and troubleshooting
some of the initial problems with it. I would like to thank my sister Emily for using
her microbiology skills to help me out in the lab for a few months. Thanks to Jiujun
Cheng for sharing his endless molecular biology knowledge and his reminders with
respect to cloning that “You only need one colony!”. Thanks to Ricardo Nordeste and
Tam Tran for being great collaborators on the PHA work. Thanks to Kathy Lam for
commiserating with me about all the molecular biology weirdness we encountered
at the bench. Thanks to Maya D’Alessio for cleaning, even if I got annoyed that I
couldn’t find things after. Thanks to Ariana Marcassa for keeping the music in the lab
interesting, even if I was vocal about not liking some of it. Thank you to all those who
came through the Charles Lab during my tenure. I’m pretty sure I learned a thing or
two from all of you. It was a pleasure working with you all.
vii

Contents
Author’s Declaration . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . iii
Abstract . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . v
Acknowledgments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . vii
List of Tables . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . xiii
List of Figures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . xv
List of Abbreviations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . xvii
1 Literature Review 1
1.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
1.1.1 Synthetic Biology . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
1.1.2 Chromosome Engineering . . . . . . . . . . . . . . . . . . . . . . . 2
1.2 Polyhydroxyalkanoates (PHAs) . . . . . . . . . . . . . . . . . . . . . . . . 3
1.2.1 The Rhizobiales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5
1.3 Recombination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5
1.3.1 The Application of Recombination to Chromosome Engineering . 9
1.4 In vitro Chromosome Synthesis . . . . . . . . . . . . . . . . . . . . . . . . 11
1.5 In vivo Chromosome Synthesis and Engineering . . . . . . . . . . . . . . 13
1.5.1 Chromosome Editing . . . . . . . . . . . . . . . . . . . . . . . . . . 14
1.5.2 Delivery of Large DNA Fragments into the Chromosome . . . . . 16
1.5.3 In vivo Chromosome Synthesis . . . . . . . . . . . . . . . . . . . . 18
1.5.4 Chromosome Engineering for Combinatorial Studies . . . . . . . 21
1.6 This Work . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23
1.6.1 Claims of Contributions to Scientific Knowledge . . . . . . . . . . 26
2 Materials and Methods 29
2.1 Bacterial Strains and Plasmids . . . . . . . . . . . . . . . . . . . . . . . . . 29
2.2 Oligonucleotides . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42
2.3 Bacterial Culture and Microbiological Techniques . . . . . . . . . . . . . 52
2.3.1 Bacterial Growth Media . . . . . . . . . . . . . . . . . . . . . . . . 52
2.3.2 Preparation of Bacterial Frozen Stocks . . . . . . . . . . . . . . . . 54
2.4 ΦM12 Transductions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 54
2.4.1 Preparation of ΦM12 Phage Lysates . . . . . . . . . . . . . . . . . 54
ix
2.4.2 Determining Titer of ΦM12 Phage Lysates . . . . . . . . . . . . . 54
2.4.3 Transduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 55
2.5 Triparental Mating . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 55
2.6 Plasmid Construction with λ Red Recombineering . . . . . . . . . . . . 56
2.7 Molecular Cloning Techniques . . . . . . . . . . . . . . . . . . . . . . . . 57
2.7.1 DNA Ligation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 57
2.7.2 Agarose Gel Electrophoresis . . . . . . . . . . . . . . . . . . . . . 58
2.7.3 Gel Extraction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 59
2.7.4 Preparation of CaCl2 Competent Cells . . . . . . . . . . . . . . . . 60
2.7.5 CaCl2 Transformation . . . . . . . . . . . . . . . . . . . . . . . . . 61
2.7.6 Electroporation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 62
2.7.7 Restriction Enzyme Digest of DNA . . . . . . . . . . . . . . . . . 62
2.7.8 Polymerase Chain Reaction (PCR) . . . . . . . . . . . . . . . . . . 63
2.7.9 Colony PCR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 65
2.7.10 Sanger Sequencing . . . . . . . . . . . . . . . . . . . . . . . . . . . 66
2.7.11 Genomic Sanger Sequencing . . . . . . . . . . . . . . . . . . . . . 66
2.8 DNA Purification . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 67
2.8.1 Purification of DNA Using a Silica Gel Column . . . . . . . . . . 67
2.8.2 Ethanol Precipitation of DNA . . . . . . . . . . . . . . . . . . . . . 67
2.8.3 Miniature Preparation of Bacterial Plasmid DNA . . . . . . . . . 68
2.8.4 Large Scale Preparation of Bacterial Genomic DNA for Direct
Genomic Sanger Sequencing . . . . . . . . . . . . . . . . . . . . . 69
2.8.5 Miniature Preparation of Bacterial Genomic DNA . . . . . . . . . 71
2.9 Southern Blotting . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 72
2.9.1 Creation and Quantification of DIG Labeled Probe . . . . . . . . . 73
2.9.2 Transfer of DNA onto Membrane . . . . . . . . . . . . . . . . . . . 75
2.9.3 Hybridization of the Probe . . . . . . . . . . . . . . . . . . . . . . 76
2.9.4 Detection of the Probe . . . . . . . . . . . . . . . . . . . . . . . . . 77
2.10 β-Glucuronidase (GusA) Assay . . . . . . . . . . . . . . . . . . . . . . . . 78
2.11 Sequence Alignments, Genomic and Plasmid Maps . . . . . . . . . . . . 78
3 Integrase Mediated Cassette Exchange 79
3.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 79
3.2 Materials and Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 84
3.2.1 Construction of SmUW227 LP-Strain . . . . . . . . . . . . . . . . 84
3.2.2 Construction of Ow0013 LP-Strain . . . . . . . . . . . . . . . . . . 85
3.2.3 Construction of At11142 LP-Strain . . . . . . . . . . . . . . . . . . 86
3.2.4 Construction of pJC2 ΦC31 Integrase Expression Plasmid . . . . 87
3.2.5 Construction of pJH110 IMCE Donor Plasmid . . . . . . . . . . . 87
3.2.6 Construction of pJH122 IMCE Donor Plasmid . . . . . . . . . . . 88
3.2.7 Southern Blotting . . . . . . . . . . . . . . . . . . . . . . . . . . . . 88
x
3.2.8 IMCE Tetraparental Mating . . . . . . . . . . . . . . . . . . . . . . 89
3.2.9 Colony PCR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 92
3.2.10 Visualization of RFP Fluorescence . . . . . . . . . . . . . . . . . . 92
3.3 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 93
3.3.1 LP-strain Confirmation . . . . . . . . . . . . . . . . . . . . . . . . 93
3.3.2 IMCE Tetraparental Mating Process . . . . . . . . . . . . . . . . . 98
3.3.3 IMCE Efficiency . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 105
3.3.4 IMCE Confirmation by PCR . . . . . . . . . . . . . . . . . . . . . 109
3.4 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 111
4 Integrase Mediated Cassette Exchange Tools and Reverse Integrase Medi-
ated Cassette Exchange 119
4.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 119
4.2 Materials and Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 122
4.2.1 Construction of pJH145: Mobilizable attB Donor Fosmid . . . . . 122
4.2.2 Construction of pJH121: Gentamicin attB Donor Vector with Gate-
way . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 122
4.2.3 Construction of pJH123 and pJH124: Hygromycin attB Donor
Vectors with Gateway . . . . . . . . . . . . . . . . . . . . . . . . . 123
4.2.4 Construction of pJH141 . . . . . . . . . . . . . . . . . . . . . . . . 123
4.2.5 Construction of pJH143 . . . . . . . . . . . . . . . . . . . . . . . . 124
4.2.6 In vivo Gateway Recombination . . . . . . . . . . . . . . . . . . . 124
4.2.7 RIMCE Tetraparental Mating . . . . . . . . . . . . . . . . . . . . . 125
4.2.8 IMCE using SacB LP-strain . . . . . . . . . . . . . . . . . . . . . . 125
4.3 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 126
4.3.1 RIMCE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 126
4.3.2 SacB IMCE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 130
4.3.3 Gateway Recombination into IMCE Vector . . . . . . . . . . . . . 134
4.3.4 Test IMCE with pJH145 . . . . . . . . . . . . . . . . . . . . . . . . 136
4.4 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 138
5 Recombination Synthesis of PHA Genes 143
5.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 143
5.2 Materials and Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 149
5.2.1 Construction of pJRT8 . . . . . . . . . . . . . . . . . . . . . . . . . 149
5.2.2 Construction of pJRT9 . . . . . . . . . . . . . . . . . . . . . . . . . 150
5.2.3 Construction of pJRT10 . . . . . . . . . . . . . . . . . . . . . . . . 150
5.2.4 Construction of pJRT12 . . . . . . . . . . . . . . . . . . . . . . . . 151
5.2.5 Construction of pJRT15 . . . . . . . . . . . . . . . . . . . . . . . . 151
5.2.6 Construction of pJRT16 . . . . . . . . . . . . . . . . . . . . . . . . 151
5.2.7 Construction of pJH146 . . . . . . . . . . . . . . . . . . . . . . . . 152
xi
5.2.8 Construction of pJH147 . . . . . . . . . . . . . . . . . . . . . . . . 152
5.2.9 Construction of pJH148, pJH149, and pJH150 . . . . . . . . . . . . 152
5.2.10 Construction of pJH151 . . . . . . . . . . . . . . . . . . . . . . . . 153
5.2.11 SmUW235 φ SmUW227 . . . . . . . . . . . . . . . . . . . . . . . . 153
5.2.12 SmUW497 φ SmUW227 . . . . . . . . . . . . . . . . . . . . . . . . 153
5.2.13 IMCE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 154
5.2.14 RS Triparental Mating . . . . . . . . . . . . . . . . . . . . . . . . . 154
5.2.15 RS Transduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . 155
5.2.16 Reporter, and Fluorescent Dye Visualization . . . . . . . . . . . . 156
5.2.17 Colony PCR and Sequencing . . . . . . . . . . . . . . . . . . . . . 157
5.2.18 Direct Genomic Sanger Sequencing . . . . . . . . . . . . . . . . . 157
5.2.19 Transduction Linkage Mapping . . . . . . . . . . . . . . . . . . . . 158
5.2.20 Cell PHA Content Analysis Gas Chromatography and Mass Spec-
trometry (CG-MS) . . . . . . . . . . . . . . . . . . . . . . . . . . . 158
5.3 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 160
5.3.1 RS Transduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . 160
5.3.2 RS Conjugation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 163
5.3.3 In vitro Assembly of PHA Operons . . . . . . . . . . . . . . . . . . 172
5.3.4 IMCE strains Containing Plasmids . . . . . . . . . . . . . . . . . . 174
5.4 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 174
6 General Discussion 181
Bibliography 191
Appendix A Supplementary Figures 205
Appendix B Hyaluronic Acid Project 211
B.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 211
B.2 Materials and Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 212
B.2.1 Construction of Hyaluronic Acid Operon . . . . . . . . . . . . . . 212
B.2.2 Oligonucleotides . . . . . . . . . . . . . . . . . . . . . . . . . . . . 214
B.2.3 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 214
xii
List of Tables
2.1 Bacterial strains and plasmids . . . . . . . . . . . . . . . . . . . . . . . . 30
2.2 Oligonucleotides . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42
2.3 KOD Xtreme PCR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 64
2.4 KOD Hot Start PCR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 65
3.1 IMCE selection . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 91
3.2 IMCE efficiency of each landing pad strain . . . . . . . . . . . . . . . . . 108
xiii

List of Figures
1.1 Integrase mediated cassette exchange . . . . . . . . . . . . . . . . . . . . 25
1.2 Recombination synthesis assembling two halves of an operon. . . . . . . 25
3.1 ΦC31 integrase mechanism . . . . . . . . . . . . . . . . . . . . . . . . . . 82
3.2 The ΦC31 integrase mechanism showing only stylized DNA sites. The
arm sequences (B,B′, P, P′) surround a core dinucleotide (TT). The base-
pairing of the core dinucleotide is required for the att sites to be ligated
in the recombinant configuration as shown below the arrow. . . . . . . . 82
3.3 Integrase mediated cassette exchange . . . . . . . . . . . . . . . . . . . . 83
3.4 SmUW227 Southern blot . . . . . . . . . . . . . . . . . . . . . . . . . . . . 95
3.5 Ow0013 Southern blot . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 97
3.6 At11142 Southern blot . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 99
3.7 SmUW227 landing pad locus map . . . . . . . . . . . . . . . . . . . . . . 101
3.8 Ow0013 landing pad locus map . . . . . . . . . . . . . . . . . . . . . . . . 101
3.9 At11142 landing pad locus map . . . . . . . . . . . . . . . . . . . . . . . . 101
3.10 pJH110 map . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 102
3.11 pJH122 map . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 103
3.12 pJC2 map . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 104
3.13 IMCE tetraparental mating . . . . . . . . . . . . . . . . . . . . . . . . . . . 106
3.14 SmUW227 IMCE experiment . . . . . . . . . . . . . . . . . . . . . . . . . 107
3.15 colony PCR of IMCE derived clones . . . . . . . . . . . . . . . . . . . . . 110
4.1 SacB landing pad map . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 127
4.2 SmUW246 reverse landing pad map . . . . . . . . . . . . . . . . . . . . . 127
4.3 pJH141 map . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 128
4.4 RIMCE tetraparental mating . . . . . . . . . . . . . . . . . . . . . . . . . . 131
4.5 SacB IMCE sucrose selection . . . . . . . . . . . . . . . . . . . . . . . . . . 133
4.6 pJH121 map . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 135
4.7 pJH145 map . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 137
5.1 Recombination Synthesis . . . . . . . . . . . . . . . . . . . . . . . . . . . . 146
5.2 mcl-PHA production from acetyl-CoA . . . . . . . . . . . . . . . . . . . . 147
xv
List of Figures
5.3 RS of PHA half operons . . . . . . . . . . . . . . . . . . . . . . . . . . . . 148
5.4 Integrated JRT vectors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 161
5.5 phaC alignment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 161
5.6 phaG alignment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 162
5.7 RS PCR Amplicons . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 167
5.8 XylE Reporter Test for pJRT14, pJRT10, and pJRT12 . . . . . . . . . . . . 168
5.9 Nile Red Fluorecence Phenotype of IMCE and RS strains . . . . . . . . . 169
5.10 RS colony PCR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 170
5.11 GC-MS putative PHO Peak . . . . . . . . . . . . . . . . . . . . . . . . . . 171
5.12 In vitro assembled operon clone displaying GFP fluorescence . . . . . . . 173
A.1 At1142 blot measurement . . . . . . . . . . . . . . . . . . . . . . . . . . . 206
A.2 Ow0013 blot measurement . . . . . . . . . . . . . . . . . . . . . . . . . . . 207
A.3 Standard for Ow0013 and At11142 Southern blot . . . . . . . . . . . . . . 208
A.4 Standard for SmUW227 Southern blot . . . . . . . . . . . . . . . . . . . . 209
xvi
List of Abbreviations
Φ phage
attB attachment site bacteria
attL attachment site left
attP attachment site phage
attR attachment site right
att attachment site
attTn7 transposon seven attachment site
µ micro
oriT origin of transfer
rfp red fluorescent protein gene
sacB levansucrase gene
in vitro in glass
in vivo within the living
BAC bacterial artificial chromosome
BdhA 3-hydroxybutyrate dehydrogenase
bp base pair
CAGE conjugative assembly genome engineering
CAS CRISPR associated
CAS9 CRISPR associated protein nine
CoA coenzyme-A
xvii
CRISPR clustered regularly interspaced short palindromic repeats
DAP diaminopimelic acid
DMF dimethylformamide
DMSO dimethylsulphoxide
DNA deoxyribonucleic acid
dNTPs deoxynucleoside triphosphates
ds double stranded
DSB double strand break
DXP deoxyxylulose phosphate
ECL enhanced chemiluminescence
EDTA ethylenediaminetetraacetic acid
FAME fatty acid methyl ester
g gram
GC gas chromatography
GC-MS gas chromatorgraphy with mass spectrometry detection
Gm gentamicin
GusA β-Glucuronidase
ICE integrative and conjugative element
IMCE integrase mediated cassette exchange
Int integrase
kb kilobase pair
LB lysogeny broth
LBmc lysogeny broth with magnesium and calcium
M molar
m milli
xviii
MAGE multiplex automated genome engineering
mb megabase pair
mcl medium chain length
mM millimolar
MS mass spectrometry
NHEJ nonhomologous end joining
nm nanometer
OD optical density
OD600 optical density at 600 nm
ORF open reading frame
p plasmid
PCR polymerase chain reaction
PFU plaque forming units
PHA polyhydroxyalkanoate
PhaC PHA synthase
PhaG 3-hydroxydecanoyl-[acyl-carrier-protein]:CoA transacylase
PhaZ polyhydroxyalkanoate depolymerase
PHB polyhdroxybutyrate
PhbA β-ketothiolase
PhbB acetoacetyl-CoA reductase
PhbC PHA synthase
PHO polyhydroxyoctanoate
PHV polyhydroxyvalerate
PNPG 4-nitrophenyl-beta-D-glucopyranoside
RBS ribosome binding site
xix
RDF recombination directionality factor
RFP red fluorescent protein
RIMCE reverse integrase mediated cassette exchange
RNA ribonucleic acid
RS recombination synthesis
S Svedberg unit
SacB levansucrase
scl short chain length
SDS sodium dodecyl sulphate
Sm streptomycin
SOB super optimal broth
SOC super optimal broth with catabolite repression
Sp spectinomycin
ss single stranded
TALEN transcription activator like effector nuclease
Tn transposon
TRMR trackable multiplex recombineering
TY tryptone yeast extract media
UV ultraviolet light
X-gal 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside
X-gluc bromo-4-chloro-3-indolyl-β-D-glucuronide
ZFN zinc finger nuclease
xx
Chapter 1
Literature Review
1.1 Introduction
Recombinant DNA has provided a foundation for many important fields of research
and technologies, including genome sequencing and protein purification. Synthetic
DNA technology allowed for the creation of oligonucleotides used for PCR primers,
and the synthesis of small genes. Recombinant DNA and synthetic DNA technologies
have together formed a foundation for molecular biology in general. The application
of molecular cloning technologies has had a positive economic impact (Demain, 2000).
An early example of metabolic engineering via recombinant DNA was the production
of the dye indigo through the expression of a Pseudomonas putida gene in Escherichia
coli (Ensley et al., 1983). In recent years, the cost of DNA synthesis has fallen dra-
matically. Coupled with the advancements in cell and molecular biology, this drop in
cost has increased the scope of strain construction and design. Although the increased
scope allows for more complex strain design, the overwhelming increase in complex-
ity requires intellectual tools to make the system tractable; the intellectual tool-kit is
synthetic biology. Synthetic Biology promises to amplify the benefits of synthetic and
recombinant DNA technologies through the systematic approach of top-down engi-
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neering disciplines where the use of well-characterized components makes for pre-
dictable designs (Baker et al., 2006).
1.1.1 Synthetic Biology
Synthetic biologists aim to create cells with specific engineered functions using well
characterized parts. Parts are DNA sequences of defined function that can be ab-
stracted to different levels of detail. A part to produce protein would be built up of
the required subparts (promoter, ribosome binding site, open reading frame) but it
could be simply thought of as a protein generator. Under this paradigm, the genes
of whole pathways can be grouped into a single part or device. Such a level of ab-
straction would allow for more complex genetic designs that are still tractable. Also,
new composite parts should be more predictable than naively designed constructs if
the component parts are well characterized. The BioBrick standard (Shetty et al., 2008)
has been developed to deal with a parts-based paradigm. The BioBrick standard is
well suited to plasmid-based engineering and is currently the most widely adopted
synthetic biology assembly standard. It lays out a standard restriction site scheme
that allows for assembly of two BioBricks into a new BioBrick that may be assembled
with every other BioBrick. However, as the synthetic biology paradigm matures and
parts become larger and more complex, the chromosome of bacterial cells will provide
a more stable platform for synthetic biology than plasmids.
1.1.2 Chromosome Engineering
Chromosome engineering affords stable maintenance of large amounts of heterolo-
gous DNA at a consistent copy number. This feature is an advantage over plasmid
based systems. Many plasmids are unstable without selective pressure. Moreover
cloning genes in plasmids may alter their copy number through inadvertently chang-
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ing the expression of plasmid encoded replication factors (del Solar et al., 1998). Chro-
mosome engineering not only includes adding DNA to existing chromosomes, and
synthesizing new chromosomes, but also deleting DNA from existing chromosomes
and combining parts of synthetic chromosomes. As more becomes known about gene
functions and their implications for cell biology it will become possible through syn-
thetic biology to design chromosomes or parts of chromosomes. Methods to synthe-
size whole chromosomes have been demonstrated (Gibson et al., 2008a,b, 2010), yet
our rational design ability is not advanced enough to take advantage of the ability to
synthesize whole chromosomes.
What follows is a review of emerging chromosome engineering methods, the ad-
vances in DNA synthesis, and the recombination principles that chromosome engi-
neering approaches use to get the synthetic DNA into chromosomes. Also included
is a short review of the polyhydroxyalkanoate (PHA) bioplastics, and a short intro-
duction to the Rhizobiales. PHA production in members of the Rhizobiales is the first
application of the chromosome engineering system presented in this thesis.
1.2 Polyhydroxyalkanoates (PHAs)
PHAs are carbon storage polymers that bacteria produce under metabolic stress, such
as conditions of excess carbon and limiting nitrogen (Anderson and Dawes, 1990).
PHAs accumulate via a variety of pathways. The best studied pathway for PHA ac-
cumulation involves 3 enzymes. The enzymes are β-ketothiolase (PhbA), acetoacetyl-
CoA reductase (PhbB), that produce hydroxybutyryl-CoA, and then a PHA synthase
(PhbC, also known as PhaC), which polymerizes hydroxybutyryl-CoA into polyhy-
droxybutyrate (PHB). The cycle is completed by a depolymerase (PhaZ) and a dehy-
drogenase (BdhA) (Aneja et al., 2005) to facilitate the use of the stored PHB by the cell
(Anderson and Dawes, 1990; Slater et al., 1988; Tombolini et al., 1995). Other PHA path-
3
Chapter 1. Literature Review
ways use Co-enzyme A (CoA) linked monomers from other areas of cell metabolism
to feed a PHA synthase (Anderson and Dawes, 1990). These pathways include β-
oxidation and de novo fatty acid synthesis. CoA-linked monomers are produced via β-
oxidation when cells are fed fatty acids (Chen et al., 2006). CoA-linked monomers may
also be produced from de novo fatty acid metabolism with a (R)-3-hydroxydecanol-
ACP:CoA transacylase gene (phaG). Through the expression of phaG from Pseudomonas
putida and broad substrate specificity phaCs from Pseudomonas stutzeri (phaC1, phaC2)
in Ralstonia eutropha mcl-scl co-polymer PHAs were produced (Chen et al., 2006).
The practical uses of PHAs include the use as thermoplastics for moulding and fi-
bres, a source of monomers for fuel additives and chiral chemistry, and drug delivery
agents (Chen, 2009). Depending on the specific hydroxyalkanoate monomers incorpo-
rated into the chain, bioplastics with different physical properties are produced. There
are a variety of PHA polymers that are produced in bacteria. The chain length and the
side chain length of the monomer have an impact on the material’s physical proper-
ties. For example: Sinorhizobium meliloti produces mainly polyhydroxybutyrate (PHB)
and some polyhydroxyvalerate (PHV); both are short chain length PHAs (Tombolini
et al., 1995). Some species of Pseudomonas produce medium chain length (C6-C14) PHA
(Anderson and Dawes, 1990). PHB can be a brittle material below its glass transition
temperature of 10oC whereas a copolymer (PHB-co-HV) containing 20 mol% valerate
will remain more pliable down to its glass transition temperature of -1oC (Marches-
sault and Yu, 2001). Many medium chain length PHAs possess rubber-like properties
similar to elastomers (Kellerhals et al., 2000).
Shuffling of orthologues of genes linked to PHA synthesis may result in strains
that produce PHAs with different properties. A combinatorial PHA gene expression
approach coupled with a screen sensitive to PHAs of different chain lengths could be
useful for PHA discovery. A combinatorial assembly approach could create operons
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containing different phaG, phaC1 and phaC2 orthologues. The operons could be con-
structed in different pha gene backgrounds, providing varied sources of monomers.
This could yield a variety of PHAs containing both short-chain and medium-chain
monomers.
1.2.1 The Rhizobiales
The Rhizobiales are a diverse order of the α-proteobacteria. They include the nitrogen
fixing nodule forming Rhizobia, such as S. meliloti, a natural PHA producer. Many
intracellular pathogens, including Brucella abortus, count in the ranks of the Rhizobiales;
Ochrobactrum anthropi (Chain et al., 2011) is an opportunistic pathogen very closely
related to Brucella. The plant pathogen Agrobacterium tumefaciens, famous for its use
in the genetic modification of plants, is also a member of the Rhizobiales. Of note,
the Rhizobiales also include the methanotroph Methylosinus trichosporium. Instances
of horizontal gene transfer are very common among the Rhizobiales (Carvalho et al.,
2010). The presence of megaplasmids or extra auxiliary chromosomes is also common
among the Rhizobiales (DiCenzo and Finan, 2015; Kaneko et al., 2000; Chain et al., 2011).
Chromosome engineering of the Rhizobiales may lead to many unforeseen applica-
tions due to the broad functional diversity of this group.
1.3 Recombination
DNA Recombination is simply the joining or un-joining of DNA strands that were
previously in a different configuration. Technically speaking, cloning with restric-
tion enzymes and plasmids is a form of recombination, hence the term recombinant
DNA. However, in vitro cloning, even with a perfect restriction enzyme, is not prac-
tical for engineering chromosomal DNA, due to the fragile nature of high-molecular
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weight DNA. In vivo forms of DNA recombination are quite useful for chromosome
engineering. These forms of recombination are usually what is meant when referring
to recombination. Functions of these mechanisms include: fostering genetic diver-
sity, DNA repair, and viral infection processes. For the purposes of this review I will
focus mostly on forms of recombination that involve recognition of specific unique se-
quences, either through homology or protein DNA interactions. These forms include
general homologous recombination, λ Red recombination, and various phage based
site-specific recombination systems. An exception will be the involvement of nonho-
mologous end joining (NHEJ) in its capacity as a step in some emerging chromosome
engineering techniques.
Unlike plasmids, chromosomes cannot be effectively engineered using restriction
enzymes, because chromosomes cannot be easily handled in vitro, and their large size
makes unique restriction sites exceedingly rare. Therefore, chromosomes must be en-
gineered via recombination, usually with an altered plasmid or phage genome. For
the purpose of developing an understanding of recombination as it pertains to chro-
mosome engineering, two distinct types of recombination will be discussed: homolo-
gous recombination and site-specific recombination. General homologous recombina-
tion, reviewed by Otero et al. (1995), involves recombination between two homologous
strands of double-stranded DNA catalyzed by a host of proteins; a critical one is RecA.
In contrast, site specific recombination, reviewed by Grindley et al. (2006), is catalyzed
by one or a few enzymes that directly recognize specific sites on the DNA to be re-
combined. There is also the λ Red system (Ellis et al., 2001; Poteete, 2001) which is a
homologous recombination system from phage λ. The λ Red system works with small
homologous regions (50 bp, compare with >200 bp for regular homolous recombina-
tion), recombines linear and single stranded DNA, and is RecA independent.
Some form of homologous recombination is active in most if not all bacteria en-
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countered, due to its role in DNA repair. Recombination through the RecBCD path-
way, a specific mechanism for homologous recombination, involves formation of a
single stranded nucleoprotein filament, the presynaptic filament, which invades a ho-
mologous strand to form a heteroduplex region. This is followed by migration of the
heteroduplux region, formation of a Holliday junction, isomerization of the junction,
and resolution of the junction to form recombinant products (Otero et al., 1995). The
activity of RecA is very important for the functioning of the pathway since it stabi-
lizes the single stranded DNA in the presynaptic filament and it catalyzes the for-
mation of the heteroduplex region. RecA is also important for other mechanisms of
homologous recombination that involve formation of a heteroduplex region, such as
the RecF pathway (Otero et al., 1995). Therefore, it is noteworthy that many strains of
Escherichia coli such as DH5α (Hanahan, 1983) cannot perform homologous recombi-
nation due to their recA mutations. The mutations are advantageous from a plasmid
cloning perspective, but abolish the strains’ usefulness for chromosome engineering
using wild-type homologous recombination. However, λ Red may still be used in recA
backgrounds. λ Red relies on three λ phage genes (exo, bet, gam) that allow efficient
recombination of DNA segments with ≈ 40-50 bp of homology. λ Red works well in
E. coli and has been used in other proteobacteria with reduced efficiency (Lesic and
Rahme, 2008). The use of λ Red for chromosome engineering is often called recombi-
neering, a term coined by Ellis et al. (2001). It is important to note that for homologous
recombination (including λ Red) to occur, the two homologous sites (unless palin-
dromic) must be aligned parallel to each other. This constraint causes the recombina-
tion result to be consistent when the orientation of the homologous sites is a certain
way. If the sites are parallel to each other on the same duplex, the result of homologous
recombination between the two sites will be the excision of the DNA between the two
sites and the reduction of the copy number of the site to one. If the sites were anti-
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parallel on the same duplex, the recombination result would be an inversion of the
DNA between the two sites and conservation of both homologous site copies. If the
alignment constraint did not exist (it does not in some cases of site specific recombi-
nation) there could be an even mixture of both events. An example of the implications
of the alignment constraint of recombination can be seen in work with large serine
recombinases (Ghosh et al., 2003). In this study, a particular part of the recombination
sites was made palindromic, causing mixtures of excision and inversion results when
recombination was carried out.
The site-specific recombinases are split into two families: the tyrosine recombi-
nases (Nunes-Duby et al., 1998) and the serine recombinases (Smith and Thorpe, 2002).
Tyrosine recombinases include the λ integrase used in Invitrogen’s Gateway tech-
nology (Mumm et al., 2006; Katzen, 2007) and the Cre recombinase (Sternberg and
Hamilton, 1981). The serine recombinases include the ΦC31 integrase (Kushtoss and
Rao, 1991) and the resolvase protein encoded by transposons Tn3 and γδ (Smith and
Thorpe, 2002). The mechanisms of the tyrosine and serine recombinases are markedly
different. The tyrosine recombinase mechanism involves the formation of short het-
eroduplex regions (RecA independent), formation of a Holliday junction, isomeriza-
tion, and resolution. The serine recombinase mechanism involves double strand break-
age, rotation, and re-ligation (Grindley et al., 2006). Regardless of the mechanistic dif-
ferences between the two families, there are often conceptual parallels between the
two with respect to the requirements for recombination, and the recombination site
configurations that yield integration, inversion, and excision. For that reason, the
nomenclature of the sites involved in the recombination process may be the same for
enzymes in both families. ΦC31 integrase and λ integrase both recombine attB and
attP (for attachment bacteria and attachment phage) and produce attL and attR com-
posite sites; although, the λ att sites are completely different than the ΦC31 att sites.
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On the other hand, the Cre recombinase (tyrosine recombinase) recombines loxP sites
to form loxP sites. Given that the product of recombination is the same as the initial
recombination site (loxP), DNA integrated with the Crelox system is unstable. The λ
system produces stable recombinant products in the absence of its cognate excisionase
(Xis) (Mumm et al., 2006), yet integration host factor (IHF) is required, so the λ sys-
tem is less portable than other systems. The ΦC31 system is particularly well suited
to chromosome engineering because its recombination products are stable, and it re-
quires no co-factors. TheΦC31 system works in a variety of hosts including Drosophila,
human cell lines, bacteria, and yeast (Bateman and Wu, 2008; Dafhnis-Calas et al., 2005;
Thomason et al., 2001).
1.3.1 The Application of Recombination to Chromosome Engineer-
ing
Homologous recombination is used when precise modifications to a chromosome
need to be made. The advantage of homologous recombination is that the target can be
very specific and there will be no surrounding mutations or recombinase sites present
when the modification is complete. Homologous recombination (including recombi-
neering) may be used to insert constructs, delete genes, to make mutations, and gene
fusions. A well used vector system, which takes advantage of homologous recombi-
nation in many species, is the SacB system. There are a great deal of vectors contain-
ing the Bacillus subtilus or Bacillus amyloliquefaciens sacB gene, encoding levansucrase,
(Schafer et al., 1994; Gay et al., 1985; Bramucci and Nagarajan, 1996) for positive se-
lection of double recombinant clones in many bacteria. This particular levansucrase
is toxic to many bacteria when sucrose is present. To insert or delete DNA from the
bacterial chromosome, homologous DNA from the target locus is cloned into the vec-
tor. In the case of making an insertion, it is cloned flanking the DNA to be inserted.
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The vector is introduced into the target host, where the vector cannot replicate, and
the host cells are plated on selective media containing the antibiotic for which the vec-
tor backbone encodes resistance, thus selecting for vector-chromosome co-integrants.
Co-integrant clones are plated on media containing sucrose, thus selecting for the loss
or inactivation of sacB. Sucrose-sensitive clones are screened for the correct antibiotic
sensitivity, to distinguish double recombinants from sacB mutants. The double recom-
binants are then screened phenotypically, with PCR or Southern analysis, to determine
if they are wild-type revertants or the desired insertion or deletion mutants.
Site-specific recombination is typically much more efficient than homologous re-
combination (Mumm et al., 2006; Groth and Calos, 2004; Thomason et al., 2001; Ghosh
et al., 2003). The use of site-specific recombinases for chromosome engineering is ap-
pealing, however strains containing the DNA sequence specific to the recombinase
must be constructed in many cases. Homologous recombination can be used to insert
these sequences at specific loci of the chromosome. Some site-specific systems do have
existing target sites within certain phyla. The attTn7 sites are present downstream of
the glmS gene in a number of γ-proteobacteria (Choi and Schweizer, 2006b). The Tn7
system is based on a transposase that uses a cut and paste mechanism that is unre-
lated to the serine or tyrosine recombinases (Biery et al., 2000). Another system that
has a similar natural host range to Tn7 is the integrative conjugative element (ICE) clc,
which is based on a tyrosine recombinase (Miyazaki and van der Meer, 2013). If the
goal is to modify organisms that fall outside the γ-proteobacteria, the fact remains that
recipient strains will have to be engineered. In the long term it makes more sense for
recipient strains to be constructed rather than found. This way some of the same tools
may be used in divergent organisms.
Before considering how to integrate the proper recombinase sites into the target
chromosome, an idea will be needed of how the system will function, what sites to
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add, and which selection schemes to use. In the following sections various chromo-
some engineering schemes illustrating these principles will be discussed.
1.4 In vitro Chromosome Synthesis
In vivo recombination is an integral part of chromosome engineering as a whole, but
it is important to discuss the advances in in vitro DNA synthesis. In vitro DNA syn-
thesis provides a means to make a DNA molecule that has no existing template in
nature. The method provides the flexibility to codon optimize genes and/or to rear-
range genes or sections of genes.
Synthesized genes have become an easily obtainable commodity thanks the ad-
vancement of gene synthesis through phosphoramidite-based oligonucleotide synthe-
sis. It is certainly remarkable how accessible synthetic DNA has become considering
the first synthesis of a gene segment (77 bp of a yeast transfer RNA gene) by Khorana
et al. (1972) was such a monumental achievement in its time that the experimental re-
alization of it was released as a series of twelve papers. Since then, the complete chem-
ical synthesis of the polio virus cDNA genome (7.5 kb) (Cello et al., 2002), the bacterio-
phageΦX174 genome (5.3 kb) (Smith et al., 2003), and quarter genome sections (144 kb)
of Mycoplasma genitalium have been synthesized (Gibson et al., 2008a) and assembled
in vitro using a combination of oligonucleotide synthesis and in vitro enzymatic assem-
bly or polymerase extension. The synthesis of the polio cDNA genome (Cello et al.,
2002) was quite a large undertaking. Overlapping phosphorylated oligonucleotides
of an average length of 69 nucleotides (nt) were assembled using ligation and cloned
into vectors as 400-600 bp fragments which overlapped with their to be adjacent frag-
ments. A total of 5-15 clones were sequenced to identify error free clones, or clones
that could be readily corrected with PCR-based site-directed mutagenesis. The correct
400-600 bp clones were assembled into two of the three larger fragments (fragments
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1 and 3). The authors do not mention how the cloned and sequenced segments were
excised from the vector and used in the subsequent assembly of fragments. Frag-
ment 3 was assembled using similar oligonucleotides but used a PCR to generate the
600 bp segments, which were cloned into a T-vector, sequenced, and subsequently as-
sembled by restriction and ligation. The three large fragments were assembled via
restriction digest and ligation to yield the full cDNA copy of the genome. The ΦX174
synthesis project (Smith et al., 2003) aimed to reduce the resources needed for qual-
ity control of the sequence, so that a correct sequence could be made more quickly
and economically. They chose to skip the intermediate cloning and sequencing steps,
and instead increase the efficiency of their assembly process. Like Cello et al. (2002),
they annealed and ligated overlapping phosphorylated oligos, except they performed
their ligation at 55oC using Taq ligase. The theory is that if the ligation temperature
were increased, there would be a stronger selection against mismatches in the over-
lapping regions, due to higher stringency preventing mutated intermediates from lig-
ating. The entire ΦX174 genome was not assembled by ligation, even though all of
the oligos were pooled and included in the ligation reaction. The authors’ statistical
model predicted that random variation in the concentration of each given oligo of 20%
would make the probability of achieving a full length ligation product exceedingly
low. As a result, they used a PCR-like reaction called polymerize cycling assembly
(PCA), where the ligation products were extended to generate full length product.
Synthetic DNA molecules were circularized and introduced into Escherichia coli. The
DNA from the plaques that arose was sequenced and they found that the frequency
of correct genomes was close to what they had estimated. The fidelity of their method
would produce 1 kb of DNA with an average of≈2 errors. In their experiments, phage
viability was a selection for correctness of the sequence. Without a selection, DNA se-
quencing must be done to verify the correctness of the final sequence. As the size of
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the synthetic DNA increases, so does the amount of clones that need to be sequenced
to find a correct one. Gibson et al. (2008a) assembled quarter-length segments of the M.
genitalium genome via in vitro recombination of synthetic fragments. These were com-
mercially synthesized 5-7 kb fragments, presumably made in a similar manner as the
ΦX174 genome, that were assembled in parallel to produce intermediate assemblies.
Eventually, the last intermediate assemblies were assembled into the final genome,
but only 1/4 length segments were achieved in vitro. To achieve in vitro recombina-
tion, each synthetic fragment contained a region of overlap. A custom BAC was made,
using PCR, with complementary regions to the ends of the assembly. The BAC was
included in the assembly reaction with the fragments. The fragments and the BAC
were subjected to a 3’ exonuclease digestion, exposing their sticky ends, and allowing
them to anneal. The assembly was completed by filling in gaps with Taq polymerase
and sealing with Taq ligase. The final assemblies were married by homologous re-
combination in Saccharomyces cerevisiae. Gibson et al. approached the limit of in vitro
assembly. Blake et al. (2010) have proposed a method called pairwise selection assem-
bly (PSA) that was used to assemble a 91-kb chromosome arm from S. cerevisiae that
relies on in vitro reactions, but intermediates are selected in vivo through the assem-
blies’ activation of antibiotic resistance gene expression in the carrier plasmid. At this
time, it is quite obvious that taking advantage of in vivo recombination for synthetic
DNA assembly is necessary at some point and, when coupled with the technology
to cheaply synthesize shorter ΦX174 genome sized segments, in vivo assembly can be
quite powerful.
1.5 In vivo Chromosome Synthesis and Engineering
DNA in a tube is, after all, just DNA. Therefore it is important to have robust pro-
tocols for introducing DNA into cells, and for reasons already mentioned, integrate
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the DNA into a chromosome. Depending on the construct, it may also be important
to make modifications to existing chromosomes to make the cell work well with syn-
thetic DNA being introduced. Another approach, famously taken by Gibson et al.
(2010), is to build the whole chromosome elsewhere (in vivo or in vitro in a different
cell) and import the new chromosome into a cell, thereby replacing the cell’s existing
chromosome. Two main paradigms for chromosome building to facilitate synthetic
biology are emerging. One being: building a chromosome in place in vivo sequen-
tially; the other being: building a chromosome outside of its intended destination and
using the synthetic chromosome to replace the genome of an existing cell, by intro-
ducing the synthetic genome. However, chromosome engineering encompasses more
than just chromosome building. There are also methods emerging that focus more
on directed evolution and combinatorial development of existing chromosomes such
as MAGE (Wang et al., 2009) and TRMR (Warner et al., 2010). The chromosome can
also be used in the place of a cloning vector for large insert functional screening, or
synthetic biology applications.
1.5.1 Chromosome Editing
Many chromosome engineering strategies take advantage of the cell’s DNA repair ca-
pabilities. One way to increase the cell’s DNA repair activity is to damage the DNA,
and a particularly dire form of damage is the double strand break (DSB). DSBs can be
repaired through non-homologous end joining or through the use of a homologous
template. In order to accomplish a chromosome engineering objective, a targeted
DSB could be made, and a homologous DNA containing an edit could be supplied
to serve as a template in the required DNA repair. The resultant cell then contains
the desired chromosomal change included in the homologous DNA. Until recently
the above scenario would be nearly impossible except for certain sites targeted by a
14
1.5. In vivo Chromosome Synthesis and Engineering
homing endonuclease. Now a specific endonuclease can be created that will cut at
a desired target site. There are three types of nucleases that allow custom targeting:
zinc-finger nucleases (ZFNs) (Carroll, 2011), transcription activator like effector nu-
cleases (TALENs) (Sanjana et al., 2012), and CRISPR associated protein endonucleases
(CAS9) (Wiedenheft et al., 2009; Jinek et al., 2012; Jiang et al., 2013). Each type works
on a similar principle where a sequence independent endonuclease domain is steered
to a DNA target by a custom domain or RNA. In the case of ZFNs and TALENS, it
is a custom protein domain; for CAS9 it is a custom guide RNA. The use of ZFNs,
TALENS and CAS9 for genome editing has been recently reviewed. (Gaj et al., 2013).
Chromosome editing, or genome editing, is the term that has emerged for the gen-
eral approach of making a DSB with a custom nuclease and then providing a repair
template to make desired changes or relying on non-homologous end joining for error
prone repair to make mutations.
To date, the primary application of chromosome editing has been the editing of eu-
karyotic chromosomes. It seems that there is a sufficient base of methods for bacterial
chromosome engineering that the new chromosome editing techniques have made
less of an impact in the bacterial sphere. For instance, recombineering techniques pro-
vide analogous capabilities and results in Escherichia coli when compared to chromo-
some editing. The slow adoption of chromosome editing techniques in the prokaryotic
sphere of research does not mean there is not quite a bit of potential in chromosome
editing techniques for bacterial chromosome engineering.
Jiang et al. (2013) report using CAS9 to edit bacterial chromosomes. They demon-
strated markerless mutations in E. coli and Streptococcus pneumoniae. They demon-
strated the use of CAS9 in these distantly related bacterial backgrounds, thereby demon-
strating that CAS9 will be useful in a wide range of bacterial phyla. In one of their
reported methods using E. coli, recombineering was used as the primary means of
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genome editing, and CAS9 was used to target the non-edited DNA such that cells that
had not undergone successful λ-Red recombination were killed by CAS9 targeting.
This CAS9 targeting offered a means to select for successfully recombineered cells
without the use of a selectable marker. They also demonstrated genome editing as
characterized above. Perhaps the main constraint on the use of CAS9 they discuss is
that the edited DNA must be sufficiently different in order to prevent CAS9 target-
ing, a DSB, and subsequent cell death. There are certain regions of the targeting RNA
where a single-nucleotide change will abolish targeting. There are other regions where
targeting will be minimally affected by a single nucleotide change. Therefore, making
small changes is more difficult than making big changes, like deletions and insertions
that encompass whole genes. When single nucleotide changes are to be made, it is
imperative that the change be in the protospacer adjacent motif (PAM). The PAM is a
3 bp site (NGG) that is required for CAS9 targeting. The other constraint is that CAS9
targeting is only effective adjacent to NGG sequences. This constraint could be an
issue in AT rich regions.
CAS9, and the other custom nucleases, have some drawbacks, but they will un-
doubtedly offer a powerful set of capabilities to the bacterial chromosome engineer-
ing process. The DNA targeting technology also has the potential to contribute to
synthetic biology in general by fusing the targeting domains to proteins other than
nucleases.
1.5.2 Delivery of Large DNA Fragments into the Chromosome
The state of our understanding of genomes is not to a point where we may rationally
design whole genomes, yet some ambitious ideas for the application of synthetic bi-
ology have been proposed. In their review, Thaker and Wright (2012) proposed a
synthetic biology approach to generating libraries of candidate antibiotics through
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mixing and matching genes for synthesis of the scaffold or core molecule with genes
for accessorizing the scaffold. Antibiotic synthesis gene clusters can exceed 100 kb in
size (Banik and Brady, 2008) and therefore they exceed the stable capacity of cloning
vectors, except for BACs. Large gene cluster constructs can benefit from the stability
and consistency chromosomal insertion provides. By extension, chromosomal inser-
tion may also lend itself to functional screening of large insert libraries.
A few strategies for inserting segments into bacterial chromosomes have been re-
ported. The aforementioned recombineering strategies could conceivably be used.
One drawback to a recombineering approach using λ Red is the specificity of target-
ing. If λ Red were to be implemented in a general system, a stretch of DNA with
sufficient homology occuring in many bacteria would have to be found. A potential
difficulty with this approach is the fact that well conserved genes are often essential.
Therefore, integration may be more or less host-specific depending on the chosen non-
essential target. If future flexibility is desired, and this specificity is not desired. One
could insert synthetic sequences into the chromosome, to serve as targets for homolo-
gous integration by λ Red, but in that case the use of a site specific recombinase would
be preferred.
In an attempt to satisfy the need for a broad host range system, elements from
the transposon Tn7 have been used. Tn7 systems are useful because they can insert
a DNA segment into a fairly well conserved attTn7 site that is present at the end of
a well conserved glmS gene (Choi et al., 2005; Choi and Schweizer, 2006b). A BLAST
(Altschul et al., 1997) search of the NCBI genome database reveals that the attTn7 site is
present in many γ-proteobacteria; other classes don’t seem to be represented. Therefore,
the advantages afforded by the Tn7 system having ready-made hosts do not extend to
many well studied bacteria.
Another method using parts of the integrative and conjugative element (ICE) clc
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from Pseudomonas knackmussii B13 has been reported (Miyazaki and van der Meer,
2013). The reasoning behind the use of an ICE clc based system to insert large DNA
sequences is that the natural element moves 103 kb of DNA through conjugation and
inserts it into an attB site at the end of the tRNAgly gene. The tRNAgly gene is not dis-
rupted by this particular recombination event, due to the sequence of the attB and attP
sites. The recombination sites’ 18 bp sequences are identical; the result of integration
is a DNA segment surrounded by direct repeats (Gaillard et al., 2006). For this reason,
the att site nomenclature is fairly misleading in the ICE clc system. As is the case with
the Tn7 attTn7 site, a BLAST search of the 18 bp sequence reveals that it is present in
many γ-proteobacteria. Some problematic behaviours of ICE clc have been observed.
ICE clc has been observed to be integrated in two separate loci and a total of up to 7
copies due to tandem integration (Ravatn et al., 1998). Tandem integration is possible
due to the identical sequence of the ICE clc att sites.
The integration of multiple Tn7 elements at one attTn7 locus has not been reported.
That occurrence is unlikely given our understanding of Tn7 transposition. The attTn7
site has a different sequence from each of Tn7L and Tn7R sites that flank the transpo-
son (Biery et al., 2000; Waddell and Craig, 1989; Arciszewska et al., 1989). Furthermore,
insertion of Tn7 into random loci is reduced by the exclusion of the tnsE gene from the
helper plasmid used by Choi et al. (2005). TnsE promotes random integration at a
low frequency whereas TnsD promotes integration at the attTn7 sequence (Waddell
and Craig, 1989). It seems that the Tn7 system is the preferable system for use in the
γ-proteobacteria.
1.5.3 In vivo Chromosome Synthesis
There have been a variety of methods proposed to build chromosomes in vivo in an
iterative way. Holt et al. (2007) proposed that a BAC library be made from partially
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digested Haemophilus influenzae genomic DNA. Then inserts would be end sequenced
and mapped to the H. influenzae genome. They selected clones to form a “minimal
tiling” that contains the whole genome with minimal overlap between clones. The
BAC containing the first clone would be propagated and the second piece of the
genome would be added on by digesting the second BAC with NotI to excise the frag-
ment, purifying the insert with pulse field gel electrophoresis, transforming into E.
coli carrying the first BAC and recombination with the first BAC via λ Red recombi-
nation. This method was not actually demonstrated, rather it was proposed as a way
to go about sequential chromosome building in vivo. A similar method was used by
Itaya et al. (2005) to clone the entire genome of Synechocystis PCC 6803 into into Bacil-
lus subtilus. The method used was called “inchworm elongation”. They used native
B. subtilus homologous recombination to integrate “landing pad sequences” into the
B. subtilus genome followed by integrating a Synechocystis genomic fragment into the
landing pad site via another homologous recombination. Then a new landing pad
sequence was integrated that was targeted to the end of the growing Synechocystis
construct, allowing for the subsequent addition of the next Synechocystis fragment tar-
geted to the last landing pad sequence. Holt’s method would have an advantage over
Itaya’s method in that it would produce no scar sequences between pieces. Another
iterative in vivo approach was demonstrated by Dafhnis-Calas et al. (2005). Their ap-
proach used the combined activity of two site-specific recombinases (Cre and ΦC31)
in DT40 chicken cells to assemble a vertibrate centromeric sequence on a human mini-
chromosome. The first plasmid, contained ΦC31 attB sites flanking a Cre loxP site and
a selectable marker. This first plasmid was integrated into a chromosomal attP locus
engineered to contain a loxP site followed by a selectable marker, followed by the attP
site. The plasmid contains the synthetic chromosome piece. When this integration oc-
cured the action of the ΦC31 integrase removed the duplicated loxP site and the initial
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chromosomal selectable marker. This leaves the chromosome ready to accept a new
synthetic chromosome piece and selectable marker. For each iteration, the two mark-
ers are alternated between the chromosome and integrating plasmid. This method
takes advantage of the efficiency of site-specific recombinases, but also leaves scars
between pieces of the assembly. These methods are scalable, and could be useful for
strain development activities, where the goal is not to build an entire chromosome,
but rather to introduce a gene cluster that exceeds the capacity of cloning vectors.
Gibson et al. (2008a) managed to assemble very large fragments in vitro but relied
on in vivo assembly via Saccharomyces cerevisiae homologous recombination to assem-
ble the four quarters into the complete Mycoplasma genitalium chromosome. Shortly
after their first publication, they showed that they could assemble the whole M. gen-
italium genome by transforming the ≈5 kb fragments they received from the DNA
synthesis companies into S. cerevisiae (Gibson et al., 2008b). The synthetic DNA frag-
ments were designed to overlap with each other and the terminal fragments were
designed to overlap with a yeast vector. Because M. genitalium grew prohibitively
slowly the group decided to continue their work using Mycoplasma capricolum and
Mycoplasma mycoides instead. Previous work at the Venter institute had already shown
that it was possible to take a purified intact M. mycoides genome, transplant that into
M. capricolum genome and change the species of the recipient cell from M. capricolum
to M. mycoides (Lartigue et al., 2007). They improved methods to purify the synthetic
DNA from S. cerevisiae and solved the restriction problems that prevented the syn-
thetic DNA from entering the recipient: M. capricolum. Recently they managed to
combine all of these methods to change the species of a recipient M. capricolum to M.
mycoides with a synthetic M. mycoides genome synthesized by homologous recombi-
nation of overlapping synthetic framgments in S. cerevisiae (Gibson et al., 2010). Their
final strategy was to assemble≈1 kb fragments to make 10 kb intermediates. The 10 kb
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intermediates were isolated from S. cerevisiae and transformed into E. coli. They were
then sequenced for quality control. Ten of the neighbouring 10 kb fragments were
then assembled in S. cerevisiae, and the process was repeated. Three stages of this as-
sembly protocol (10 kb, 100 kb and 1.09 mb) yielded a final assembled genome. There
were varying purification and error checking considerations at each stage due to the
increasing size of the molecules. The final synthetic genome was properly methylated
with M. capricolum crude extract and transplanted into M. capricolum using the estab-
lished genome transplantation method (Lartigue et al., 2007). M. mycoides cells con-
taining the synthetic genome were selected with tetracycline. The latest development
is a combination of previous accomplishments, that allows them to claim the remark-
able achievement of changing the species of a cell with a synthetic genome. Although
the work of the Venter institute is a huge technical achievement, at the time of writing,
there are no applications ready to take advantage of a fully synthetic genome.
1.5.4 Chromosome Engineering for Combinatorial Studies
Methods such as multiplex automated genome engineering (MAGE) (Wang et al.,
2009), and trackable multiplex recombineering (TRMR) (Warner et al., 2010) have been
developed to alter the E. coli genome in a massively parallel way. These methods rely
on recombination of single stranded DNA (ssDNA) into the E. coli genome via λ Red
recombination. MAGE is an automated technique that allows a large group of genes to
be targeted for combinatorial mutation to generate a diverse population of cells which
can be screened for a desirable phenotype. It involves growing the cells, inducing the
λ bet gene, washing the cells, and introducing a pool of degenerate oligonucleotides
into the cells via electroporation. The bet gene allows for the ssDNA to integrate into
the chromosomal locus it is mostly homologous to. After many rounds of this, the
population of cells is quite diverse. Wang et al. (2009) used their method to improve
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lycopene production through the DXP pathway. MAGE was subsequently improved
by using co-selection. The oligonuceotide pool was spiked with an oligonucleotide
that would cause a selectable mutation in the target host’s chromosome (prototrophy
or antibiotic resistance). Therefore, only cells that had taken up nucleic acids and
had expressed the bet gene grew into colonies. This improved the efficiency of MAGE
(Wang et al., 2012). TRMR is similar to MAGE but the oligos are barcoded so the recom-
binant genes can be identified on a microarray. The oligos are attached to a functional
sequence that serves to either upregulate or down-regulate the target gene by adding
a promoter or replacing a ribosome binding site with a poor ribosome binding site.
All of the genes are targeted at the same time in a similar protocol as MAGE. Based
on isolated phenotypic changes in certain growth conditions, inferences can be made
about the up or down-regulated genes’ functions, and certain genes can be further
targeted (Warner et al., 2010).
A notable addition to the MAGE method is CAGE: conjugative assembly genome
engineering (Isaacs et al., 2011). CAGE combined small MAGE edited regions, where
TAG stop codons were converted to TAA, into one cell. CAGE was used to change
TAG stop codons into TAA stop codons, genome wide. This was done by inserting an
oriT selectable marker cassette into a MAGE-edited cell line and using conjugation to
combine the DNA with another MAGE edited cell line. The selectable markers were
chosen wisely in order to continue this process until 32 MAGE edited segments could
be combined into one cell using conjugation.
These methods work in E. coli but it has yet to be seen how they will work in other
bacteria. Because they rely on a λ Red gene, one could speculate that these methods
would be applicable in other bacteria, but perhaps at reduced efficiency.
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1.6 This Work
The objective of this work was to develop and validate a platform for bacterial chro-
mosome engineering that could be implemented in a broad range of hosts, and to
use it for the production of mcl-PHA in Sinorhizobium meliloti. This would require a
means to assemble large fragments of DNA and a means to incorporate that DNA
into target bacteria. The general strategy was to integrate a medium-to-large insert
into the chromosome using a phage integrase system, and to subsequently assemble
those large integrated inserts by a genetic cross. I hypothesized that the expression of
Pseudomonas putida phaG and phaC genes would allow S. meliloti to produce mcl-PHA.
It was also hypothesized that the mixing of phaG and phaC homologues expressed in
the cells, would produce variation in the PHA material produced. The chromosome
engineering system was employed to test these hypotheses.
To insert relatively large pieces of DNA into the chromosome, as discussed above,
I have used the Streptomyces phage C31 (ΦC31) integrase system to insert DNA seg-
ments into the chromosomes of three α-proteobacteria (Heil et al., 2012). ΦC31 integrase
is a serine recombinase. It recombines an attB site with an attP site to create attL and
attR sites. The recombination does not reverse if gp3, the gene for recombination di-
rectionality factor (RDF) (Khaleel et al., 2011), is not expressed with the integrase gene
(int). The system is set up with two attB sites flanking a cloning site in a donor vec-
tor, and two attP flanking marker genes in the chromosome (landing pad). When the
donor vector is introduced into the recipient host along with a helper plasmid, cas-
sette exchange is catalyzed. In order to use the system in a new host it is necessary
to integrate the required attP sites and markers, i.e. the landing pad, into the chro-
mosome through another method, thereby creating a landing pad strain. A simplified
representation of this cassette exchange is shown in Figure 1.1.
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The ΦC31 integrase is functional in a broad range of cells across kingdoms of life.
It has been used in human cells (Groth et al., 2000), Drosophila melanogaster (Bateman
and Wu, 2008), and bacteria (Heil et al., 2012). It stands to reason that ΦC31 will work
in any sufficiently genetically developed bacterial background no matter its phylum.
Once the challenge of creating a landing pad strain is met, the new host becomes com-
patible with the existing vectors designed to work with the ΦC31 cassette exchange
system. There is no risk of multi-copy integration because the Int cannot cause exci-
sion on its own. The bacterial ΦC31 system can offer the benefits of the Tn7 system
for a broader range of bacterial species.
To assemble overlapping pieces of DNA that are already integrated with IMCE
(i.e. phaC or phaG homologues), a genomic conjugation strategy was attempted. This
strategy is called Recombination Synthesis (RS). In the examples of RS demonstrated
in this thesis, one IMCE insert contains a gentamicin resistance gene on its left flank
(just inside the att site) and the corresponding IMCE insert (in an isogenic background)
contains a hygromycin resistance gene on its right flank. The gentamicin IMCE insert
also contains an R388 origin of transfer (Llosa et al., 1991). R388 conjugation is used
to cross the two IMCE strains: The gentamicin strain as a donor and the hygromycin
strain as a recipient. Then a homologous recombination event (Figure 1.2) assembling
the desired construct is the likely event leading to the dual antibiotic resistance of the
transconjugants. The first application of this chromosome engineering system was to
create operons to allow S. meliloti to make mcl-PHAs. Overlapping half operons were
constructed and integrated by IMCE, and crossed using the RS system to complete the
assembly.
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Integrase-Mediated Cassette Exchange
Plasmid
Chromosome
gene
marker
attB attB
attPattP
gene
marker
attR attR
attLattL
Figure 1.1: A: Integrase mediated cassette exchange: In the presence of integrase (not
shown), recombination between attB and attP results in the exchange of marker genes
on the chromosome with the “gene(s)” on the plasmid. This leaves attL and attR sites
which are not substrates for recombination.
Figure 1.2: Recombination synthesis assembling two halves of an operon.
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1.6.1 Claims of Contributions to Scientific Knowledge
• Developed the Integrase Mediated Cassette Exchange (IMCE) system based on
the site specific recombinase from the Streptomyces phage ΦC31 that allows for
the simplified insertion of DNA constructs into engineered host strains, and 3
corresponding host strains (landing pad strains). IMCE applies bacterial conju-
gation to further simplify the integration procedure.
• Constructed the pJH110 and pJH122 IMCE donor vectors carrying a red fluores-
cent protein gene, with gentamicin resistance and hygromycin resistance respec-
tively.
• Constructed the pJH143 RIMCE donor vector with sacB, gusA, and spectino-
mycin/streptomycin resistance flanked by attL sites. It may be used to turn a
post-IMCE clone into a SacB landing pad strain.
• Developed the ability to reverse the IMCE reaction direction and its application
to change the contents of the landing pad strain to add new IMCE selection func-
tionality.
• Designed and constructed the pJH145 IMCE donor vector fosmid with inducible
high copy number, that may be used for single-copy genomic or metagenomic
libraries and to increase the utility of IMCE for use in library screening.
• Demonstrated that the conjugative transfer of genomic DNA from S. meliloti car-
rying phaG into an isogenic S. meliloti recipient results in transconjugants that
stably maintain the transferred genetic material.
• Demonstrated that the expression of phaG in S. meliloti causes the resultant colonies
to fluoresce on media containing Nile red, suggesting the accumulation of lipids.
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• Demonstrated that the addition of phaC from P. putida GPo1 and phaG from P.
putida KT2440 into the S. meliloti chromosome allows S. meliloti to create medium
chain length polyhydroxyalkanoates.
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Materials and Methods
2.1 Bacterial Strains and Plasmids
The bacterial strains used in this thesis are shown in Table 2.1. When indicated, strains
are saved in the strain collection of Trevor Charles’ laboratory. Strains were saved as
a permanent stock by mixing overnight culture in equal parts with DMSO diluted to
14% in LB media, to give a final DMSO concentration of 7%, placing the mixture in
polypropylene 2 ml vials, and storing at−75◦C. For each stock, there is an entry in the
Laboratory’s strain collection binders. The entry goes into the binder that corresponds
to the species being entered. A select group of plasmid sequences has been uploaded
to AddGene. In this case a 5 digit ID number is present in the Reference column of
Table 2.1. The plasmid information on AddGene may be accessed by adding the 5
digit ID number to the URL: “http://www.addgene.org”. For example, the URL for
pJH110 is: “http://www.addgene.org/68376/”.
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Table 2.1: Bacterial strains and plasmids
Strain or
Plasmid
Genotype or Description Freezer position Reference
E. coli DB3.1 F- gyrA462 endA1 ∆(sr1-recA)
mcrB mrr hsdS20 (rB- mB-)
supE44 ara-14 galK2 lacY1
proA2 rpsL20 (Smr) xyl-5 ∆leu
mtl-1
E. coli Box Z
Vial 10
(Bernard et al.,
1993)
E. coli
βDH10B
F- mcrA
∆(mrr-hsdRMS-mcrBC)
φ80dlacZ∆M15 ∆lacX74
endA1 recA1 deoR
∆(ara,leu)7697 araD139 galU
galK nupG rpsL λ- ∆dapA
E. coli Box U
Vial 1
(Rowe-Magnus,
2009)
E. coli DH5α F- supE44 ∆lacU169 hsdR17
recA1 endA1 gyrA96 thi-1
relA1 (Φ80lacZ ∆M15)
E. coli Box M
Vial 87
(Hanahan,
1983))
E. coli MT616 MT607 carrying mobilization
plasmid pRK600 CmR
E. coli Box A
Vial 25
(Finan et al.,
1986)
E. coli DH5α
Rif
Spontaneous rifampicin
resistant mutant of E. coli
DH5α
E. coli Box O
Vial 2
(House et al.,
2004)
E. coli EPI300 Epicentre copy control strain
contains integrated trfA; F-
mcrA ∆(mrr-hsdRMS-mcrBC)
φ80dlacZ∆M15 ∆lacX74
recA1 endA1 araD139 ∆(ara,
leu)7697 galU galK λ- rpsL
(StrR) nupG trfA dhfr.
E. coli Box Y
Vial 3
Epicentre,
Illumina Inc
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Table 2.1: Bacterial strains and plasmids
Strain or
Plasmid
Genotype or Description Freezer position Reference
S. meliloti
Rm1021
SU47 str-21 S. meliloti Box 5
Vial 48
(Leigh et al.,
1985)
S. meliloti
SmUW227
SU47 str-21
SMc04453-SMc01185::LP
S. meliloti Box
13 Vial 69
This work
S. meliloti
SmUW245
Rm1021 ∆ hsdR S. meliloti Box
13 Vial 87
This work
S. meliloti
SmUW246
SmUW227 :: rfp GmR S. meliloti Box
13 Vial 87
This work
S. meliloti
SmUW235
Rm1021 ∆phbC S. meliloti Box
13 Vial 77
Constructed by
Ricardo
Nordeste; this
work
S. meliloti
SmUW497
Rm1021 ∆(phbC phbA phbB
phaZ)
S. meliloti Box
16 Vial 95
Constructed by
Ricardo
Nordeste; this
work
S. meliloti
SmUW235
φSmUW227
Rm1021 ∆phbC
SMc04453-SMc01185::LP
S. meliloti
collection
Constructed by
Ricardo
Nordeste; this
work
S. meliloti
SmUW497 φ
SmUW227
Rm1021 ∆(phbC phbA phbB
phaZ) landing pad strain
S. meliloti
collection
Constructed by
Ricardo
Nordeste; this
work
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Table 2.1: Bacterial strains and plasmids
Strain or
Plasmid
Genotype or Description Freezer position Reference
S. meliloti
JRT15-JRT10
RS
RS strain KT2440 phaG GPo1
phaC
John Heil IMCE
RS box
This work
S. meliloti
JRT15-JRT12
RS
RS strain KT2440 phaG
phaC1400
John Heil IMCE
RS box
This work
S. meliloti
JRT16-JRT10
RS
RS strain UW4 phaG GPo1
phaC
John Heil IMCE
RS box
This work
S. meliloti
JRT16-JRT12
RS
RS strain UW4 phaG
phaC1400
John Heil IMCE
RS box
This work
S. meliloti
SmUW574
SmUW227 with LP replaced
with SacB LP
S. meliloti Box
18 Vial 6
This work
S. meliloti
SmUW579
JRT16 IMCE (SmUW584)
with pTH1227
S. meliloti Box
18 Vial 22
This work
S. meliloti
SmUW580
JRT16 IMCE (SmUW584)
with pTH1227-Gpo1-phaC
S. meliloti Box
18 Vial 23
This work
S. meliloti
SmUW581
JRT8 IMCE (SmUW582) with
pRK7813-KT2440-phaC
S. meliloti Box
18 Vial 24
This work
S. meliloti
SmUW582
JRT8 IMCE, contains KT2440
phaG ∆phbC SmUW235
landing pad background
S. meliloti Box
18 Vial 25
This work
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Table 2.1: Bacterial strains and plasmids
Strain or
Plasmid
Genotype or Description Freezer position Reference
S. meliloti
SmUW583
JRT15 IMCE, contains
KT2440 phaG with R388 oriT,
∆phbC SmUW235 landing
pad background
S. meliloti Box
18 Vial 26
This work
S. meliloti
SmUW584
JRT16 IMCE, contains UW4
phaG with R388 oriT, ∆phbC
SmUW235 landing pad
background
S. meliloti Box
18 Vial 27
This work
S. meliloti
SmUW585
JRT10 IMCE, contains GPo1
phaC, ∆phbC SmUW235
landing pad background
S. meliloti Box
18 Vial 28
This work
S. meliloti
SmUW586
JRT12 IMCE, contains
phaC1400, ∆phbC SmUW235
landing pad background
S. meliloti Box
18 Vial 29
This work
S. meliloti
SmUW587
JH151 IMCE, contains UW4
phaG GPo1 phaC, ∆phbC
SmUW235 landing pad
background
S. meliloti Box
18 Vial 30
This work,
S. meliloti
SmUW588
JH151 IMCE, contains UW4
phaG GPo1 phaC, ∆(phbC
phbA phbB phaZ) SmUW497
landing pad background
S. meliloti Box
18 Vial 30
This work
O. anthropi
ATCC 49188
wild-type isolate O. anthropi Box
1 Vial 3
(Holmes et al.,
1988)
O. anthropi
Ow0012
ATCC 49188 RifR isolate O. anthropi Box
1 Vial 19
This work
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Table 2.1: Bacterial strains and plasmids
Strain or
Plasmid
Genotype or Description Freezer position Reference
O. anthropi
Ow0013
Ow0012 ∆ampC::LP Ap
sensitive SmR SpR
O. anthropi Box
1 Vial 20
This work
O. anthropi
Ow0014
JRT15 IMCE O. anthropi Box
1 Vial 21
This work
O. anthropi
Ow0015
JRT16 IMCE O. anthropi Box
1 Vial 22
This work
O. anthropi
Ow0016
JRT10 IMCE O. anthropi Box
1 Vial 23
This work
O. anthropi
Ow0017
JRT12 IMCE O. anthropi Box
1 Vial 24
This work
A. tumefaciens
A136
Parental strain of At11142,
lacking Ti plasmid RfR
A. tumefaciens
Box 1 Vial 3
(Watson et al.,
1975)
A. tumefaciens
At11142
A136 RfR ∆tetA :: LP A. tumefaciens
Box 5 Vial 41
This work
pHS62 Source for ΦC31 integrase E. coli Box Q
Vial 91
(Thorpe and
Smith, 1998)
pRK7813 Broad host range RK2
cosmid vector, with RK2 oriT,
Tc resistance
E. coli Box A
Vial 28
(Jones and
Gutterson,
1987)
pJ23118 (part:
J23118)
rfp with constitutive
promoter from registry of
standard biological parts
UW iGEM
strain Box 1 vial
8
(Shetty et al.,
2008)
(Campbell et al.,
2002)
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Table 2.1: Bacterial strains and plasmids
Strain or
Plasmid
Genotype or Description Freezer position Reference
pMB403 plasmid containing hph
coding for hygromycin
resistance
E. coli Box R
Vial 91
(Barnett et al.,
2000)
pJET Blunt end PCR cloning kit commercial kit
Thermo Fisher
K1231
(Lubys et al.,
2007)
pJC2 pRK7813 containing ΦC31
integrase under control of lac
promoter
E. coli Box R
Vial 8
Constructed by
Dr. J. Cheng
68381
pK19mobsacB Used to create integration
vectors KmR
E. coli Box K
Vial 84
(Schafer et al.,
1994)
pK19mob Used to create integration
vectors KmR
E. coli Box L
Vial 75
(Schafer et al.,
1994)
pHP45Ω Used as source for
spectinomycin resistance
gene (aadA)
E. coli Box A
Vial 5
(Fellay et al.,
1987)
pPH1JI Source for gentamicin
resistance gene
E. coli Box A
Vial 29
(Hirsch and
Beringer, 1984)
pR751 Source for Trimethoprim
resistance gene
E. coli Box A
Vial 23
(Thorsted et al.,
1998)
pTH1227 Used as the source for uidA
ORF
E. coli Box L
Vial 77
(Cheng et al.,
2007)
pTH1703 Used as the source for gfp
reporter
E. coli Box M
Vial 83
(Cowie et al.,
2006)
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Table 2.1: Bacterial strains and plasmids
Strain or
Plasmid
Genotype or Description Freezer position Reference
pTAM Used as the source for
phaC1400
E. coli collection (Tran, 2015)
Tn5 XylE Used as the source for xylE
reporter
E. coli Box D
Vial 48
(de Lorenzo
et al., 1990)
pMB403 Used as a source of hph for
Hy resistance
E. coli Box R
Vial 91
(Barnett et al.,
2000)
pMK2016 Source of Gateway
Destination for subcloning
E. coli Box P
Vial 63
(House et al.,
2004)
pKD46 λ Red helper plasmid E. coli Box R
Vial 27
(Datsenko and
Wanner, 2000)
pJC8 lac35
clone
Test clone for Gateway
recombination
E. coli Box S
Vial 39
J Cheng, pJC8
genbank
accession
KC149513.1
pXINT129 In vivo Gateway
recombination recombinase
expression plasmid
personal box (House et al.,
2004)
pJET-gp3 RDF clone source from Calos
Lab
personal box (Farruggio
et al., 2012)
pCC1fos Fosmid vector with copy
control from Epicentre kit
Pure DNA from
kit
Illumina Inc.
pSU711 R388 self-mobilizing
plasmid: used as mobilizer
and R388 oriT source
E. coli Box T
Vial 7
(Francia et al.,
1993)
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Table 2.1: Bacterial strains and plasmids
Strain or
Plasmid
Genotype or Description Freezer position Reference
pJH101 pK19mobSacB containing
EcoRI-SmaI fragment
generated by PCR of Rm1021
intergenic region
intermediate
that was not
saved
This work
pJH102 pK19mobSacB containing
EcoRI-SmaI and SphI-HindIII
fragments generated by PCR
of Rm1021 intergenic region
E. coli Box Q
Vial 94
This work
pJH103 pJH102 with cloned
uidA-attP fragment
intermediate
that was not
saved
This work
pJH104 pJH103 with cloned
aadA-attP fragment
E. coli Box R
Vial 12
This work
68384
pJH106 pK19mobSacB containing
dhfr attB fragment
E. coli Box R
Vial 10
This work
pJH107 pK19mobSacB containing
aacC1 attB fragment
E. coli Box R
Vial 11
This work
pJH108 pK19mobSacB containing an
attB fragment
E. coli Box R
Vial 26
This work
pJH109 pJH106 containing rfp-attB
fragment
E. coli Box R
Vial 50
This work
pJH110 pJH107 containing rfp-attB
fragment
E. coli Box R
Vial 42
This work
68376
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Table 2.1: Bacterial strains and plasmids
Strain or
Plasmid
Genotype or Description Freezer position Reference
pJH113 pk19mobSacB containing O.
anthropi ∆ampC construct
(EcoRI-PstI) EcoRI-PstI
E. coli Box R
Vial 43
This work
pJH115 pJH113 containing Landing
Pad sequence from pJH104
(PacI)
E. coli Box R
Vial 44
This work
pJH116 pUC57 with GmR FRT attB
(side project)
E. coli Box R
Vial 64
This Work
pJH117 pUC57 with TpR FRT attB
oriT (side project)
E. coli Box R
Vial 65
This Work
pJH118 pk19mobsacB with A.
tumefaciens C58 ∆tetA
(EcoRI-PstI)
E. coli Box R
Vial 66
This Work
pJH119 pJH118 containing Landing
Pad sequence from pJH104
(PacI)
E. coli Box R
Vial 87
This Work
pJH121 GmR attB donor vector with
Gateway destination
E. coli Box S
Vial 14
This Work
68378
pJH122 HyR attB donor vector with
rfp stuffer
E. coli Box S
Vial 15
This Work
68377
pJH123 HyR attB donor vector with
Gateway destination
E. coli Box S
Vial 16
This Work
68379
pJH124 HyR attB donor vector with
Gateway destination in
opposite orientation
E. coli Box S
Vial 17
This Work
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Table 2.1: Bacterial strains and plasmids
Strain or
Plasmid
Genotype or Description Freezer position Reference
pJH127 NmR attB in pUC57 (IMCE
donor vector for RS selection
with Nm)
E. coli Box S
Vial 86
This Work
pJH141 in
βDH10B
for rIMCE, integrase and
RDF expression plasmid
E. coli Box U
Vial 50
This work
68383
pJRT1 for PHA gene RS, upstream
construct: Ptac lacIq, 3′
truncated gfp in
pk19mobsacB (Schafer et al.,
1994)
E. coli Box S
Vial 42
This work
pJRT2 for PHA gene RS,
downstream construct: 5′
truncated gfp, xylE in
pk19mobsacB (Schafer et al.,
1994)
E. coli Box S
Vial 43
This work
pJRT8 JRT1 construct in pJH110
(SphI) with P. putida kt2440
phaG (PacI–PmeI)
E. coli Box S
Vial 44
This work
68385
pJRT9 JRT1 construct in pJH110
(SphI) with P. putida UW4
phaG (PacI–PmeI)
E. coli Box S
Vial 45
This work
68386
pJRT13 JRT1 markers in pJH110
(SphI)
E. coli Box S
Vial 46
This work
pJRT14 JRT2 markers in pJH1122
(SphI)
E. coli Box S
Vial 47
This work
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Table 2.1: Bacterial strains and plasmids
Strain or
Plasmid
Genotype or Description Freezer position Reference
pJRT10 P. putida gpo1 phaC in pJRT14
(PacI–PmeI)
E. coli Box Z
Vial 5
This work
68387
pJRT11 S. meliloti Rm1021 phaC in
pJRT14 (PacI–PmeI) note:
that this was derived from a
synthetic clone, that turned
out to be truncated, and
therefore was not used
E. coli Box Z
Vial 6
This work
pJRT12 phaC 1400, engineered phaC
from Tam Tran in pJRT14
(PacI–PmeI)
E. coli Box Z
Vial 7
This work
68388
pJRT15 R388 oriT added to pJRT8
(JRT1 construct in pJH110
(SphI) with P. putida kt2440
phaG (PacI–PmeI)
E. coli E. coli
Box Z Vial 8
This work
68389
pJRT16 R388 oriT added to pJRT9:
JRT1 construct in pJH110
(SphI) with P. putida UW4
phaG (PacI–PmeI)
E. coli E. coli
Box Z Vial 9
This work
68390
pk19attlsac attlsac fragment cloned into
pk19mob as a HindIII EcoRI
fragment
personal box This work
pJH145 Mobilizable IMCE fosmid
with copy control in EPI300
E. coli Box W
Vial 75
This work
68380
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Table 2.1: Bacterial strains and plasmids
Strain or
Plasmid
Genotype or Description Freezer position Reference
pJH143 RIMCE donor vector
containing containing SacB
landing pad sequence
E. coli Box Y
Vial 98
This work
68382
pJH146 pJET PHA operon clone
KT2440 phaG GPo1 phaC
E. coli Box y
Vial 99
This work
pJH147 pJET PHA operon clone
KT2440 phaG phaC1400
E. coli Box Y
Vial 100
This work
pJH148 pJET PHA operon clone UW4
phaG GPo1 phaC, clone 1
E. coli Box Z
Vial 01
This work
pJH149 pJET PHA operon clone UW4
phaG GPo1 phaC, clone 3
E. coli Box Z
Vial 02
This work
pJH150 pJET PHA operon clone
UW4 phaG GPo1 phaC, clone
displaying GFP
E. coli Box Z
Vial 03
This work
pJH151 pJH110 PHA operon
sub-clone from pJH148
E. coli Box Z
Vial 4
This work
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2.2 Oligonucleotides
The oligonucleotides used in this thesis are shown in Table 2.2. Oligonucleotides were
synthesized by various third party suppliers. Upon arrival they were resuspended in
2 mM Tris-HCl pH 8.0 to a concentration of 100 µM. For use they were further diluted
to 10 µM in the same solvent. All oligonucleotides were stored at −20◦C.
Table 2.2: Oligonucleotides
Name Sequence Function
L fwd EcoRI ATAGAATTCCTTTCTCAAGAAACGCATCG clone L homo for
pK19
L-rev 2 PacI SmaI TCACCCGGGTTAATTAAGTAGGAGCGGC-
GATGCTG
clone shortened L-
homo
R fwd PacI SphI AGCGCATGCTTAATTAAGCCAAGCGCAG-
GGATGACGATA
clone R homo add
PacI site
R rev HindIII TAAAAGCTTCGCAGGTGAGATGGGCATGT clone R-homo for
pK19
GmR fwd ACTGCATGCCGCACACCGTGGAAACGGAT for creation of
pJH110
GmR rev AAGAAGCTTGTGCCAGGGCGTGCCCTTGG-
GCTCCCCGGGCGCGTGAAATAAGTGGCT-
GCGCGC
for creation of
pJH110
TpR fwd ACTGCATGCGAACCCAGTTGACATAAGC-
CTGTT
for creation of
pJH109
TpR rev AAGAAGCTTGTGCCAGGGCGTGCCCTTGG-
GCTCCCCGGGCGCGGGCTTGAGCGCTGA-
GCGGTG
for creation of
pJH109
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Table 2.2: Oligonucleotides
Name Sequence Function
GW DS fwd AATGCATGCGATTCCCTTTGTCAACAGCA-
ATG
For creation of
Gateway compati-
ble ABCDE donor
vectors, not used
GW DS rev ACTGCATGCGTGCCAGGGCGTGCCCTTGG-
GCTCCCCGGGCGCGCAGCAATGGATATC-
AACCACTTTG
For creation of
Gateway compati-
ble ABCDE donor
vectors, not used
GW US fwd AATGCATGCGTGCCAGGGCGTGCCCTTGG-
GCTCCCCGGGCGCGGATTCCCTTTGTCAA-
CAGCAATG
For creation of
Gateway compati-
ble ABCDE donor
vectors, not used
GW US rev ACTGCATGCCAGCAATGGATATCAACCA-
CTTTG
For creation of
Gateway compati-
ble ABCDE donor
vectors, not used
attP-aadA-F SmaI ATACCCGGGCCCCAACTGGGGTAACCTTT-
GAGTTCTCTCAGTTGGGGGCATGCCCGTT-
CCATACAGAAG
for creation of
pJH104
aadAR XbaI GGGTCTAGATTATTTGCCGACTACCTTGGT for creation of
pJH104
gusA-F SalI GGGGTCGACGAGGAGTCCCTTATGTTACG-
TC
for creation of
pJH104
gusA-attP-R SphI ATAGCATGCCCCCAACTGGGGTAACCTTT-
GAGTTCTCTCAGTTGGGGGTCATTGTTTGC-
CTCCCTGCT
for creation of
pJH104
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Table 2.2: Oligonucleotides
Name Sequence Function
INT-F ATACTGCAGTGATTGATTGAGGAGAACA-
GCTATGGACACGTACGCGGGTGCT
For creation
of pJC2 IMCE
integrase plasmid
INT-R GGGGGATCCTTAGGCTAACTAACTAAACC-
G
For creation
of pJC2 IMCE
integrase plasmid
US XbaI RFP attB F ACTTCTAGAGGTGCCAGGGCGTGCCCTTG-
GGCTCCCCGGGCGCGGCATGCTTGACGGC-
TAGCTCAGTCCTAG
for construction of
pJH110
US PstI RFP R CATCTGCAGCGATCTACACTAGCACTATC-
AGC
for construction of
pJH110
DS RFP F TTGACGGCTAGCTCAGTCCTAG changed plans, not
used
DS RFP attB R GGTGCCAGGGCGTGCCCTTGGGCTCCCCG-
GGCGCGGCATGCCGATCTACACTAGCACT-
ATCAGC
changed plans not
used
ampC US F EcoRI ATTGAATTCCCCACTATGCTGGCATTCCG For creation of
pJH115
ampC US R XO AAAAAAGAACCCCGGAAAATCC For creation of
pJH115
ampC DS F XO CGGATTTTCCGGGGTTCTTTTTTAATTAAA-
GATAAATAAACCTCATGATTATG
For creation of
pJH115
ampC DS R PstI ATTCTGCAGCAGGTCGATGAACGGGTAG For creation of
pJH115
US tetA EcoRI CATGAATTCTTTCAAGAGCTTTTGCAAGC-
AG
For creation of
pJH118
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Table 2.2: Oligonucleotides
Name Sequence Function
US tetA R XO CGTCCGGAGTCTTAATTAAGGTATGGCAT-
CCCTATAAAGC
For creation of
pJH118
DS tetA F XO GATGCCATACTTAATTAAGACTCCGGACG-
TCATGCGCC
For creation of
pJH118
DS tetA R PstI CATCTGCAGCGGTATTATCATTGGGAAAC For creation of
pJH118
hph red 1a F TAACGCTGATAGTGCTAGTGTAGATCGCT-
GCAGGCATGCGAATTACCACAGCAATGA-
CAAAG
for Λ red recombi-
nation of hph into
pJH110 to create
pJH122
hph red 2a R GGCTGCGCGCATAAAGCGGGTGATGGGA-
CTAACGCCTGACTAGTAACATAGATGAC-
ACC
for Λ red recombi-
nation of hph into
pJH110 to creat
pJH122
hsdR US F EcoRI ATTGAATTCATGCCCAACCTAAACACAGG-
TATC
for assembly
PCR and cloning
homology for
Sinorhizobium
meliloti hsdR
deletion
hsdR US R XO TGGAAGCCAAAGTCTATTCCGCAGCCTCG-
GCAAAG
for assembly
PCR and cloning
homology for
S. meliloti hsdR
deletion
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Table 2.2: Oligonucleotides
Name Sequence Function
hsdR DS F XO TGCGGAATAGACTTTGGCTTCCAGTCTCC-
CCG
for assembly
PCR and cloning
homology for
S. meliloti hsdR
deletion
hsdR DS R PstI ATTCTGCAGGCAAAGCAGCCAAGCCCGGT for assembly
PCR and cloning
homology for
S. meliloti hsdR
deletion
GFPstart-F PmeI XbaI CATTCTAGAGTTTAAACGATCTGATTGAT-
TGAGGAGATTAATAATG
for PHA half
operon cloning
GFPstart-R SphI EcoRI CATGAATTCGCATGCCTTTCGAAAGGGCA-
GATTG
for PHA half
operon cloning
GFPend-F PstI SphI CATCTGCAGGCATGCGCACAAATTTTCTG-
TCAGTGGAG
for PHA half
operon cloning
GFPend-R PacI XbaI CATTCTAGATTAATTAACATCGGATCTCA-
TTATTTGTAGAGC
for PHA half
operon cloning
GPO1-F PacI CATTTAATTAAGCTAGGAGTCCCTTATGT-
CC
for PHA half
operon cloning
GPO1-R PmeI CATGTTTAAACTCATCAGTGGTGGTGGTG-
GTG
for PHA half
operon cloning
XylE/T-F PmeI XbaI CATTCTAGAGTTTAAACCATCACCCAGAG-
CTGTTGGGGGA
for PHA half
operon cloning
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Table 2.2: Oligonucleotides
Name Sequence Function
XylE/T -R SphI EcoRI CATGAATTCGCATGCCTCTGCAATAAGTC-
GTACCGGAC
for PHA half
operon cloning
lactac-F PstI SphI CATCTGCAGGCATGCGAATGGTGCAAAA-
CCTTTCGC
for PHA half
operon cloning
lactac-R PacI XbaI CATTCTAGATTAATTAAGCTCGTATAATG-
TGTGGAATTG
for PHA half
operon cloning
phaG-F PacI CATTTAATTAACTAGGAGTCCCTTATGAG-
GCCAGAAATCGCTGTAC
for PHA half
operon cloning,
kt2440 phaG
phaG-R PmeI HIS CATGTTTAAACTCATCAGTGGTGGTGGTG-
GTGGTGGATGGCAAATGCGTGCTGCCCCT-
GCTG
for PHA half
operon cloning
kt2440 phaG
phbC-F PacI CATTTAATTAACAGAGCTAGGAGTCCCTT-
ATG
for PHA half
operon cloning
phbC -R PmeI CATGTTTAAACTCATCAGTGGTGGTGGTG-
GTG
for PHA half
operon cloning
phaGUW4-F PacI CATTTAATTAACTAGGAGTCCCTTATGAG-
GCCAGAAATCGCTGTG
for PHA half
operon cloning
phaGUW4-R PmeI HIS CATGTTTAAACTCATCAGTGGTGGTGGTG-
GTGGTGAAGTGCCAATGCATGGTGGTCC
for PHA half
operon cloning
phaC1400-F PacI(2) CATTTAATTAAAGGAGTCCCTTATGTCGA-
AC
for PHA half
operon cloning
phac1400-R PmeI(2) CATGTTTAAACCAGTCGTTGCGCTGCAG for PHA half
operon cloning
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Table 2.2: Oligonucleotides
Name Sequence Function
attLsac F CATAAGCTTGTGCCAGGGCGTGCCCTTGA-
GTTCTCTCAGTTGGGGGGGATCGATCCTTT-
TTAACCCATCAC
For construction of
sacB landing pad
R388 F attB XbaI TCTAGAGGTGCCAGGGCGTGCCCTTGGGC-
TCCCCGGGCGCGCCGCCTCGTCCTCCAAA-
AGTG
For cloning the
R388 oriT
R388 SalI R ACATGTCGACCTCATTTTCTGCATCATTGT-
AGCAC
For cloning the
R388 oriT
attLsac R CATGAATTCGTGCCAGGGCGTGCCCTTGA-
GTTCTCTCAGTTGGGGGGTTTAAACGTTG-
GGCGTCGCTTGGTCGGTC
For construction of
sacB lanidng pad
gusspec F CATGTTTAAACCATGCCCGTTCCATACAG-
AAG
For construction of
sacB landing pad
gusspec R CATGTTAAACTCATTGTTTGCCTCCCTGCT-
G
For construction of
sacB landing pad
RDF fix F CATGGATCCAGGAGAACAGCTATGGCGA-
AGCGTTCGATC
For construction of
rIMCE recombina-
tion plasmid
RDF fix R CATGGATCCCTAGTCGGCAATCGCGTCGT-
TG
For construction of
rIMCE recombina-
tion plasmid
Gm-rev CGACCCAAGTACCGCCACC For colony PCR to
verify IMCE and
screen for orienta-
tion
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Table 2.2: Oligonucleotides
Name Sequence Function
Hy-fwd GCGCGCGGTGTCATCTATGTTAC For colony PCR to
verify IMCE and
screen for orienta-
tion
RDF-fix F CATGGATCCAGGAGAACAGCTATGGCGA-
AGCGTTCGATC
For cloning ΦC31
RDF to create
pJH141
RDF-fix R CATGGATCCCTAGTCGGCAATCGCGTCGT-
TG
For cloning ΦC31
RDF to create
pJH141
attlsac F CATAAGCTTGTGCCAGGGCGTGCCCTTGA-
GTTCTCTCAGTTGGGGGGGATCGATCCTTT-
TTAACCCATCAC
For SacB landing
pad construction
attLsac R CATGAATTCGTGCCAGGGCGTGCCCTTGA-
GTTCTCTCAGTTGGGGGGTTTAAACGTTG-
GGCGTCGCTTGGTCGGTC
For SacB landing
pad construction
gusspec F CATGTTTAAACCATGCCCGTTCCATACAG-
AAG
For SacB landing
pad construction
gusspec R CATGTTAAACTCATTGTTTGCCTCCCTGCT-
G
For SacB landing
pad construction
KL12-F CCTAAGCTTTCGGTCTTGCCTTGCTCGTCG-
G
For cloning RK2
oriT to construct
pJH145
KL13-R CCTAAGCTTGCGCTTTTCCGCTGCATAAC-
CC
For cloning RK2
oriT to construct
pJH145
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Table 2.2: Oligonucleotides
Name Sequence Function
attBfos-F GTGACGCGCCCGGGGAGCCCAAGGGCAC-
GCCCTGGCACGGATCCTCTAGAGTCGACC-
TGCAG
For creating
pJH145
attbfos-R GTGCGCGCCCGGGGAGCCCAAGGGCACG-
CCCTGGCACGGATCCCCGGGTACCGAGCT-
CG
For creating
pJH145
gfpXO-41-F GCCCGAAGGTTATGTACAGG For direct genomic
sanger sequencing;
designed with
primer3 (Un-
tergasser et al.,
2012)
gfpXO-313-F TAGCATCACCTTCACCCTCTC For direct genomic
sanger sequencing;
designed with
primer3 (Un-
tergasser et al.,
2012)
gfpXO-691-R CTTTTCGTTGGGATCTTTCG For direct genomic
sanger sequencing;
designed with
primer3 (Un-
tergasser et al.,
2012)
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Table 2.2: Oligonucleotides
Name Sequence Function
gfpXO-755-R GCTCATCCATGCCATGTGTA For direct genomic
sanger sequencing;
designed with
primer3 (Un-
tergasser et al.,
2012)
gfp-junction-R GTAAGCTTTCCGTATGTAGCATCA For direct genomic
sanger sequencing;
designed with
primer3 (Un-
tergasser et al.,
2012)
phaG gfp F SphI GCATGCGAATGGTGCAAAACCTTTCGCGG For in vitro assem-
bly and cloning of
PHA half operons
phaG gfpR XO CTTTCGAAAGGGCAGATTGTGTC For in vitro assem-
bly and cloning of
PHA half operons
phaC gfpF XO GCACAAATTTTCTGTCAGTGGAG For in vitro assem-
bly and cloning of
PHA half operons
phaC gfpR SphI GCATGCCTCTGCAATAAGTCGTACCGGAC For in vitro assem-
bly and cloning of
PHA half operons
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2.3 Bacterial Culture and Microbiological Techniques
Bacterial strains were cultured in liquid media that was aerated on a shaker at 150
rpm at the desired growth temperature: 37◦C for Escherichia coli strains and 30◦C for
Sinorhizobium meliloti, Ochrobactrum anthropi, and Agrobacterium tumefaciens. Bacterial
strains were also cultured on plates solidified with 1.5% agar (Bio Basic bacteriological
grade). Plates were incubated at the desired temperature: 37◦C for E. coli strains and
30◦C for S. meliloti, O. anthropi, and A. tumefaciens.
Strains containing plasmids were cultured with the appropriate antibiotic(s) in the
media to provide selective pressure for plasmid maintenance.
2.3.1 Bacterial Growth Media
Growth media was sterilized by autoclaving at 121◦C (103 kPa in addition to atmo-
spheric pressure) for 20 minutes. Heat-labile media components, such as antibiotics
were filter sterilized (0.22 µm filter), or sterilized by dissolution in an organic solvent.
Heat labile substances were added when media was cool (liquid media), or just before
plates were poured (agar media). Agar media was solidified with 1.5% bacteriological
grade agar (Bio Basic, Markham ON)
The complex media used for E. coli, A. tumefaciens, O. anthropi, and sometimes
S. meliloti was lysogeny broth (LB) (Lennox, 1955). S. meliloti was often grown on
tryptone yeast (TY) complex media (Beringer, 1974). S. meliloti was also grown on
LB supplemented with 2.5 mM MgSO4 and 2.5 mM CaCl2; this media is referred to as
LBmc (Finan et al., 1984). To promote the accumulation of polyhydroxyalkanoates and
a mucoid colony appearance, S. meliloti was grown on yeast extract mannitol media
(Vincent, 1970). For electroporation, and sometimes for CaCl2 transformation, super
optimal broth with catabolite repression (SOC) (Hanahan, 1983) was used to revive
cells before plating.
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Antibiotics were obtained from Bio Basic (Markham ON) as a pure powder. The
powder was dissolved in a suitable solvent to make a 1000 times concentrate stock
solution.
For E. coli, antibiotics were used at the following concentrations in µg/ml in agar
solidified media, or half the stated concentration in liquid media: kanamycin sulfate,
25; gentamicin sulfate, 25: hygromycin B, 50; tetracycline hydrochloride, 10; ampicillin
sodium salt, 100; rifampicin, 50; spectinomycin dihydrochloride, 50; streptomycin sul-
fate, 100; chloramphenicol, 12.5 for pCC1fos selection, or 25 otherwise.
For S. meliloti, antibiotics were used at the following concentrations in µg/ml in
agar solidified media, or half the stated concentration in liquid media: neomycin sul-
fate, 200; gentamicin sulfate, 25 to 50; Hygromycin B, 50; tetracycline hydrochloride,
10; rifampicin, 50; spectinomycin dihydrochloride, 100; streptomycin sulfate, 200.
For A. tumefaciens, antibiotics were used at the following concentrations in µg/ml
in agar solidified media, or half the stated concentration in liquid media: gentamicin
sulfate, 25, hygromycin B, 200; tetracycline hydrochloride, 10; rifampicin, 50; specti-
nomycin dihydrochloride, 100; streptomycin sulfate, 200.
For O. anthropi, antibiotics were used at the following concentrations in µg/ml in
agar solidified media, or half the stated concentration in liquid media: gentamicin
sulfate, 25; hygromycin B, 200; rifampicin, 50; spectinomycin dihydrochloride, 100;
streptomycin sulfate, 200.
5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside (X-gal) was dissolved at 50 mg/ml
in dimethylformamide (DMF) and added to media at one µl per ml to give a final
concentration of 50 µg/ml. 5-Bromo-4-chloro-3-indolyl-β-D-glucuronide (X-gluc) was
weighed out for the desired amount of media, to give a final concentration of 100-200
µg/ml. The weighed out x-gluc was dissolved in an 0.5-1 ml of dimethyl sulfoxide
(DMSO) and all of the solution was added to the agar media. X-gal and X-gluc were
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purchased from Gold Biotechnology USA.
2.3.2 Preparation of Bacterial Frozen Stocks
Cultures were grown in the appropriate growth media. The culture was mixed in a
1:1 ratio in a cryogenic storage vial with an LB media solution containing 14% DMSO.
The vial was stored at −75◦C.
2.4 ΦM12 Transductions
ΦM12 bacteriophage was used to transduce mutations linked to a selectable marker
between Sinorhizobium meliloti backgrounds (Finan et al., 1984).
2.4.1 Preparation of ΦM12 Phage Lysates
Mutants to be transduced were subcultured in LBmc and incubated at 30◦C with shak-
ing to produce actively growing cultures. When the cultures reached early log phase
(OD600 of 0.4), 50 µl of an Rm1021 lysate was added. The infected cultures were left
to incubate under the same conditions for a period of 6 hours to overnight. After
infection, the cultures appeared clear indicating cell lysis had occurred. 100 µl of chlo-
roform was added to each lysate to prevent regrowth of surviving bacterial cells. To
pellet any cell debris and chloroform, the lysates were centrifuged at 5000 x g in a
benchtop centrifuge in 15 ml conical centrifuge tubes. The lysates were either used
immediately or stored at 4◦C
2.4.2 Determining Titer of ΦM12 Phage Lysates
Ten-fold serial dilutions of the phage lysates were made by diluting 10 µl of phage in
90 µl of TY media. To ensure proper mixing, the liquid was pipetted up and down 20
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times following each new dilution. The vortexer was not used, because vortexing can
cause destruction of the phage.
Dilutions from 10−6 to 10−12 were added to a cool but still liquid 0.7% LBmc agar
overlay along with 50 µl of saturated Rm1021 culture. The overlay was poured onto
LBmc agar plates. The plates were incubated for 1-2 days until plaques were visible.
The titer was determined by multiplying the number of plaques on a plate by the
dilution factor of the counted plate. The number of colonies on a 10−10 plate would
be multiplied by 1010.
2.4.3 Transduction
Transduction was carried out by adding 200 µl of mid-log phase recipient culture to
200 µl of phage lysate diluted in LBmc media. The amount of lysate used is based
on the titer of the lysate, and the titer of the cells. The dilution is chosen to give a
multiplicity of infection (MOI) of 0.5. The recipient culture and the phage are incu-
bated together for 30 minutes so that the phage particles could adsorb to the cells.
The cells were then washed 3 times in 1 ml 0.85% NaCl solution to dilute cations and
wash away unbound phage. After washing, the cells were plated on the appropriate
selective media, which was LB (due to its lack of calcium and magnesium) with the
appropriate antibiotic for selection of the marked mutation being transferred.
2.5 Triparental Mating
Preparation of Culture
Cultures of the donor strain, recipient strain, and mobilizer strain were prepared by
inoculating a single colony in 3-5 ml of LB media. Antibiotics were added to the media
for plasmid maintenance (Table 2.1. Concentrations are found in section 2.3.1. Growth
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conditions are found in Section 2.3.
Mating
Once cultures were grown, 1.5 ml of culture was removed and washed 2 times in
sterile 0.8% NaCl. The pellet was then resuspended in 100 µl of sterile 0.85% NaCl. To
10 µl of resuspended culture was then spotted on a TY agar plate. These spots served
as negative controls. The triparental mating was prepared by adding 40 µl of all three
resuspended cultures into a sterile 1.5 ml tube and mixing. Then the mixture was
spotted on a TY agar plate. The spots were dried on the plate(s) by leaving the plate
open in a laminar flow hood. The plate(s) were incubated at 30◦C for 16-20 hours.
Selection
After the incubation, the control spots were streaked on selective media containing
antibiotics that were counterselective against donor and recipient, therefore selective
for transconjugants. The triparental mating spot was also streaked on the same media.
One quarter to one half of the triparental mating spot was resuspended in 0.85% NaCl
and a 10 fold dilution series to 10−7. Typically this was done by diluting 10 µl of cul-
ture into 90 µl of 0.85% NaCl. 40 µl of each dilution, 10−2-10−6, was spread plated on
media selective for transconjugants; 40 µl of each dilution 10−4-10−7 on media selec-
tive for recipients and transconjugates. Plates were then incubated at the appropriate
temperature for the appropriate time (section 2.3).
2.6 Plasmid Construction with λ Red Recombineering
The plasmids pKD46 (Datsenko and Wanner, 2000) (to express λ exo, bet, gam genes
required for recombination) and the target plasmid were introduced into Escherichia
coli DH5α by transformation into calcium chloride competent cells. A segment of DNA
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for insertion into the target plasmid was amplified by PCR. This insert DNA had 40
base pairs of homology for the target plasmid added to each end. The PCR product
was purified by absorption and elution using a silica gel spin column.
The strain containing the target plasmid and pKD46 was grown in 5 ml of LB media
containing the relevant antibiotics. The culture was prepared for electroporation by 3
times washing in ice cold sterile 10% glycerol. The cell pellet was then resuspended in
200 µl of 10% glycerol. The purified insert DNA was electroporated into the prepared
cells containing the target plasmid and pKD46. Electroporation was done in a 0.1
cm gap electroporation cuvette (Bio-Rad Laboratories Inc.). A voltage of 1 kV was
applied using a Bio-Rad micropulser electroporation machine (Bio-Rad Laboratories
Inc.). SOC media containing 10 mM L-arabinose was used to rescue cells. Arabinose
was used to induce the genes on pKD46. The rescued cells (in SOC 10% L-arabinose)
were incubated at 30◦C for 2 hours. pKD46 replication is temperature sensitive. The
electroporated cultures were then plated on media containing appropriate antibiotics
for selection. In the case that the insert was an antibiotic resistance gene: the antibiotics
for the backbone resistance and the insert resistance. The plates were incubated for 16-
20 hours at 30◦C. Colonies were evaluated for the expected phenotype.
2.7 Molecular Cloning Techniques
2.7.1 DNA Ligation
The cut DNA fragments were purified. Usually a gel extracted insert was used with
a gel extracted vector, especially for double digest cloning steps. If the concentration
of the DNA fragment solutions was below 10 ng/µl, then they were concentrated in
a SpeedVac concentrator (Savant, Thermo Fisher Scientific Inc), such that the ligation
reaction would fit in a small volume (10-20 µl). 50-100 ng of vector DNA was added to
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the tube, a corresponding amount of insert DNA was added. The insert DNA amount
was calculated to give the desired molar ratio of insert to vector (commonly 1:1, 3:1,
5:1). Next 1/10 volume of the final volume of 10x ligase buffer was added (Thermo
Fisher Scientific Inc). Water was added to bring the volume to 0.5 µl below the final
volume. Finally, 0.5 µl of T4 DNA ligase at 5 Weiss units/µl (Thermo Fisher Scientific
Inc) was added. The tube was flicked to mix, and quickly centrifuged to collect the
liquid at the bottom of the tube. Then the tube was incubated at room temperature for
30 minutes to overnight.
2.7.2 Agarose Gel Electrophoresis
Agarose gel electrophoresis was used to analyze the size and condition of DNA frag-
ments from a variety of processes. Routine agarose gel electrophorsis was done using
a 0.8-1% agarose gel, that was made in 1 times Tris-Acetate-EDTA (TAE) buffer. The
running buffer was also 1 times TAE. The protocol was adapted from Sambrook and
Russell (2001).
The powdered biotechnology grade agarose (Bioshop Canada) was weighed out,
and added to the TAE buffer in an erlenmeyer flask. The flask was microwaved at
max power until the liquid boiled (usually about 40 seconds). The flask was swirled
to distribute the agarose particles and microwaved again for a shorter time. The flask
was swirled until there were no more visible granules of undissolved agarose. The
agarose was then allowed to cool to 50◦C and 1 µl of 1/5 concentrate Gel Red (Biotium
Inc.) was added per 10 ml of agararose gel volume. The agarose was then cast in an
Owl gel electrophoresis system of the appropriate size. After the gel had solidified the
casting gaskets were removed and the running buffer was added. Then the comb was
removed.
The samples to be electrophoresed were prepared by adding 1/6 volumes of 6
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times concentrated loading dye to the sample.
The electrophoresis system was connected to the power supply with the black lead
connected to the terminal behind the wells, and the red lead connected to the terminal
in the direction the DNA was to run. The power supply was set at a constant voltage
such that the electric field was 7 V/cm e.g. a system that was 10 cm long from elec-
trode to electrode would be run at 70 V. The time the electrophoresis system was run
was commonly in the range of 40-50 minutes.
2.7.3 Gel Extraction
This protocol was adapted from Sambrook and Russell (2001).
Gel extraction was used to purify a piece of DNA of a particular size. An agarose
gel was prepared as stated above, but the TAE buffer also contained 1 mM guanosine
to protect the DNA from UV exposure (Gründemann and Schömig, 1996).
The desired DNA band was excised from the gel using a straight razor blade. The
mass of the excised gel was determined by weighing a 1.5 ml centrifuge tube, weigh-
ing the tube containing the excised band, and subtracting the weight of the tube. The
excised gel was assumed to have the same density of water (1 g/ml) and the volume
of the excised gel was calculated.
To dissolve the agarose 3 volumes of binding buffer were added. The composi-
tion of the binding buffer was: 140 mM 2-[N-Morpholino] ethanesulfonic acid (MES)
pH adjusted to 7.0 with sodium hydroxide; 20 mM ethylenediaminotetraacetic acid
(EDTA), and 5.5 M guanidine isothiocyanate (Gu-ITC) (Kim and Morrison, 2009).
Then the tubes were incubated at 60◦C for 5 minutes.
The dissolved agarose solution was added to a silica gel spin column (Bio Basic
Markham ON), and the solution was forced through the column by centrifugation at
max speed (typicaly 15 000 x g) for 30 seconds. The flow through was discarded. The
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column was washed with 500 µl of wash buffer (80% ethanol, 10 mM Tris-HCl pH 7.5)
by forcing the wash buffer through the column by centrifugation at 15 000 x g for 1
minute. Again the flow through was discarded. The wash step was repeated, and to
dry the column the centrifugation was repeated again once more without the addition
of wash buffer.
To elute the DNA from the column 35 µl of 2 mM tris-HCl pH 8.0 was added to
the column and allowed to incubate for 5 minutes. The column was placed in a new
collection tube and spun at 8000 x g for 1 minute. The column was discarded and the
flow through was the final purified DNA fragment.
2.7.4 Preparation of CaCl2 Competent Cells
This method was adapted from protocol manual by Sambrook and Russell (2001).
A single colony of Escherichia coli DH5α was inoculated into 3 ml of LB media
in a 16 mm test tube. The tube was incubated at 37◦C with constant shaking for 16
hours. 2-9 250 ml baffled Erlenmeyer flasks each containing 50 ml of LB media were
inoculated with 200 µl of saturated culture from the previous step. The shaker that
was available made using these types and numbers of flasks convenient. The flasks
were shaken at 37◦C until they reached an OD600 of 0.3-0.4, this took approximately 3.5
hours. The culture was decanted into 250 ml polypropylene GSA centrifuge bottle(s)
(Nalgene, Thermo Fisher Scientific Inc.). The centrifuge was balanced. The cells were
pelleted by centrifugation in a Sorval GSA rotor or equivalent (Sorval, Thermo Fisher
Scientific Inc.) at 4000 x g for 10 minutes at 4◦C. The supernatant was decanted and
the pellet was resuspended in 0.1 M MgCl2 totaling 1/3 the volume of the culture.
The cells were centrifuged again with the same settings. Note once divalent cations
were added the pellet formed mostly on the side of the bottle and not on the bottom,
so care was taken not to lose this more diffuse pellet. The pellet was resuspended in
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0.1 M CaCl2 totaling 1/5 the volume of the culture. The bottles were placed on ice
and placed in the 4◦C fridge for an overnight incubation. The cell suspension was
then moved into 40 ml oakridge tubes (Nalgene, Thermo Fisher Scientific Inc.) and
centrifuged in an SS34 rotor or equivalent (Sorval, Thermo Fisher Scientific Inc.) at
4000 x g for 10 minutes at 4◦C. The supernatant was decanted and the pellet was
resuspended in 0.1 M CaCl2 in 15% glycerol totaling 1/50 the volume of the culture.
200 µl aliquots were made by pipetting 200 µl of suspension into pre-chilled ice cold
1.5 ml microcentrifuge tubes. The aliquots were stored on ice, then flash frozen in
liquid nitrogen, and then stored at -75◦C.
2.7.5 CaCl2 Transformation
1.5 ml microcentrifuge tubes were labeled and chilled on ice. The required number
of frozen competent cell aliquots were removed from the freezer and thawed on ice.
The DNA in a 10 µl volume or less (20-100 ng for a ligation, 0.01-50 ng for supercoiled
plasmid) was added to the chilled tubes, and 100 µl of thawed ice-cold competent cells
were added and mixed with the DNA solution. The DNA cell mixture was allowed
to incubate on ice for 30 minutes. After incubation the tubes were placed into a 42◦C
water bath for 60 seconds. After 60 seconds the tubes were promptly removed and
placed back on ice for 5 minutes. After which, the cells were pelleted by spinning at
max speed in a microcentrifuge for 30 seconds. The supernatant was poured off, leav-
ing approximately 50-100 µl in the tube. The cells were resuspended in the reduced
volume and the cells were spread plated on media containing the selective antibiotic
appropriate for the plasmid. The plates were incubated at 37◦C for 16 hours.
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2.7.6 Electroporation
For the electroporation of plasmid or linear DNA, minimization of salts in both the
cell suspension and DNA solution was important. To make electrocompetent cells,
log phase cells were washed three times in sterile ice-cold 10% glycerol diluted in
deionized water. The cells were then resuspended in a volume 1/40 of the original
culture in the same ice-cold 10% glycerol. These cells could be used right away or
frozen for future use.
DNA (plasmid, linear, ligation mixture) was either ethanol precipitated or purified
using a silica gel spin column. 1-50 ng of DNA was mixed with 50 µl of electrocom-
petent cells and added to pre-chilled 0.1 cm gap electroporation cuvettes (Bio-Rad
Laboratories Inc.). Cuvettes were placed one at a time into a Bio-Rad micropulser
electroporation unit and a voltage of 1 kV was applied in a short pulse (instrument
default for ec1 setting); immediately after the voltage pulse the 1 ml of SOC media
was added slowly to the cuvette. The media was gently aspirated and dispensed once
more. The media cell suspension was allowed to sit in the cuvette at room temper-
ature until the other samples had been processed and then the cell suspension was
transferred to a sterile 1.5 ml centrifuge tube. The tubes were then incubated at 37◦C
(for Escherichia coli) for 1 hour before plating the cells on selective media. If a high
efficiency was expected, a portion of the cell suspension could be plated (50 µl of the
ml), or all of the cells could be plated by pelleting the cells and resuspending in 50 µl
of media prior to spread plating. The plates were incubated for 16-20 hours at 37◦C.
2.7.7 Restriction Enzyme Digest of DNA
DNA was restricted using fast digest restriction enzymes (Thermo Fisher Scientific
Inc.). For 1 µg of DNA, 1 µl of fast digest restriction enzyme was used. Fast digest
restriction enzymes were purchased in a concentration of 1 fast digest unit (FDU) per
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µl. An FDU was defined as the enzyme cutting 1 µg of DNA in 5 minutes. To ade-
quately dilute the glycerol contained in the enzyme storage buffer, the final volume of
the digest reaction mixture was set at greater than 10 times the volume of restriction
enzyme used. Nuclease free water was used to dilute the reaction to the final volume.
Fast digest reaction buffer was added to one tenth of the final volume.
The reactions were incubated at 37◦C for 20 minutes if large amounts of DNA
(>1µg) were being digested. For small restrictions, 5 minutes was sufficient.
2.7.8 Polymerase Chain Reaction (PCR)
High Fidelity PCR using KOD Xtreme Polymerase
The PCR amplification was assembled by adding the components in the following
table (Table 2.3) together in a thin-walled 0.2 ml tube (EMD Millipore, 2011b). The tube
was placed in a thermocycler and cycled under appropriate conditions. The extension
time for KOD Xtreme (EMD Millipore Billerica, MA, USA).
The thermal cycling protocol used was a touchdown protocol where for the first
20 cycles the annealing temperature would decrease 0.5◦C from 65◦C to 55◦C. After
that, there were 30 cycles with an annealing temperature of 50◦C. Before the first cycle
there was a 2 minute heating step at 94◦C to start the hot start polymerase. After that
a cycle was as follows: 94◦C for 30 seconds for denaturing, 50-65◦C for 30 seconds for
annealing, and 70◦C for 1 min/kb amplicon length for extension.
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Table 2.3: KOD Xtreme PCR
Volume added (µl) Reaction component
1 Forward primer
1 Reverse primer
1-5 (depends on source and concen-
tration)
Template
10 2 mM dNTPs
1.25 (optional) DMSO
25 2X Xtreme buffer
1 KOD Xtreme DNA polymerase
top up to 50 Nuclease free water
High fidelity PCR using KOD Hot Start Polymerase
Using the hot start KOD polymerase was similar to using the Xtreme polymerase with
respect to thermal cycling, except the extension time was 30 seconds per kb of ampli-
con length. The reaction components are listed in Table 2.4, and were taken from the
user manual with some modification (EMD Millipore, 2011a).
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Table 2.4: KOD Hot Start PCR
Volume added (µl) Reaction component
1 Forward primer
1 Reverse primer
1-5 (depends on source and concen-
tration)
Template
5 2 mM dNTPs
2.5 (optional) DMSO
5 10X KOD buffer
1 KOD hot start DNA polymerase
3 25 mM MgSO4
top up to 50 Nuclease free water
2.7.9 Colony PCR
Cells were picked from a single colony and resuspended in 20-30 µl of sterile Milli-
Q (Millipore Corporation) ultrapure water. 2 µl of cell suspension was spotted on
an appropriate agar plate to save the colony for future use. The cell suspension was
heated at 95◦C for 20 minutes. The suspension was then centrifuged at max speed for
1 minute to pellet cells. 8 µl of the supernatant was used as the template
The reactions were setup on ice. 8 µl of template was added to a fresh 0.2 ml thin
walled PCR tube. 1 µl of each primer (10 pmol) was added, and 10 µl of 2X Taq Master
Mix (Thermo Fisher Scientific Inc.) was added to give a final reaction volume of 20 µl.
The reactions were temperature cycled in a Bio-Rad Mycycler (Bio-Rad Laboratories
Inc). The protocol was a touchdown protocol of 50 total cycles with temperatures as
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follow: 95◦C for 1 minute; 65◦C for 30 seconds, dropped 0.5◦C each cycle for 20 cycles
then goes to 50◦C for remaining cycles; 72◦C for 1 min/kb of amplicon length; after
all cycles a final extension 72◦C for 5 minutes; then hold at 10◦C.
2.7.10 Sanger Sequencing
Plasmids for sequencing were prepared using the silica gel column protocol for minia-
ture preparation of plasmid DNA. DNA samples were sent to The Centre for Applied
Genomics (Toronto Canada) and prepared to their specifications as follows: 200-300
ng of plasmid DNA in a 7 µl volume; if the primer was included, 5 pmol of primer
with 200-300 ng of plasmid DNA in a 7.7 µl volume; for PCR products 5 ng of DNA per
100 bp of amplicon length in the same volume and primer molarity as for plasmids.
2.7.11 Genomic Sanger Sequencing
For sequencing using bacterial genomic DNA as the template, samples were sent to
the Mobix Lab at McMaster University (Hamilton Canada) and prepared to the their
specifications. The samples were prepared as follows: 5 µl of genomic DNA per sam-
ple at a concentration of 2 µg/µl; 5 µl of primer per sample was sent at a concentration
of 20 µM.
It was important to shear the genomic DNA samples to reduce their viscosity.
Sodium acetate instead of ammonium acetate was used for the ethanol precipitation
step in the genomic DNA preparation procedure because ammonium ions might have
inhibited the DNA polymerase in the sequencing reaction.
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2.8 DNA Purification
2.8.1 Purification of DNA Using a Silica Gel Column
To the DNA containing solution there was added three volumes of binding buffer con-
taining 5.5 M guanidine thiocyanate, 140 mM 2-(N-morpholino)ethanesulfonic acid
(MES) pH to 7 with NaOH, and 20 mM ethylenediaminetetraacetic acid (EDTA). The
DNA binding buffer mixture was added to a silica spin column (Bio Basic, Markham
Canada). The column was centrifuged at 15 000 x g for 1 minute. The flow through
was discarded and 500 µl of wash buffer, containing 75% ethanol and 10 mM tris-HCl
pH 7.5, was added. Centrifugation was repeated with the same settings as above. The
flow through was discarded and the wash step was repeated once more. After the
flow through of the final wash was discarded, the centrifugation was repeated once
or twice to dry the column. 35-50 µl of 2 mM tris-HCl elution buffer was added to the
column and allowed to incubate at room temperature for 2 minutes. The column was
placed in a 1.5 ml centrifuge tube and centrifuged as above. The flow through of this
step was the final product, and it was either used immediately or stored at -20◦C.
2.8.2 Ethanol Precipitation of DNA
One tenth volume of 3 M sodium acetate was added to the DNA solution. Then 2 vol-
umes of ice-cold ethanol was added. If DNA shearing was not a problem the samples
were then vortexed for 10 seconds. If DNA shearing was to be avoided the samples
were inverted gently and DNA was allowed to precipitate on ice for 20 minutes. The
samples were then centrifuged for 5-20 minutes at 17 000 x g. DNA that was smaller
in length had to be spun longer. The supernatant was discarded, and the pellet was
washed in 70% ethanol by pippetting up and down and dislodging the pellet. The cen-
trifugation was repeated. The supernatant was discarded. The pellet was dried until
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the edges were translucent and then the pellet was resuspended in 2 mM Tris-HCl pH
8.0.
2.8.3 Miniature Preparation of Bacterial Plasmid DNA
A single colony of plasmid containing Escherichia coli endA1 strain was inoculated into
3 ml of LB media in a 16 mm test tube containing the appropriate antibiotic (see 2.3.1
for concentrations). The test tube was incubated for 16 hours at 37◦C with constant
shaking at 200 rpm.
1.5 ml of culture was added to a 1.5 ml microcentrifuge tube. The cells were pel-
leted by centrifugation at 15 000 x g for 1 minute. The supernatant was decanted. For
a greater yield, the remaining 1.5 ml of culture was added and centrifuged as before.
The cell pellet was resuspended in 250 µl of buffer P1 (100 mM Tris-HCl ph 8.0, 10
mM EDTA, 100 µg/ml RNAse A). Then to lyse the cells 250 µl of buffer P2 (0.2 N
NaOH, 1% SDS) was added. The tube was inverted several times to provide gentle
mixing. The cells were allowed to lyse for 1-3 minutes. Then 350 µl of buffer N3 (4.2
M Guanidine thiocyanate, 0.9 M potassium acetate, pH to 4.8 with acetic acid) was
added. The tube was immediately inverted serveral times to ensure quick and even
neutralization. The tube was then centrifuged for 5 minutes at 15 000 x g to a silica
spin column (Bio Basic, Markham Canada). The column was centrifuged at 15 000 x g
for 1 minute. The flow through was discarded 500 and µl of wash buffer (75% ethanol
and 10 mM tris-HCl pH 7.5) was added. Centrifugation was repeated with the same
settings as above. The flow through was discarded and the wash step was repeated
once more. After the flow through of the final wash was discarded, the centrifugation
was repeated once or twice to dry the column. 35-50 µl of 2 mM tris-HCl elution buffer
was added to the column and allowed to incubate at room temperature for 2 minutes.
The column was placed in a 1.5 ml centrifuge tube, and centrifuged as above. The
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flow through of this step was the final product, and it was either used immediately or
stored at -20◦C.
2.8.4 Large Scale Preparation of Bacterial Genomic DNA for Direct
Genomic Sanger Sequencing
A single colony was inoculated into 3 ml of LB media in a 16 mm test tube. For growth
conditions and temperature see section 2.3. After this initial culture was saturated, it
was added to 200 ml of LB broth in a 1 l flask. The flask was incubated with shaking.
An overnight incubation would usually be sufficient even with more slowly growing
species.
After growth, the 200 ml culture was decanted into a 250 ml polypropylene GSA
centrifuge bottle (Nalgene, Thermo Fisher Scientific Inc.). The centrifuge was balanced
with a second sample or an identical bottle containing 200 ml of water. The cells were
pelleted by centrifugation in a Sorval GSA rotor or equivalent (Sorval, Thermo Fisher
Scientific Inc.) at 4000 x g for 10 minutes at 20◦C. The supernatant was decanted and
the pellet was resuspended in 40 ml of 10 mM Tris-HCl pH 8.0 25 mM EDTA. The
resuspended cells were transferred into a 50 ml disposable centrifuge tube (various
manufacturers: known as “falcon tubes”). The cells were pelleted by centrifugation at
6500 x g in an Eppendorf F35-6-30 rotor (Eppendorf AG). The cells were resuspended
in 15 ml of the same Tris-EDTA as above. 1.5 ml of 12.5 % SDS, 50 µl of 19 mg/ml
proteinase K, and 1.8 ml of 5 M NaCl were added. The tube was incubated at 65◦C
for 30 minutes. The tube was cooled to room temperature and 15 ml of a 1:1 phenol
chloroform mixture was added. The tube was vortexed for 15 seconds. The layers
were separated by centrifugation at 6500 x g for 5 minutes in the Eppendorf f35-6-30
rotor. Then using a 5 ml pipette the phenol-chloroform layer (bottom) was removed.
Fresh phenol-chloroform (1:1) was added, the tube vortexed and the centrifugation
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repeated. This extra step helps to denature and remove all the protein; there were
protein strands in the aqueous layer that interfered with that layer’s recovery if this
was not done. Next the aqueous layer was removed and placed into a new 50 ml
falcon tube. Then 15 ml of chloroform was added, the tube was vortexed, and the
centrifugation was repeated. The aqueous layer was then removed and placed into
a new 50 ml falcon tube. One tenth volume of 3 M sodium acetate was added (1-1.5
ml depending on recovery). 30 ml of ice cold 95% ethanol was added. The tube was
inverted. At this point DNA visibly precipitated. The DNA precipitate was removed
from the tube with a 200 µl pipette tip loaded onto a micropipettor. The DNA precipi-
tate was placed in a 1.5 ml microcentrifuge tube. The precipitate was washed 1 x with
1.5 ml of 70% ethanol. The ethanol was removed and the precipitate was allowed to
dry until the edges were translucent. The precipitate was resuspended in 400 µl of
2 mM Tris-HCl pH 8.0. 20 µl of 10 mg/ml DNAse free RNAse A was added to the
tube. The tube was allowed to incubate at 20◦C for 2 hours. The 400 µl of DNA so-
lution was split into 4 100 µl aliquots and each of them was purified as described in
section 2.8.1 except the final elution was done with 50 µl of 0.2 mM Tris-HCl pH 8.0.
After purification, the 4 tubes containing 50 µl of DNA solution were pooled into 1
tube. The DNA was quantified with a nanodrop spectrophotometer (Thermo Fisher
Scientific Inc.). The concentration and purity was noted. The absorbance at 260 nm to
280 nm ratio was typically 1.88, indicating pure DNA with little RNA or protein con-
tamination. The absorbance at 260 nm to 230 nm ratio was greater than 1.6 indicating
little contamination with choatropic salts. The DNA was then concentrated by using
the DNA speedVac concentrator (Savant, Thermo Fisher Scientific Inc). The volume
left after concentrating was estimated by trial and error with a micropipettor and the
volume was adjusted by adding 0.2 mM Tris-HCl pH 8.0 to give a final concentration
of 2 µg/µl.
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2.8.5 Miniature Preparation of Bacterial Genomic DNA
This method was adapted from the method published by Charles and Nester (1993).
A single colony was inoculated into 3 ml of LB media in a 16 mm test tube. For
growth conditions and temperature, see section 2.3. A 1.5 ml volume of culture was
decanted into a 1.5 ml microcentrifuge tube, and the cells were pelleted by centrifuga-
tion at 15 000 x g for 1 minute. The supernatant was discarded and the remaining 1.5
ml of culture was added to the tube and the tube was centrifuged again. The pellet was
washed in 1 ml 10 mM Tris-HCl pH 8.0 25 mM EDTA, then the pellet was resuspended
in 400 µl of Tris-HCl pH 8.0 with 25 mM EDTA. 40 µl of 12.5 % SDS was added; 10 µl
of 19 mg/ml proteinase K was added; 50 µl of 5 M NaCl was added. Then the tube
was incubated at 65◦C for 30 minutes. 260 µl of 7.5 M ammonium acetate was added,
and the tube was incubated on ice for 30 minutes to allow protein to precipitate. The
tube was then centrifuged for 15 minutes at 17 000 x g to pellet the protein. The su-
pernatant was saved and added to a new tube. The protein pellet was discarded. 1
volume of chloroform was added to the solution (depending on recovery from pro-
tein pellet about 700 µl). The tube was inverted for a minute to extract organic soluble
impurities. Then the tube was centrifuged for 5 minutes at 15 000 x g, to separate the
phases. The aqueous phase (top layer) was removed and added to a new tube. Then 1
volume of isopropanol was added, the tube was inverted to mix, and the tube was left
for 20 minutes for the DNA to fully precipitate. Sometimes the DNA was immediately
visible as a string-like precipitate; in those cases the DNA was immediately removed
on a pipette tip, dipped in a liberal volume (1.5 ml) of 70 % ethanol and then removed
to a clean tube to dry. When the precipitate was not so abundant, the tube was spun at
15 000 x g for 10 minutes; the supernatant was removed; the pellet was washed with
70 % ethanol and allowed to dry after the 70 % ethanol was removed. Once the DNA
precipitate was dry the pellet was resuspended in 50-200 µl of 2 mM Tris-HCl pH 8.0.
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The DNA could be used at this point for some applications. To remove RNA 1 µl of
10 mg/ml RNAse A was added. After incubation at room temperature for 20 minutes
the DNA was re-purified by ethanol precipitation (see section 2.8.2).
2.9 Southern Blotting
Reagents were purchased as part of the Roche DIG High Primer DNA Labeling and
Detection Starter Kit II. Protocols from the manual (Roche Applied Science, 2009) were
followed and are described below. Where there is a lapse in the Roche protocol, or
where it refers to standard methods, the Southern blot protocol from Current Protocols
in Molecular Biology (Brown, 2001) was used.
The solutions used were as follows.
Maleic Acid Buffer
0.1 M maleic acid, 0.15 M NaCl, adjust pH to 7.5 with solid NaOH
Washing Buffer
maleic acid buffer with 0.3% v/v Tween 20
Detection Buffer
0.1 M Tris-HCl, 0.1 M NaCl, pH 9.5
Blocking Solution
1:10 dilution of supplied blocking solution in maleic acid buffer
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Antibody Solution
1:10 000 dilution, in maleic acid buffer, of the provided anti-DIG-AP-conjugate (pro-
vided vial centrifuged at 15 000 x g for 10 minutes prior to use)
Hybridization Buffer
64 ml of water with 1 bottle of DIG Easy Hyb Granules.
20 X SSC Buffer
For 1 L: 175.3 g NaCl, 88.2 g trisodium citrate, adjust to pH 7.0 with HCl, add Milli-Q
water to 1 L, sterilized by autoclaving.
Stringency Wash 1 Buffer
2 x SSC, 0.1% SDS
Stringency Wash 2 Buffer
0.5 x SSC, 0.1% SDS
Denaturing Solution
1.5 M NaCl, 0.5 M NaOH
Neutralization solution
1.5 M NaCl, 0.5 M Tris-HCl, pH 7.0 (adjusted with HCl)
2.9.1 Creation and Quantification of DIG Labeled Probe
DNA was random primed labeled with Digoxigenin-11-dUTP by adding 30-100 ng of
template DNA to the labeling reaction. First the DNA was denatured by boiling for
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10 minutes and quickly chilling in ice-water. The volume of the DNA was adjusted
to 16 µl. 4 µl of DIG-High Prime reagent was added. The tube was then incubated
at 37◦C for 16 hours. The reaction was then stopped by adding 2 µl of 0.2 M EDTA.
The concentration of the probe was estimated from the chart provided in the manual
at 1000-1500 ng in 20 µl.
Based on the estimated concentration a sample of the probe was diluted to 1 ng/µl.
A 10-fold dilution series to 0.01 pg/µl was made. The same dilution series was made
with the provided DIG-labeled control DNA. 1 µl of each dilution was spotted on a
nylon membrane (Boehringer Mannheim, acquired by Roche). The DNA was cross-
linked to the membrane by UV-light exposure in a BioRad GS Gene Linker UV cham-
ber on the damp nylon membrane setting (150 mJoule). The membrane was then
incubated in 20 ml of maleic acid buffer on a rotary shaker for 2 minutes at 20◦C. The
membrane was incubated in 10 ml of blocking solution for 30 minutes. The membrane
was incubated in 10 ml of anti-DIG AP conjugate antibody solution for 15 minutes; the
solution was drained and then fresh solution was added for another 15 minute wash.
The membrane was washed in 10 ml of washing buffer for 15 minutes; the buffer
was drained; fresh buffer was added, and the wash was repeated. The membrane was
then equilibrated in 10 ml of detection buffer for 5 minutes. The membrane was placed
DNA side up on a plastic folder bag, 100 µl of CPSD ready to use solution was evenly
spread on the membrane, and the membrane was sealed between two plastic sheets
using the heat sealer. The membrane was then placed in a digital enhanced chemilu-
minescence (ECL) imager. A 15 minute exposure was taken. The brightness of the dots
were evaluated by eye and compared to the control to determine the concentration of
the probe.
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2.9.2 Transfer of DNA onto Membrane
The genomic DNA was isolated as described in section 2.8.5. 1-3 µg of DNA was
restricted as described in section 2.7.7. Then the restricted DNA was electrophoresed
as described in section 2.7.2 but with care to use a lower voltage than usual (1/4 to
1/2 of usual) to ensure even running. A ruler was included in the photograph of the
gel so a standard curve of band migration could be generated.
After electrophoresis was complete, the gel was prepared as follows. First, the
gel was rinsed in deionized water. Next, the gel was incubated with shaking in 10
gel-volumes of 0.25 M HCl until 10 minutes after the bromophenol blue dye from the
electrophoresis loading dye turned yellow (Brown, 2001). The gel was rinsed with
deionized water again. The gel was incubated with shaking in 10 gel volumes of
denaturing solution for 20 minutes. The solution was poured off and fresh denaturing
solution was added for another 20 minute incubation. Next the gel was incubated with
shaking as before but with 10 gel volumes of neutralization solution for 20 minutes.
This was repeated with fresh neutralization solution.
The gel was then assembled into the transfer stack. A glass casserole dish was used
to hold the liquid and the stack. Next a DNA gel casting tray was placed upside down
in the dish for use as a solid support. A piece of Whatman 3 MM chromatography
paper that was the same height as the solid support, but wider, was used as a wick.
The paper was folded under the solid support on the sides, such that the side of the
paper would be immersed in the liquid. Eight pieces of Whatman 3 MM were cut to
the exact dimensions of the gel. The Whatman 3 MM pieces were made wet with 10 x
SSC (including the wick). A piece of nylon membrane was cut to the exact dimensions
of the gel. The nylon membrane was equilibrated in deionized water. Next, four pieces
of wet Whatman 3 MM were placed on the wick covered solid support. The prepared
gel was placed on top of these. The prepared membrane was placed on top of the
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gel. The other 4 pieces of wet Whatman 3 MM were placed on top of the membrane.
a 4 cm stack of paper towels, cut to the dimensions of the gel (or slightly smaller),
was placed on top of the Whatman 3 MM sheets. A glass plate was placed on top of
the paper towels. A weight (usually an Erlenmeyer flask with water in it) was placed
on top of the glass plate. The casserole dish was filled about 2 cm deep with 10 x
SSC. The stack was wrapped with plastic food wrap to hold it together and prevent
excessive evaporation. The stack was allowed to sit for 12 hours. The next day it was
disassembled.
The membrane was placed in the DNA cross-linker and the DNA was cross-linked
by exposure to 150 mJoule of UV radiation (as above).
2.9.3 Hybridization of the Probe
The appropriate hybridization temperature Topt was determined by the following
equations where l is the length of the probe in base pairs.
Tm = 49.82 + 0.41(%GC)− (600/l)
Topt = Tm − 20
These numbers are relatively accurate when Topt is above 25◦C.
A volume of hybridization buffer (10 ml/100 cm2) was preheated to the hybridiza-
tion temperature (Topt), and added to a preheated VWR hybridization bottle with the
membrane. The bottle was placed in the hybridization oven (VWR 5400 oven, VWR
International LLC Mississauga ON). The membrane was incubated in the oven with
the hybridization buffer for 30 minutes with gentle rotation.
The DIG labeled probe was denatured by boiling for 10 minutes and quickly cool-
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ing in ice water. The probe was added to preheated hybridization buffer at a concen-
tration of 25 ng/ml. The probe solution (the probe in hybridization buffer) was mixed
well but gently to avoid bubble formation. 3.5 ml of probe solution was used to for
100 cm2 of membrane area. Before adding the preheated (to Topt) probe solution, the
prehybridization solution was poured off. The membrane was incubated with probe
solution for hybridization of the probe to the bound DNA for 16 hours at Topt.
After hybridization, The probe solution was poured off. two stringency washes
were carried out. In the first wash, 20 ml of stringency wash 1 buffer (an excess
amount; more could be used if desired) was added and the membrane was incubated
for 5 minutes at 25◦C with constant rotation. The buffer was poured off and fresh
buffer was added for another 5 minute incubation. The next stringency wash was
done in the same way but with stringency wash 2 buffer, a temperature of 68◦C, and
a time of 15 minutes for each buffer change.
2.9.4 Detection of the Probe
The membrane was rinsed for 1-5 minutes in washing buffer. Then the membrane was
incubated for 30 minutes in 100 ml of blocking solution on a rotary shaker at 20◦C. The
membrane was incubated in 20 ml of anti-DIG AP conjugate antibody solution for 30
minutes. The membrane was washed in 100 ml of washing buffer for 15 minutes. The
buffer was drained; fresh buffer was added, and the wash was repeated. The mem-
brane was then equilibrated in 20 ml of detection buffer for 5 minutes. The membrane
was placed DNA side up on a plastic folder bag. Then 500 µl of CPSD ready to use
solution was evenly spread on the membrane, and the membrane was sealed between
two plastic sheets using the heat sealer. The membrane was then placed in a digital
enhanced chemiluminescence (ECL) imager. A 15 minute exposure was taken. A ruler
was included in the photograph to locate the probed band(s) on a standard curve gen-
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erated from the DNA molecular weight standards on the original electrophoresis gel.
This was done to provide accurate sizing of the probed band(s).
2.10 β-Glucuronidase (GusA) Assay
A 3-5 ml saturated culture was prepared as described in section 2.3. The OD600 was
measured in a Spectronic 20D spectrophotometer. 100 µl of culture or 100µl of a di-
luted culture was used. 400 µl of assay buffer (0.0125% SDS, 50 mM sodium phosphate
buffer pH 7.0, 1 mM EDTA, 458 µg/ml PNPG) was added and the reaction was incu-
bated for 30 minutes at 20◦C. 500 µl of stop buffer (1 M Na2CO3) was added. The
reaction was added to a 1 ml cuvette and the absorbance at 405 nm (A405) was mea-
sured in a Pharmacia Biotech Ultrospec 2000 UV/visible spectrophotometer.
The GusA activity in Miller units (Miller, 1972) were calculated as follows. Where
t = incubation time in minutes, and v = volume in ml.
Miller Units =
1000× A405
t×OD600 × v
2.11 Sequence Alignments, Genomic and Plasmid Maps
The sequence alignments, plasmid maps, and genomic maps shown in this thesis were
created with Geneious R8 software (Kearse et al., 2012).
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Integrase Mediated Cassette Exchange
3.1 Introduction
Integrase mediated cassette exchange (IMCE) takes advantage of the site-specific in-
tegration activity of the ΦC31 integrase. This integrase is a member of the family of
large serine recombinase proteins (Leschziner et al., 1995; Thorpe and Smith, 1998).
The large serine recombinases, like other site-specific recombinases, catalyze a strand
exchange reaction between two sites of a specific DNA sequence. In the case of ΦC31
integrase attB and attP sites (34 bp and 39 bp in length, respectively) are recombined
with each other. Such recombination results in attL and attR sites, which are compos-
ites of attB and attP sites. Even in the presence of integrase, the attL and attR sites
do not recombine. Although the nomenclature used to describe the species required
for recombination is similar to the λ phage recombination system used in Gateway
technology (Katzen, 2007), the large serine recombinases differ from this system in
that they require no cofactors. They work by a concerted strand exchange mechanism
and do not go through a Holliday junction intermediate like in λ integrase recom-
bination (Gupta et al., 2007; Mumm et al., 2006). The recombination mechanism is
shown in Figure 3.2. They are considered large serine recombinases since they have
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a large carboxy-terminal domain not present in other serine recombinases. In the
case ofΦC31 integrase the carboxy-terminal domain is responsible for conferring non-
permissiveness of recombination between attL and attR (Rowley et al., 2008). To the
best of my knowledge, at the time of writing six enzymes from this family, including
ΦC31 integrase, have been characterized (Christiansen et al., 1996; Crellin and Rood,
1997; Kushtoss and Rao, 1991; Matsuura et al., 1996; Popham and Stragier, 1992; Sato
et al., 1990; Thorpe et al., 2000).
When the required att sites are in single copy, one on each DNA molecule to be
recombined, the end result of recombination is a cointegrant. This configuration mir-
rors the wild type system of the phage where the phage genome integrates into the
host genome during lysogeny. When the att sites are arranged to flank a sequence,
and the corresponding att sites are on a separate DNA molecule, the end result of a
ΦC31 catalyzed recombination between the two molecules is an exchange of the two
sequences in between the att sites. This configuration results in cassette exchange (Fig-
ure 3.3). The use of a cassette exchange system for the integration of genetic constructs
into the chromosome allows for the consistent insertion of sequence in a reliable and
repeatable way. It simplifies the process of integrating constructs. The chromosome
can be used to maintain these constructs more stably than on a plasmid, without the
requirement for selection.
The integration can be done in a similar way, practically speaking, as homolo-
gous recombination using conjugative plasmids (Schafer et al., 1994). That is, to use
bacterial conjugation to transfer the donor plasmid, containing attB sites, into the re-
cipient strain, containing the corresponding attP sites. The main distinguishing dif-
ferences are that the att sites are present in both the recipient chromosome and the
donor plasmid in the place of homologous DNA and that an integrase enzyme must
be expressed. The ΦC31 integrase may be expressed from another plasmid that is
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transferred to the recipient at the same time as the donor plasmid.
In this chapter, I describe IMCE as the integration, through doubleΦC31 catalyzed
recombination, of an attB flanked segment of DNA from a plasmid vector such that
it replaces an attP flanked segment of DNA resident on the chromosome. The strain
containing the attB flanked DNA segment is referred to as the landing pad strain (LP-
strain). The LP-strains had to be constructed, because ΦC31 integrase sites do not
naturally occur in the genomes of most bacteria outside the natural Streptomyces host
of ΦC31. The absence of att sites is advantageous because the integration context may
be chosen. The vectors containing an attB flanked cassette and the vector used to
express the ΦC31 integrase (pJC2) also had to be constructed.
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SS
SS
attB
attP
attR
attL
Activation, and formation of 
phosphoserine covalent linkageFormation of synapse Strand exchange and re-ligation
Figure 3.1: TheΦC31 integrase mechanism: Integrase tetramer DNA complex. Figure
adapted from (Gupta et al., 2007)
Figure 3.2: The ΦC31 integrase mechanism showing only stylized DNA sites. The
arm sequences (B,B′, P, P′) surround a core dinucleotide (TT). The base-pairing of the
core dinucleotide is required for the att sites to be ligated in the recombinant configu-
ration as shown below the arrow.
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Integrase-Mediated Cassette Exchange
Plasmid
Chromosome
gene
marker
attB attB
attPattP
gene
marker
attR attR
attLattL
Figure 3.3: A: Integrase mediated cassette exchange. In the presence of integrase (not
shown), recombination between attB (GTGCCAGGGCGTGCCCTTGGGCTCCCCG-
GGCGCG) and attP (CCCCAACTGGGGTAACCTTTGAGTTCTCTCAGTTGGGGG)
results in the exchange of marker genes on the chromosome with the “gene(s)” on the
plasmid. This leaves attL (GTGCCAGGGCGTGCCCTTGAGTTCTCTCAGTTGGGG-
G) and attR (CCCCAACTGGGGTAACCTTTGGGCTCCCCGGGCGCG) sites, which
are not substrates adequate for recombination by ΦC31 integrase alone.
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3.2 Materials and Methods
3.2.1 Construction of SmUW227 LP-Strain
Sinorhizobium meliloti homologous DNA segments were first cloned into pK19mobSacB
(Table 2.1). The homologous DNA was chosen to target the landing pad sequence to
integrate into a large intergenic region between the ORF: SMc04453 and SMc01885
(Figure 3.4). The fragments were PCR amplified using S. meliloti Rm1021 DNA as the
template. The primer sets used were, L-fwd-EcoRI with L-rev-2-PacI-SmaI to create
the left fragment, and R-fwd-PacI-SphI with R-rev-HindIII (Table 2.2). These two PCR
steps created the left and right homologous fragments, respectively. The left fragment
was cloned into pK19mobSacB as a EcoRI-SmaI fragment, also inserting a PacI site on
the right (or inside) edge of the left fragment, and creating pJH101. The right frag-
ment was cloned into pJH101 as an SphI-HindIII fragment, also inserting a PacI site
on the inside edge (left edge of right fragment), to create pJH102. The plasmid pJH102
has both homologous regions flanking two added PacI sites, placed for future sub-
cloning of the landing pad sequence. Next, the landing pad sequence was constructed
by cloning two genes to construct a poly-cistron. attP sites were added on the ends of
these genes such that the resultant construct was flanked by attP sites. The first gene
to be cloned was gusA. It was amplified from the plasmid pTH1227 (2.1), using the
primers, gusA-F-SalI with gusA-attP-R-SphI. The gusA gene was amplified so that a
ribosome binding site sequence was included before the start codon of the open read-
ing frame. The gusA-attP fragment was cloned into pJH102 using SalI and SphI to
create pJH103. The aadA gene (streptomycin-spectinomycin resistance) including its
promoter was PCR amplified using pHP45Ω (Table 2.1) as the template. The primers
used were attP-aadA-F-SmaI with aadA-R-XbaI (2.2). The resultant aadA-attP frag-
ment was cloned into pJH103 using SmaI and XbaI to create pJH104. The aadA gene
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was cloned upstream of the gusA gene so that gusA would be transcribed.
To integrate the completed landing pad sequence into S. meliloti Rm1021, pJH104
was used as a donor in a triparental mating (see Section 2.5 where S. meliloti Rm1021
was used as the recipient, and Escherichia coli MT616 was used as the mobilizer). The
conjugation mixture was plated on TY agar containing neomycin at 200 µg/ml to
select for the integration of the whole plasmid into the S. meliloti Rm1021 chromo-
some, and streptomycin at 200 µg/ml to select against the donor and mobilizer. The
resultant cointegrant colonies contained the integrated pJH104. Next, a cointegrant
was streaked on TY 10% sucrose containing 100 µg/ml spectinomycin. The resultant
colonies were either sacB mutants or landing-pad strains (with an integrated landing
pad sequence). To differentiate between the two possibilities, colonies were screened
on TY agar plates containing 200 µg/ml neomycin. Colonies that were sensitive to
neomycin had the vector backbone removed. A neomycin sensitive colony was cho-
sen and streak purified three times. The LP-strain (SmUW227) was later verified by
Southern blot analysis.
3.2.2 Construction of Ow0013 LP-Strain
To construct the Ochrobactrum anthropi LP-strain, the ampC gene (locus tag: OANT
RS13415) (ampicillin resistance) was chosen as a replacement target for the landing
pad sequence. The integration of the landing pad sequence would cause the deletion
of the entire ampC ORF. The targeting construct was assembled in vitro through a 2 step
PCR protocol. First, O. anthropi ATCC 49188 (Table 2.1) DNA was used as the template
in two PCRs: one contained the primers ampC-US-F-EcoRI and ampC-US-R-XO, and
the other containing the primers ampC-DS-F-XO, and ampC-DS-R-PstI (Table 2.2).
Subsequently, both PCR products were used as a template with the primers ampC-US-
F-EcoRI and ampC-DS-R-PstI. Because of overlapping sequence between the two PCR
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products, the PCR results in assembly of the two products. A PacI site in the centre
of the upstream and downstream portions was also inserted. This assembled PCR
product was cloned into pK19mobSacB as an EcoRI-PstI fragment to create pJH113.
The landing pad sequence was then subcloned from pJH104 into pJH113 as a PacI
fragment to create pJH115.
To make an O. anthropi recipient that could be properly selected in a triparental
mating, a rifampicin resistant derivative was isolated by plating 50 µl of O. anthropi
ATCC 49188 saturated culture onto LB agar containing 100 µg/ml of rifampicin. A
colony was chosen and streak purified three times. The culture was then saved and
named Ow0012.
To integrate the landing pad sequence into Ow0012 the triparental mating proce-
dure was followed, selecting with kanamycin at 30 µg/ml and rifampicin at 50 µg/ml.
Then the double recombinants were selected with sucrose and streptomycin at 200
µg/ml. Kanamycin sensitive colonies were isolated next. Colonies that were strepto-
mycin resistant and sucrose sensitive were putative LP-strain candidates. After isola-
tion of the LP-strain, Ow0013, its ampicillin sensitivity was confirmed.
3.2.3 Construction of At11142 LP-Strain
To construct the Agrobacterium tumefaciens LP-strain, the tetA gene (locus tag: Atu4206)
(cryptic tetracycline resistance) (Luo and Farrand, 1999) was targeted for replacement.
The integration of the landing pad sequence was targeted such that the whole tetA
ORF is deleted upon its integration. The cloning strategy was as described for Ow0013
construction, except the primers used to create pJH119 were US-tetA-F-EcoRI, US-
tetA-R-XO, DS-tetA-F-XO, and DS-tetA-R-PstI; respectively substituting for: ampC-
US-F-EcoRI, ampc-US-R-XO, ampC-DS-F-XO, and ampC-DS-R-PstI (Table 2.2).
For the same reasons as in the construction of Ow0013, a rifampicin resistant mu-
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tant of A. tumefaciens was required. Therefore, A. tumefaciens A136 was used (Table
2.1). For the integration of the LP-sequence, contained in pJH119, into A. tumefaciens
A136 the same procedure used for the construction of Ow0013 was used.
3.2.4 Construction of pJC2 ΦC31 Integrase Expression Plasmid
This plasmid was constructed by Dr. Jiujun Cheng.
The ΦC31 integrase gene (int) was amplified by PCR with the primers: INT-F and
INT-R (table 2.2) and the template: pHS62 (table 2.1). The PCR product was amplified
as a PstI-BamHI fragment. The restriction sites were added with 5′ extensions on the
PCR primers. The INT-F primer also added stop codons in all three reading frames
just downstream of the PstI site. A ribosome binding site was included on the INT-F
primer downstream of the stop codons. The PCR product was cloned into pRK7813
as a PstI-BamHI fragment. The lacI promoter on the vector drives expression of int.
3.2.5 Construction of pJH110 IMCE Donor Plasmid
The primers: GmR-fwd and GmR-rev (Table 2.2) were used to amplify the aacA gene
using pPH1JI (Table 2.1) as a template. An SphI site was added with the GmR-fwd
primer 5′ extension. An attB site and HindIII site were added with the GmR-rev
primer 5′ extension. This PCR product was cloned into pK19mobSacB as an XbaI-PstI
fragment to create pJH107 (Table: 2.1). The primers US-XbaI-RFP-attB-F and US-PstI-
RFP-R (Table 2.2) were used to amplify the rfp gene with a constitutive promoter, using
the J23118 biobrick as a template (Table 2.1). The attB site was added by the forward
primer, and an SphI site next to the attB site was also included. This PCR product was
cloned into pJH107 as a XbaI-PstI fragment to create pJH110. Because of the SphI sites
added during the vector construction, an SphI digest can be used to replace rfp and
leave the attB sites intact, thereby cloning the desired construct between the two attB
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sites.
3.2.6 Construction of pJH122 IMCE Donor Plasmid
The primers, hph-red-1a-F and hph-red-2a-R were used to amplify hph, including
the cauliflower mosaic virus promoter using pMB403 (Table 2.1) as a template. The
primers added 40 bp of DNA homology surrounding the aac1 gene in pJH110. Using
this homology, λ Red recombineering (Section 2.6) was used to replace aac1 in pJH110
to create pJH122.
3.2.7 Southern Blotting
Southern blotting was used to verify the insertion of the landing pad sequences into
the LP-strains. The procedure followed was as stated in Section 2.9.
SmUW227
The template for DIG-labeled probe synthesis was the right fragment amplified with
the primers: R-fwd-PacI-SphI and R-rev-HindIII (Table 2.2), with pJH104 (Table 2.1) as
the template. The S. meliloti SmUW227 and Rm1021 (parental control) genomic DNA
was cut with SalI.
Ow0013
The template for DIG-labeled probe synthesis was the upstream of ampC fragment
amplified with the primers: ampC-US-F-EcoRI and ampC-US-R-XO (Table 2.2), with
pJH113 (Table 2.1) as the template. The O. anthropi OW0013, and Ow0012 (parental
control) genomic DNA was cut with EcoRV and HindIII.
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3.2.8 IMCE Tetraparental Mating
Preparation of Culture
Cultures of the donor (pJH110, or other in E. coli), landing pad recipient (SmUW227
or other see 2.1), integrase helper strain (pJC2 in E. coli DH5α), and mobilizer (MT616)
were grown in 5 ml of LB media supplemented with antibiotics when required for
plasmid maintenance. Typically, those antibiotics were: kanamycin at 10 µg/ml for
the donor plasmid, tetracycline at 5 µg/ml for the integrase helper plasmid, and chlo-
ramphenicol at 10 µg/ml for the mobilizer plasmid. The S. meliloti landing pad strain
was incubated at 30 ◦C with constant shaking at 180 RPM for 2-3 days, until the cul-
ture was saturated. Other landing pad strains, that may substitute SmUW227 (A.
tumefaciens, O. anthropi), were incubated under the same conditions for 16-20 hours.
The other strains, in E. coli backgrounds, were incubated at 37 ◦C for 16-20 hours with
constant shaking at 180 RPM.
Mating
Once cultures were grown, 1.5 ml of culture was removed and washed 2 times in ster-
ile 0.8% NaCl. The pellet was then resuspended in 100 µl of sterile 0.85% NaCl. Then
10 µl of resuspended culture was then spotted on a TY agar plate. These spots served
as negative controls. For a no-integrase negative control 40 µl of each resuspended
culture, excluding pJC2 was added to a sterile 1.5 ml centrifuge tube and mixed by
pippetting up and down. The mixed culture was spotted on a TY agar plate. The tetra-
parental mating was prepared in the same way except 40 µl of the pJC2 resuspended
culture was added. The spots were dried by placing the plates open in a laminar flow
hood. The plates were incubated at 30 ◦C for 16-20 hours.
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Selection
After the incubation the control spots were streaked on selective media (see table 3.1)
that was selective for transintegrants. The tetraparental mating spot was also streaked
on the same media. One quarter to one half of the tetraparental mating spot was
resuspended in 0.85% NaCl and a 10 fold dilution series to 10−7. Typically, this was
done by diluting 10 µl of culture into 90 µl of 0.85% NaCl. 40 µl of each dilution,
10−2-10−5, was spread plated on media selective for transintegrants; 40 µl of each
dilution 10−4-10−7 on media selective for recipients and transintegrants. Plates were
then incubated at 30 ◦C for three days in the case of S. meliloti landing pad strains, and
two days for O. anthropi and A. tumefaciens landing pad strains.
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Table 3.1: Selection of transintegrants from various
donor recipient combinations. The construction of
pJRT vectors is described in subsequent chapters
Donor Landing pad
strain
Transintegrant
selection
Recipient and
transintegrant
selection
pJH110;
pJRT15;
pJRT16
SmUW227 and
derivatives
Streptomycin
200 µg/ml;
Gentamicin
30 µg/ml
Streptomycin
200 µg/ml
pJH122;
pJRT10;
pJRT11;
pJRT12
SmUW227 and
derivatives
Streptomycin
200 µg/ml;
Hygromycin
50 µg/ml
Streptomycin
200 µg/ml
pJH110;
pJRT15;
pJRT16
Ow0013;
At11142
Rifampicin
50 µg/ml;
Gentamicin
30 µg/ml
Rifampicin
50 µg/ml
pJH122;
pJRT10;
pJRT11;
pJRT12
Ow0013;
At11142
Rifampicin
50 µg/ml;
Hygromycin
200 µg/ml
Rifampicin
50 µg/ml
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3.2.9 Colony PCR
Colony PCR, as described in Section 2.7.9, was used to confirm the integration of attB
flanked cassettes. It was also used to ascertain the orientation of the integrated cas-
sette. The primers used were L-fwd-EcoRI with GmR-rev or R-rev-HindIII with HyR-
Fwd (Table 2.2). The template used was the particular IMCE colony derived from
S. meliloti LP-strain tetraparental matings. The primer set with HyR-Fwd was used
with IMCE involving pJH122 and its derivatives; the set with GmR-rev was used with
IMCE involving pJH110 and its derivatives. When screening transintegrants derived
from Ow0013, the R-rev-HindIII primer was replaced by ampC-DS-R-PstI, and L-fwd-
EcoRI was replaced with ampC-US-F-EcoRI. When screening transintegrants derived
from At11142, the R-rev-HindIII primer was replaced by DS-tetA-R-PstI, and L-fwd-
EcoRI was replaced with US-tetA-F-EcoRI.
3.2.10 Visualization of RFP Fluorescence
Colonies containing RFP on agar Petri plates were visualized by shining white light
(from a white phosphor plate on a UV transilluminator) through a LEE filters 139
primary green filter, onto the plate, and then placing a LEE filters 128 bright pink filter
on the plate. This assembly was inside a dark box with a camera mounted on top (Heil
et al., 2011).
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3.3 Results
3.3.1 LP-strain Confirmation
The objective was to construct three LP-strains, one in Sinorhizobium meliloti, Ochrobac-
trum anthropi, and Agrobacterium tumefaciens. After their construction, the LP-strains
were confirmed by phenotypic analysis and Southern Blot analysis. Before moving
ahead with the applications of IMCE discussed later in this thesis, it was important to
verify the newly constructed landing pad strains. The vectors that go with the strains
were verified as part of the conventional cloning process. Later analysis of the resul-
tant colonies from IMCE (colony PCR) also showed consistent results with the analysis
discussed in this section.
SmUW227
The S. meliloti LP-strain SmUW227 has the expected phenotypes associated with the
landing pad sequence integrated into its chromosome: GusA activity and spectino-
mycin resistance. Rm1021 is streptomycin resistant to begin with, due to a ribosomal
mutation. SmUW227 is resistant to spectinomycin at 100 µg/ml. SmUW227 has a
GusA activity of 49 Miller units, whereas the wildtype Rm1021 has no GusA activity
and is spectinomycin sensitive. The colonies of SmUW227 are also blue, After 5 days
of growth on TY plates containing 200 µg/ml of X-gluc (a GusA substrate). Rm1021
has no GusA activity so its colonies never turn blue on this media. SmUW227 is sen-
sitive to kanamycin and resistant to sucrose, as is expected after the sucrose selection
step in its construction.
The integration of the landing pad sequence into the Rm1021 chromosome does
not delete any genes, only a short stretch of intergenic sequence. Therefore, it was
necessary to use Southern blotting to verify the location of the integrated landing pad
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sequence in the chromosome. The Southern blotting results (Figure 3.4) show that
the expected landing pad sequence is integrated in the targeted locus and that the
vector backbone sequence is not present in SmUW227, because a much larger SalI
fragment would have been detected had the entire vector been integrated (data not
shown). SmUW227 also yields the proper sized amplicon in colony PCR experiments
post IMCE (Section 3.3.4). SmUW227 works with IMCE, and the landing pad sequence
was integrated in the intended locus.
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Figure 3.4: S. meliloti SmUW227 (LP-strain) Southern blot. An image of the Southern blot is shown
in panel A, on the left. Lane A1 contains SmUW227 genomic DNA, and the size of the probed SalI
fragment corresponds with map 1 in panel B (expected SmUW227 sequence), on the right. The same
is true for lane A2 (the parental control: Rm1021) and map B2. The expected migration of the probed
band for the LP-strain (map B1) is 2.3 cm (2.6 kb, lane A1), and ran at 1.9 cm; for the parental strain (map
B2) it is 4 cm (0.9 kb, lane A2), and ran at 4.8 cm. The expected sizes are based on the standard curve
made from the 1 kb ladder (Fisher Scientific Inc) on the original agarose gel (A.4). These differences
from expected migration can be accounted for by the fact that both bands are out of the linear range of
agarose resolution.
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Ow0013
A similar approach as the one used to verify SmUW227 was used to verify that Ow0013
was constructed correctly. There was an additional phenotype to check, because the
integration of the landing pad sequence causes the deletion of ampC instead of a small
section of non-coding DNA.
The O. anthropi LP-strain Ow0013 also has the expected phenotypes associated
with integration of the landing pad sequence, GusA activity and spectinomycin/streptomycin
resistance. Ow0013 is sensitive to kanamycin and sucrose resistant, indicating the in-
tended loss of the vector backbone sequence. The colonies are blue after 2 days growth
on LB plates containing 100 µg/ml of the GusA substrate, X-gluc. Ow0012 has no
GusA activity; its colonies never turn blue on this media.
The integration of the landing pad sequence by double recombination into Ow0012
causes the deletion of the ampC gene, coding for a broad-substrate range β-lactamase.
Ow0012 is ampicillin resistant at 100 µg/ml in LB plates. Ow0013 is completely sensi-
tive to ampicillin at that concentration. The ampicillin sensitivity of OW0013 indicates
that the landing pad sequence is integrated in the intended locus, and that ampC is
deleted. It is extremely unlikely to delete ampC without a double recombination event
having occurred. A Southern blot (Figure 3.5) shows the expected physical arrange-
ment of the DNA as well. The colony PCR experiments (Section 3.3.4) post IMCE give
the proper sized amplicon. Ow0013 works in IMCE, and there is no doubt that the
landing pad sequence is integrated in the correct locus.
At11142
As with the previous two LP-strains At11142 was verified using the same methods, ex-
cept a Southern blot of equivalent quality to the other blots was not obtained. The cur-
rent Southern result is shown in Figure 3.6. The A. tumefaciens LP-strain At11142, like
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Figure 3.5: O. anthropi Ow0013 (LP-strain) Southern blot. An image of the Southern blot is shown in
panel A, on the left. Lane A1 is the Ow0013 lane. This lane corresponds with map B1 (expected Ow0013
sequence map) in panel B on the right. The same is true for lane A2 (the parental control: Ow0012) and
map B2. The expected migration of the probed band for the LP-strain (map B1) is 2 cm (3 kb, lane A1);
for the parental strain (map B2) it is 3 cm (1.6 kb, lane A2). The expected sizes are based on the standard
curve made from the 1 kb ladder (Fisher Scientific Inc) on the original agarose gel (Figure A.3).
97
Chapter 3. Integrase Mediated Cassette Exchange
the other two LP-strains, has the expected phenotypes associated with integration of
the landing pad sequence, GusA activity and spectinomycin/streptomycin resistance.
At11142 is sensitive to kanamycin and sucrose resistant, indicating the intended loss
of the vector backbone sequence. The colonies are blue 2 days after streaking At11142
on LB plates containing 100 µg/ml of the GusA substrate, X-gluc. The parental strain
A136 Rif has no GusA activity; its colonies never turn blue on this media.
The integration of the landing pad sequence into the A. tumefaciens A136 back-
ground by double recombination causes the deletion of the tetA gene, which confers
cryptic tetracycline resistance in A. tumefaciens C58 (Luo and Farrand, 1999). The dele-
tion of tetA should cause the elimination of any tetracycline resistance. However, A136
did not display the expected high frequency of tetracycline resistance in my experi-
ments, leaving no room for comparison. The landing pad sequence location is less
certain than in other strains. Some more work is needed to be completely confident
in the landing pad sequence’s location. Direct genomic Sanger sequencing outward
from the edge of the landing pad sequence may provide the needed evidence.
3.3.2 IMCE Tetraparental Mating Process
The culmination of the correct assembly of the involved parts (strains and plasmids) is
the IMCE tetraparental mating. The three LP-strains, SmUW227 (Figure 3.7), Ow0013
(Figure 3.8), and At11142 (Figure 3.9) were constructed. Two attB donor vectors,
pJH110 (Figure 3.10) and pJH122 (Figure 3.11), were constructed. The plasmid pJH122
is identical to pJH110 except the gentamicin resistance gene was replaced by the hy-
gromycin resistance gene. The second donor vector was made to accommodate the
selection scheme for recombination synthesis (discussed in Chapter 5). The final part
that was needed was the ΦC31 integrase expression plasmid pJC2 (Figure 3.12), that
was completed with some help from Dr. Jiujun Cheng. All of the constructed plasmids
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Figure 3.6: At11142 Southern blot. An image of the Southern blot is shown in panel A, on the left.
Lane A1 is the At11142 LP-strain lane. This lane corresponds with map B1 (expected At11142 sequence)
in panel B, on the right. The same is true for lane A2 (the parental control: A136) and map B2. The
expected migration of the probed band for the LP-strain (A1) is 4 cm (1 kb); for the parental strain (A2)
it is 3 cm (1.5 kb). The expected sizes are based on the standard curve made from the 1 kb ladder (Fisher
Scientific Inc) on the original agarose gel. This blot contains extra bands so it is not fully conclusive,
however it should be noted that the expected 1.4 kb band present in the parental control lane, is not
expected to be present in the At11142 lane, and this is what is seen on the blot (Figures A.1A.3).
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are mobilizable. This made it possible to use the tetraparental mating process.
The establishment of this process formed the foundation for a much of the work
discussed later in this thesis. The same general mating procedure was used for varia-
tions on the IMCE procedure discussed in Chapter 4. This exact IMCE procedure is the
first step in the Recombination Synthesis chromosome engineering process discussed
in Chapter 5.
The tetraparental mating process allows for the introduction of the attB donor plas-
mid and the ΦC31 integrase expression plasmid (pJC2) into the recipient LP-strain.
The mating process involves four strains. The attB donor vector strain, the landing
pad recipient, the ΦC31 integrase expression strain (pJC2), and the fourth strain car-
ries the mobilizer plasmid (pRK600). The mobilizer plasmid moves into the donor
strains, and once there it allows the expression of the transfer genes required to mobi-
lize the attB donor plasmid and pJC2 (Figure 3.13).
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Figure 3.7: S. meliloti SmUW227 map: The landing pad locus map of the SmUW227 chromosome is
shown.
Figure 3.8: O. anthropi Ow0013 map: A: The landing pad locus map of the Ow0013 chromosome is
shown. B: The parental strain chromosome map at the landing pad locus is shown.
Figure 3.9: A. tumefaciens At11142 map: A: The landing pad locus map of the At1142 chromosome is
shown. B: The parental strain chromosome map at the landing pad locus is shown.
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Figure 3.10: The attB donor vector pJH110: The pJH110 attB donor vector map is shown. It contains
the gentamicin resistance gene within the attB flanked cassette.
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Figure 3.11: The attB donor vector pJH122. The pJH122 attB donor vector map is shown. It contains
the hygromycin resistance gene within the attB flanked cassette.
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Figure 3.12: The integrase expression plasmid pJC2. The pJC2 integrase expression plasmid map is
shown.
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3.3.3 IMCE Efficiency
IMCE was carried out with pJH110 as a donor. In this IMCE, a cassette exchange oc-
curs between the JH110 cassette (GmR rfp) and the landing pad cassette (SmR/SpR
gusA). Therefore, the resultant colonies that grow in the initial selection are gentam-
icin resistant and fluoresce red. These colonies are called transintegrants. A subset of
these colonies has undergone true cassette exchange and these colonies will be specti-
nomycin sensitive and lack GusA activity. In Table 3.2, the efficiencies of the formation
of transintegrants is shown. The transintegration efficiency is stated as a proportion
of transintegrants to total recipients. Of the transintegrants, those that were found
to be spectinomycin sensitive had undergone true cassette exchange. The proportion
of these, stated as a proportion relative to transintegrants, is also shown in Table 3.2.
The colonies for subsequent routine IMCE experiments were not counted, but there
was a great deal of consistency in the results. The plates looked very similar every
time. There was some variability in the proportion of transintegrants that turned out
to have undergone true cassette exchange. A statistical analysis has not been done be-
cause the purpose of knowing these efficiencies is to give a guideline to the user of the
IMCE system, not as an indicator of a difference relative to some control experiment.
In all IMCE conjugation experiments a no-integrase control was included, where the
ΦC31 integrase expression plasmid, pJC2, was left out. There were never any transin-
tegrants obtained from this control mating, indicating that IMCE is indeed dependent
on ΦC31 integrase. Photographs of the plates show an example of an IMCE experi-
ment carried out with S. meliloti SmUW227 (Figure 3.14).
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Figure 3.13: IMCE tetraparental mating: an illustration of the conjugation process is shown. The
mobilizer plasmid (pRK600) is self-mobilizable and it moves into the strains containing pJC2 (integrase
expressing plasmid) and pJH110 (IMCE donor plasmid). Once in these strains, it facilitates the mobi-
lization of these mobilizable plasmids. pJC2 and pJH110 move into the recipient LP-strain (SmUW227)
and cassette exchange between the SmUW227 chromosome and pJH110 is facilitated. pJH110 is un-
able to replicate in any of the LP-strains. Therefore, LP-strains that have undergone cassette exchange
may be selected using the antibiotic marker contained in pJH110 between the two attB sites. The donor
strains are counter-selected, using streptomycin in the case of this figure. Rifampicin may be used in
the case of OW0013 and At11142. pJC2 does replicate, but is unstable in these hosts and may be cured
by passaging 106
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Figure 3.14: A: Mating spot plate on a non-selective TY plate showing dried cell mixtures on agar
surface. B: Mating spots streaked on streptomycin-gentamicin-X-gluc plate, from top left clockwise
no integrase control, IMCE into S. meliloti, E. coli DH5α containing pJC2 control, E. coli DH5α con-
taining pJH110 control, E. coli MT616 control, and S. meliloti SmUW227 control. C: 10−2 dilution of
mating spot resuspension on TY streptomycin-X-gluc agar. D: 10−2 dilution of mating spot resus-
pension on TY streptomycin-gentamicin-X-gluc agar (blue colonies are single recombinants, white
colonies have undergone true cassette exchange). E: 10−2 dilution of mating spot resuspension on
TY streptomycin-X-gluc agar showing lack of fluorescence. F: 10−2 dilution of mating spot resuspen-
sion on TY streptomycin-gentamicin-X-gluc agar showing fluorescence. Fluorescent photographs were
taken using the method outlined in Heil et al. (2011)
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Table 3.2: IMCE efficiency (transintegrants as a proportion of total recipients) for each
LP-strain, and proportion of transintegrants that are double recombinants
LP-strain Efficiency (proportion of
transintegrants to total
recipients )
Proportion true cassette
exchange to transintegrants
SmUW227 3× 10−3 0.5-0.6
Ow0013 2× 10−3 0.5-0.9
At11142 2× 10−3 0.5-0.9
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3.3.4 IMCE Confirmation by PCR
The ability of IMCE to integrate the attB flanked cassette into the landing-pad locus of
the LP-strain was verified by colony PCR. Due to the design of the LP-sequence, it is
possible for the attB sequence to integrate in either orientation with equal probability.
For the work discussed in Chapter 5, it was necessary to ensure that the DNA inte-
grated by IMCE was in a particular orientation. For this work, colony PCR was used
to ascertain whether a colony was in the arbitrarily chosen desired orientation. The
colony PCR used to do this also provided yet more evidence that IMCE was reliably
integrating the DNA segments in the landing pad locus.
Colony PCR was used with one primer annealing to the wild-type LP-strain se-
quence adjacent to the landing pad sequence and the other primer annealing to the
antibiotic resistance gene that was proximal to the first primer’s annealing site. A fre-
quency of PCR success of around 50% was observed as expected (Figure 3.2.9). The
size of the amplified product was correct (600 bp for Gm amplicon, 650 bp for Hy
amplicon in SmUW227; slightly larger for other LP-strains). This screen was done
for the S. meliloti LP-strain SmUW235 with SmUW227 incorporated by transduction
(SmUW235 φ SmUW227) (Figure 3.15), O. anthropi Ow0013 (data not shown), and
A. tumefaciens At11142 (data not shown). The expected results were observed using
SmUW235 φ SmUW227, and Ow0013 templates. Colony PCR with with At11142 as a
template did not produce any amplified product. The failure of the colony PCR using
At11142 derived IMCE strains could have been because of a failure of those particular
primers, or the presence of PCR inhibitors.
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Figure 3.15: In the left panel, a photograph of the gel electrophoresis of screened clones shows 7 out
of 20 PCRs produced the proper size DNA molecule (the size marker is the Fisher 1 kb ladder and the
second band from the bottom is 500 bp). The right panel shows the locations of the primer annealing in
the case of both possible IMCE double recombinant transintegrants.
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3.4 Discussion
In an effort to construct a chromosome engineering system that allows the reliable
integration of DNA cassettes into the bacterial chromosome, the integrase mediated
cassette exchange (IMCE) system was successfully designed and implemented. The
IMCE system required an attP landing pad strain (LP-strain), a ΦC31 integrase ex-
pression plasmid, a mobilizer plasmid, and an attB donor vector to accomplish IMCE
through a tetraparental mating procedure. All of these, except the mobilizer plasmid,
had to be constructed. For this thesis, three LP-strains in the species Agrobacterium
tumefaciens, Ochrobactrum anthropi, and Sinorhizobium meliloti were constructed. Ex-
periments were performed to verify each LP-strain. The O. anthropi and S. meliloti LP-
strains were confirmed; the A. tumefaciens LP-strain requires additional experiments
to demonstrate that the LP-sequence is integrated in the intended location. The IMCE
system was used to integrate test constructs containing the gentamicin resistance and
RFP genes. These tests were used to establish the frequency of colonies having under-
gone successful IMCE versus the number of available total recipients. In later work,
IMCE was used to integrate PHA half operons. At this stage, colony PCR was used
to verify their integration. Colony PCR showed the expected result, that the intended
sequence was integrated at the landing pad locus.
Nomenclature
The term transintegrant has been used because the recipient cells that are altered have
received the donor plasmid via conjugation, and thus are transconjugants, but have
also integrated the plasmid (single recombination) or the donor cassette (double re-
combination), so they are also integrants. The term transintegrant refers to colonies
having undergone either double or single recombinations.
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Confirmation of the LP-strains
All three LP-strains have proven very reliable. Each LP-strain produces the expected
results when used in the IMCE protocol. Multiple approaches were used to ensure the
adherence of the LP-strains the specifications. For the O. anthropi and S. meliloti LP-
strains, the Southern blotting provides very strong confirmation of those LP-strains.
For the A. tumefaciens strain, the Southern blotting was done; there was a difference
between the parental strain and the landing pad strain. The expected bands were
present, but some extraneous bands were also present. The probe hybridization con-
ditions would need to be adjusted to get a more conclusive result. However, direct
genomic Sanger sequencing from the edge of the landing pad sequence may provide
a better alternative. The behavior of all three LP-strains in the IMCE protocol is also
strong evidence for their adherence to the design specification. It is highly unlikely
that colonies with the particular phenotypes would arise in similar repeatable fre-
quencies by chance. In the case of the O. anthropi LP-strain, there is good phenotypic
evidence that the landing pad sequence is integrated in the intended locus. In that
case an antibiotic resistance gene was deleted. The physical evidence of successful
IMCE given by the colony PCR results is also in agreement with the Southern blot-
ting. It is clear that the S. meliloti and O. anthropi LP-strains have been validated very
stringently.
Design Considerations
There were a few design considerations made before the construction of the IMCE
system. Various markers used in IMCE and markers intended for use in downstream
applications were considered to avoid conflicts. GusA (also referred to as UidA) was
chosen as the blue white screen marker because it is not present in the any of the
genomes of the three species backgrounds used for the LP-strains described in this
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chapter. It was later noticed that the production of a blue colour on X-gluc containing
media is delayed in the S. meliloti background. The blue colour first appears in the cen-
tre of the colonies when they are 5 days old. In the other backgrounds the blue colour
develops quite quickly. This may be because S. meliloti may lack a transporter in its
cell envelope capable of importing X-gluc. The other major design consideration was
choosing the topology of the att sites. The attP sites flanking the landing pad sequence
are in opposite orientations, facing inwards. In other words, the att sites are in an
antiparallel configuration. This configuration of att sites was chosen so the backbone
of the donor vector would not be integrated. The attP and attB sites must synapse in
parallel with each other for recombination to occur (Gupta et al., 2007). If the land-
ing pad sequence and the donor vectors had been designed with parallel att sites, the
attB and attP sites could align in parallel no matter which particular attB site aligned
with which particular attP site. Therefore there would be no topological distinction
between the backbone portion of the vector and the cassette intended for integration,
relative to the attB sites. With an antiparallel att site design, each attP site must synapse
with its intended partner attB site in order to satisfy the conditions for successful re-
combination. Therefore, the antiparallel design ensures only the intended cassette is
transferred in the IMCE process. The disadvantage of this design is that there is no
topological difference, as far as the recombination is concerned, between both orienta-
tions of the donor cassette. That is why IMCE transintegrant clones are found in both
orientations. A design using parallel att sites would require a selection against inte-
gration of the backbone, or extra screening for the presence of the intended cassette.
The parallel design would, however, remove uncertainty about the orientation of the
integrated cassette.
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IMCE Efficiency
The IMCE system provides a reliable and rapid method to integrate attB flanked DNA
into the chromosome of the LP-strains described above. The protocol produces hun-
dreds to thousands of colonies in one conjugation step, without the need for further
selection steps. In fact, the efficiency of IMCE is such that a clone could easily be iso-
lated by the GusA blue-white screen alone, thereby producing a markerless clone. The
same blue-white screen allows for the differentiation of double recombinants (hav-
ing undergone true cassette exchange) and colonies that are merely transintegrants.
The presence of the streptomycin/spectinomycin resistance gene also allows a second
marker confirmation of the double recombination event.
The high efficiency of IMCE is quite impressive when compared with the conven-
tional means of integrating DNA into bacterial chromosomes. Homologous recombi-
nation, accomplished by introducing a plasmid containing ≈ 500 bp of host chromo-
some homology into a RecA positive host by triparental mating, gives a much lower
frequency of ten to one hundred times less. The observed transconjugant frequency
does vary when recombination is involved. It varies because of features and length
of the homologous DNA. These features include the proximity to χ-sequences (Otero
et al., 1995), and mutation frequency fluctuation. Mutation frequency fluctuation is
due to the fact that in some cases a recombination event will happen in the first few
generations of growth, during transfer, or from subsequent transfers in later gener-
ations (Luria and Delbrück, 1943; Lea and Coulson, 1949). Though it is difficult to
make a rigorous comparison of absolute transintegration frequencies between con-
ventional homologous recombination and IMCE, practically speaking, from my ex-
perience IMCE will yield approximately five hundred times the double recombinants
than homologous recombination will yield single recombinants (data not shown). The
frequency of transintegrants that are double recombinants in the homologous recom-
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bination case is usually around the square of the transintegrant frequency. This means
that a two step selection is used to obtain double recombinants(Schafer et al., 1994).
The fact that the proportion of double recombinants among the transintegrants in
IMCE is so high suggests that the bottleneck is the rate of DNA transfer. If the bot-
tleneck were the recombination event, the double recombinant frequency would be
close to the square of the overall transintegrant frequency (≈ 9× 10−6), but the ob-
served frequency (≈ 2× 10−3) is three orders of magnitude higher than that. Given
this inference, IMCE efficiency could be further improved if the integrase expression
plasmid (pJC2) were maintained in the LP-strain, making the tetraparental mating
into a triparental mating. This would increase the number of cells having acquired all
the plasmids required for IMCE, because every recipient cell would contain pJC2.
The Advantages of Phage C31 Integrase
An important advantage of developing a system based on ΦC31 integrase is the sim-
plicity of implementing the ΦC31 integrase. Only one enzyme (the integrase) is re-
quired for the initial recombination. There are no factors, like integration host factor,
needed by the tyrosine recombinase from λ phage (Mumm et al., 2006). A system like
the Tn7 site-specific integration system (Choi et al., 2005, 2006b), where many bacteria
naturally have the required att sites, provides a quick route to chromosome engineer-
ing in a particular organism, but can be complicated by species variations such as
att site copy number. The number and location of the attTn7 sites differs between
genomes (Choi and Schweizer, 2006b; Choi et al., 2006a; Choi and Schweizer, 2006a).
In the case of the Tn7 system, the att site is present only within the γ-proteobacteria. The
limitations of the Tn7 system are apparent, considering IMCE has been demonstrated
here in three α-proteobacteria, in which Tn7 integration is not possible. The ΦC31 att
sites do not occur naturally in any bacterial genomes so far investigated (Synechocys-
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tis PCC 6803, Methylosinus trichosporium OB3b, and Bacillus subtilus, in addition to the
discussed LP-strains). This is not a major disadvantage, considering the limited na-
ture of even the most broad host range natural systems. Instead this can afford design
flexibility when creating the landing pad strain.
Overcoming Limitations of IMCE
The size of the construct to be integrated by IMCE is limited by the size of DNA that
can be successfully cloned into the donor vector via ligation. Donor vectors containing
Gateway destinations (Katzen, 2007) can be used, and are especially useful for large
insert fosmid/cosmid libraries. Gateway donor vectors have been constructed as part
of this work and are described in subsequent chapters of this thesis. The antibiotic
resistance markers in the donor vectors may also be used to select for the assembly
of overlapping DNA fragments, post IMCE, by crossing two different trans-integrants
via transduction, conjugation, or genomic electroporation. In this thesis, the assembly
of already integrated segments post-IMCE is called recombination synthesis (RS) and
its implementation is discussed in subsequent chapters.
Application of IMCE to Functional Metagenomics
In functional metagenomics, screens are based on the functions of the gene expressed
from the library clone (Simon and Daniel, 2011). The identification of clones of a par-
ticular function is limited by the ability of the screening host to express the genes on
the clone, as well as a suitable selectable or screenable phenotype. Given a metage-
nomic library may contain DNA from a diverse community of bacteria, Escherichia coli
may not be able to express many of the genes present in the library. Therefore, alter-
nate screening hosts from different phyla are useful in functional metagenomics (Craig
et al., 2010). A metagenomic library made in an IMCE compatible vector would be
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compatible with any host where a landing pad strain has been, or can be constructed.
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Chapter 4
Integrase Mediated Cassette Exchange
Tools and Reverse Integrase Mediated
Cassette Exchange
4.1 Introduction
To use the IMCE system, the desired DNA must first be cloned into the attB donor
vector. If an antibiotic resistance marker is included in the sequence between the attB
sites this simplifies the IMCE protocol. IMCE is efficient enough that the blue-white
screen may be used to isolate double recombinants for the largest DNA constructs yet
tried (still less than 10 kb). However, it is desirable to have a selection that is not reliant
on the contents of the attB donor cassette. It is also desirable to have attB donor vectors
that allow for Gateway cloning (Katzen, 2007), which may streamline the subcloning
of inserts into the attB donor cassette. Gateway cloning is a plasmid-based cassette
exchange system, very similar to IMCE. It uses the λ phage integrase and excisionase.
ΦC31 attB donor vectors containing Gateway destinations (equivalent to a landing
pad sequence) were constructed.
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In functional metagenomics, a factor that limits the availability of screening hosts
is the ability of plasmids to replicate in the host. At the time of library construction, a
broad host range vector may be used. However, there will be potential hosts that will
not support its replication. Conversely, if IMCE is used for functional screens, plasmid
replication is not a factor. A LP-strain in the desired host may be created after library
construction has been completed. For use of the IMCE system involving functional
metagenomics, a fosmid vector was created.
The LP-strains were constructed using a two step homologous recombination pro-
tocol. Double recombinants were selected in the second step by plating on sucrose,
thereby selecting for the loss of sacB (Gay et al., 1985). Because sacB is on the backbone
of the vector, the vector sequences are lost, as was the goal of the selection. The sacB
gene is a useful counterselectable marker, and including it within the landing pad se-
quence is desirable. However, including sacB on the landing pad sequence precludes
its use on the vector backbone. The strategy used for the initial construction of the
LP-strains depends on the sacB gene contained on the vector backbone. Therefore, a
strategy using reverse IMCE to remodel LP-strains after their initial construction was
used to make a SacB LP-strain. To allow for reverse IMCE, the directionality of ΦC31
recombination must be reversed.
There are two aspects of ΦC31 integrase recombination that one may think of
when considering the directionality of recombination. There is the directionality of
the synapses of the two att sites during recombination. If there is no specificity for
synapse direction, a mixture of excision and inversion of the DNA between an attP
and an attB will result from recombination. The other directional consideration is the
direction of the recombination reaction itself: from attP-attB to attL-attR or the other
way (Ghosh et al., 2008; Khaleel et al., 2011).
The ΦC31 integrase recombines attP and attB sequences when they synapse in
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a parallel orientation. This parallel specificity is governed by the core dinucleotide
found in both att sites (Gupta et al., 2007). The core dinucleotide of attP must base pair
with the dinucleotide in attB. In the case of the ΦC31 att sites, the core dinucleotide is
the non-palindromic TT, so base-pairing may only be accomplished when the att sites
synapse in parallel. If the dinucleotide in the serine recombinases is mutated so that
it is a palindrome (eg. TA), then the selectivity for parallel synapses is lost (Ghosh
et al., 2003). An even mixture of excisions and inversions is observed. In the context of
chromosome engineering, this fact can be used to create different classes of att sites to
increase the specificity of recombination reactions (Colloms et al., 2013).
The other directional aspect of ΦC31 recombination is the reaction direction. This
is usually what is referred to by the term ‘’directionality” in the literature. Because
the sequences flanking the dinucleotide are inverted imperfect repeats, a recombina-
tion of attP and attB sites gives rise to two distinct composite sites: attR and attL. The
ΦC31 integrase can distinguish between attP-attB and attL-attR (Rowley et al., 2008).
The integrase will only catalyze recombination in the attP-attB to attL-attR direction.
A protein called the recombination directionality factor (RDF) is responsible for re-
versing this direction. It does so by binding to the integrase protein and changing the
specificity by which the integrase recognizes the att sites (Ghosh et al., 2008; Khaleel
et al., 2011). Expression of the RDF is how the integrated prophage would initiate lytic
growth. In the context of chromosome engineering, the use of the reverse reaction can
make the existing IMCE system more powerful. The reverse reaction can be used to
do reverse IMCE after IMCE has been completed. This reverse IMCE (RIMCE) was
used to create the SacB LP-strain.
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4.2 Materials and Methods
4.2.1 Construction of pJH145: Mobilizable attB Donor Fosmid
The primers attbfos-F and attbfos-R (Table 2.2) were used to amplify the pCC1fos vec-
tor. The primers annealed adjacent to the Eco72I cloning site of the vector, causing
the deletion of the original cloning site. ΦC31 attB sites were added flanking the vec-
tor, and on each end of the PCR product, 1/2 of an Eco72I site was added. The PCR
product was amplified with a proofreading polymerase (KOD Xtreme); it had blunt
ends. The PCR product was ligated, forming a complete Eco72I site flanked by attB
sites. The ligated plasmid was transformed into Escherichia coli EPI300 (Table 2.1).
The intermediate vector was called pCC1fosattB. The RK2 origin of transfer (oriT) was
amplified from pJC8 (Table 2.1) using the primers KL12-F and KL13-R (designed by
Kathy Lam) (Table 2.2). The PCR product was cloned into pCC1fosattB as a HindIII
fragment to create pCC1fosattBoriT. The Eco72I fragment from pJC8 (Table 2.1) was
subcloned into pCC1fosattBoriT to create pJH145.
4.2.2 Construction of pJH121: Gentamicin attB Donor Vector with
Gateway
pMK2016 (Table 2.1) was cut with SphI. The 1.9 kb fragment, the Gateway destination
sequence, was extracted from an agarose gel. It was subcloned into pJH110 as an
SphI fragment, replacing rfp. The orientation of the insert was mapped with EcoRI.
The clone with the orientation placing attR2 proximal to aac1 was saved. The plasmid
was transformed, isolated, and stored in the ccdB resistant E. coli DB3.1 because the
Gateway destination contains the ccdB gene.
122
4.2. Materials and Methods
4.2.3 Construction of pJH123 and pJH124: Hygromycin attB Donor
Vectors with Gateway
These vectors were constructed in the same way as pJH121 except the 1.9 kb fragment
was cloned into pJH122 as an SphI fragment. An EcoRI digest was completed and
the orientation of the insert was mapped. Clones of both orientations were saved.
pJH123 was determined to have the insert in the same orientation as pJH121 (attR2
proximal to hph), and pJH124 was determined to contain the insert in the opposite
orientation. The plasmid was isolated and stored in E. coli DB3.1. PJH123 restric-
tion with EcoRI produced the following expected sizes: 7013 bp, 1667 bp, 669 bp, and
407 bp. The same restriction of pJH124 produced the expected sizes: 7013 bp, 1476 bp,
860 bp, and 407 bp.
4.2.4 Construction of pJH141
The primers RDF-fix-F and RDF-fix-R (Table 2.2) were used to amplify the RDF gene
(gp3) from the template, pJET-gp3 (Table 2.1). BamHI sites and a ribosome binding
site were added by the primers. The PCR product was cloned into pJC2 as a BamHI
fragment to create a polycistron with int. The resultant clones were screened for the
proper orientation (same direction of transcription as int) by restriction mapping with
HindIII. The HindIII restriction of the expected clone produced the band sizes: 900 bp,
650 bp, 300 bp, and 750 bp (excluding much larger backbone), but there was an extra
450 bp band. Sequencing revealed that the clone was a dimer in the direct orienta-
tion. The restriction map was consistent with that sequence. The clone was saved and
named pJH141, and every subsequent attempt to repeat this construction resulted in
dimeric clones.
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4.2.5 Construction of pJH143
The sacB gene, including its promoter, was amplified from the template pK19mobSacB
(Table 2.1) using the primers attLsac-F and attlsac-R (Table 2.2). The primers added
ΦC31 attL sites flanking sacB. The primers also added a HindIII site on the 5′ end and
a EcoRI site on the 3′ end. A PmeI site was added on the inside of the downstream
attL site. The PCR product was cloned into pK19mob (Table 2.1) as an HindIII-EcoRI
fragment, producing the intermediate plasmid: pK19attlsac. The LP-sequence exclud-
ing the attBsites was amplified from pJH104 (Table 2.1) using the primers gusspec-F
and gusspec-R (Table 2.2). These primers added PmeI sites on both ends. This PCR
product was cloned into pK19attlsac as a PmeI fragment to create pJH143.
4.2.6 In vivo Gateway Recombination
The in vivo Gateway recombination protocol was described previously (House et al.,
2004). The general conjugation procedure was similar to that of a triparental mating
(section2.5), except there are 5 strains. The following strains (Table 2.1) were grown
with the appropriate antibiotic for plasmid maintenance (section 2.3): pJH121 (Gate-
way destination) with kanamycin in E. coli DB3.1, pJC8 lac clone (Gateway entry clone)
with tetracycline, Escherichia coli DH5α Rif (final recipient), E. coli MT616 (mobilizer),
pXINT129 in E. coli DH5α with ampicillin (recombinase expression). The cultures
were washed with sterile saline. The cultures were mixed and spotted on plain LB
agar with 1 mM IPTG to induce recombinase expression. The spots were dried down
and incubated for 16 hours at 37◦C. The transconjugants having undergone Gateway
recombination were selected on LB agar with rifampicin at 50 µg/ml and gentamicin
at 10 µg/ml.
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4.2.7 RIMCE Tetraparental Mating
The RIMCE protocol was nearly identical to the IMCE protocol (section 3.2.8) with a
few key differences. The pJC2 plasmid was replaced by pJH141, which contains the
ΦC31 RDF gene (gp3).The donor attB donor plasmid was replaced by the attL donor
plasmid pJH143. The LP-strain was replaced with the reverse LP-strain (rLP strain).
The rLP strain was 246, which contains an integrated cassette from pJH110. pJH143
contains the original landing pad sequence with sacB added, flanked by attL sites.
The final difference was that all E. coli strains were in a β-DH10B (Rowe-Magnus,
2009) background, which requires diaminopimelic acid (DAP) for growth. All E.
coli strains were grown in LB broth supplemented with DAP at 60 µg/ml, and sup-
plemented with the appropriate antibiotics for plasmid maintenance. The selection
against donors was the omission of DAP from the final selection plates. The selection
for reverse-transintegrants was TY media containing spectinomycin at 100 µg/ml.
For integrated clone recovery onto a plasmid, a pentaparental mating was used. A
final recipient strain, E. coli DH5α Rif, was added. The selection for a plasmid contain-
ing the pJH110 cassette was LB media containing rifampicin at 50 µg/ml and gentam-
icin at 10 µg/ml, or 10% sucrose to substitute for the gentamicin, or both sucrose and
gentamicin with the stated concentrations.
4.2.8 IMCE using SacB LP-strain
This protocol was identical to the IMCE protocol (section 3.2.8), except the LP-strain
was the SacB LP-strain derived from the RIMCE, using pJH143 as a donor. The donor
vector was pJH110. The selection for transintegrants was TY containing 10% sucrose
and streptomycin at 200 µg/ml. The 10−3 and 10−4 dilutions of the resuspended mat-
ing spot and no-integrase control spot were plated. The mating spot and all of the
controls (individual spots, and no-int,gp3 control) were also plated on TY gentamicin
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at 30 µg/ml, streptomycin at 200 µg/ml. This was done as a positive control for the
integrity of the SacB LP-strain.
4.3 Results
4.3.1 RIMCE
The reverse IMCE (RIMCE) process allows for the replacement of the landing pad
sequence. It was developed to increase the flexibility of the IMCE system and to allow
for the creation of the SacB LP-strain. The parts required for RIMCE were constructed.
They were a donor vector with an attL flanked cassette (Figure 4.1), a reverse LP-
strain (Figure 4.2), and a plasmid to express both ΦC31 integrase and RDF (Figure
4.3). Fortunately, the reverse LP-strain was made as a consequence of doing IMCE
using pJH110, the resultant strain (SmUW246) was a suitable reverse LP-strain.
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Figure 4.1: The SacB landing pad. The SacB landing pad sequence map is shown. It exists on the
plasmid pJH143, which has a pK19mob (Schafer et al., 1994) vector backbone. The attL flanked cassette
contains sacB, in addition to the aadA, and uidA (also known as gusA) genes present in the original
landing pad sequence.
Figure 4.2: The reverse landing pad. The reverse landing pad map is shown. It is present at the S.
meliloti landing pad locus between SMc04453 and SMc01885.
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Figure 4.3: RIMCE integrase expression plasmid. The map of pJH141 is shown. It contains the ΦC31
int and gp3 (RDF gene) genes. Transcription of the genes is driven by the lac promoter included in the
multiple cloning site of the original vector: pRK7813.
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The RIMCE process is a tetraparental mating process that is very similar to IMCE.
The key differences are the att sites and the inclusion of the gp3 gene on the inte-
grase expression plasmid (Figure 4.4). Also, the background Escherichia coli strain
was changed to βDH10B (Rowe-Magnus, 2009). In the tetraparental mating spot, the
self-mobilizable pRK600 was transferred into both βDH10B containing pJH143 and
βDH10B containing pJH141, where it mobilized the pJH143 and pJH141 plasmids.
The plasmids were transferred into the rLP-strain (SmUW246) where the RIMCE was
catalyzed by the integrase and RDF. E. coli βDH10B, a DAP auxotroph, was used,
because of the potential selection conflict with streptomycin. Rm1021 (SmUW246 is
one) derived strains are streptomycin resistant, and that is the usual counterselec-
tion against the donor. In this case, the streptomycin counterselection does not work,
because the donor plasmid replicates in E. coli and confers streptomycin resistance.
βDH10B requires DAP (a component of peptidoglycan) to grow. Because production
of DAP is limited to bacteria, DAP is not present in common complex media based on
casein digests and yeast extract. This makes the use of βDH10B (Rowe-Magnus, 2009)
a convenient way to select against donors in the RIMCE tetraparental mating, and the
use of streptomycin is avoided.
RIMCE was demonstrated in the S. meliloti background using SmUW246 reverse
LP-strain as a recipient. SmUW246 is the strain that resulted from IMCE into SmUW227
using pJH110 as a donor. At 3 × 10−5 as a proportion of recipients, the frequency
of transintegrants was much lower than what was obtained with IMCE. Most of the
transintegrants were single recombinants. 1 in 20 transintegrants were double recom-
binants. The double recombinants were easy to identify, because they had lost the RFP
fluorescence of SmUW246. The result of RIMCE was the creation of the SacB LP-strain:
SmUW574.
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To recover integrated clones an RIMCE conjugation with the addition of a final Es-
cherichia coli DH5α Rif recipient was added. The RIMCE cassette exchange between
pJH143 and SmUW246 reconstructs a pJH110 like plasmid (that lacks sacB on its back-
bone). This plasmid was to be selected using LB media containing rifampicin and
sucrose, or rifampicin and gentamicin. The recovery of the integrated pJH110 cassette
was attempted numerous times, but no recovered clones were obtained.
Although Figure 4.4 shows pJH141 as having a copy of the gp3, pJH141 actually
contains a dimer of gp3. All attempts to isolate a clone with a monomeric gp3 resulted
in isolating only dimers. No monomeric clones in the proper orientation were found
after screening many colonies, and the dimeric construct is in fact very stable.
4.3.2 SacB IMCE
Th SacB IMCE process is nearly the same as IMCE, except that the LP-strain differs
in having sacB in the LP-sequence. The selection was tested by doing a tetraparental
mating using pJH110 as the attB donor, MT616 as the mobilizer strain, pJC2 as the
integrase expressing donor, and SmUW574 as the LP-strain. A gentamicin selection
was done with this mating as well, and the gentamicin selection gave identical results
to IMCE using SmUW227. The SacB selection allowed for more background growth
than the gentamicin selection did, but the SacB selection was sufficient to achieve the
desired results (Figure 4.5). Transintegrants were easily isolated. I observed that plac-
ing a high density of recipient cells on the sucrose selection plate tended to result in
an excessive background growth level. In Figure 4.5, the “headstreak” of SmUW574
(SacB LP-strain) on sucrose media shows growth at the start and then clears as the
cell density drops near the end of the streak. The efficiency of SacB IMCE was similar
to that of IMCE. Single recombinants were counter-selected because single recombi-
nants still contain sacB. Of the colonies that arose on the sucrose plate, approximately
130
4.3. Results
Figure 4.4: RIMCE tetraparental mating: an illustration of the conjugation process is shown. The
mobilizer plasmid (pRK600) is self-mobilizable and it moves into the strains containing pJH141 (inte-
grase RDF expressing plasmid) and pJH143 (RIMCE donor plasmid). Once in these strains, it facili-
tates the mobilization of these mobilizable plasmids. pJC2 and pJH110 move into the recipient rLP-
strain (SmUW246) and cassette exchange between the SmUW246 chromosome and pJH143 is facili-
tated. pJH143 is unable to replicate in SmUW246. Therefore, LP-strains that have undergone cassette
exchange may be selected using the antibiotic marker contained in pJH143 between the two attL sites.
The donor strains are counter-selected by omission of DAP in the media. The plasmid pJH141 may be
cured by passaging.
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half were still spectinomycin resistant, which would indicate that they had a mutation
in sacB. The other half were sucrose resistant and spectinomycin sensitive, indicating
that they were double recombinants.
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Figure 4.5: SacB IMCE selection plates. Panel A: The sucrose selection plate with large healthy
colonies growing among some background; 10−3 dilution. Panel B: The individual strains, that were not
mated, streaked on the same sucrose selection media (only a “headstreak”); SmUW574 (SacB LP-strain)
can grow if the cell density is high, but it will not form healthy isolated colonies. Panel C: a closeup of
the sucrose resistant colonies from panel A. Panel D: The mating spot plated on TY streptomycin with
no sucrose; this level of growth at the 10−4 dilution relative to the growth on the sucrose 10−3 dilution
shows that the sucrose selection worked.
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4.3.3 Gateway Recombination into IMCE Vector
The Gateway IMCE donor vectors were confirmed by restriction mapping. Because
they were constructed by subcloning the Gateway destination, a detailed restriction
map is sufficient for their confirmation. To test the Gateway recombination, a cosmid
clone (lac35) in pJC8 was used as a Gateway entry clone in the pentaparental mat-
ing procedure using pJH121 (Figure 4.6) as the destination vector. The pentaparental
mating yielded colonies that were gentamicin resistant (selection for pJH121 plasmid
backbone) and rifampicin resistant (selection for final ccdB sensitive recipient). These
colonies arose at a frequency relative to recipient of approximately 1× 10−6, which is
relatively low. House et al. (2004) indicated they obtained hundreds to thousands per
5 mm spot of mating mixture. A larger volume was used in the current work. Given
the differences in the results are of orders of magnitude, two or four fold differences
in initial cell numbers do not account for that frequency difference. There were no
colonies when the pXINT129 strain was excluded from the mating. It is likely that the
low numbers of colonies obtained were not merely spontaneous ccdB resistant mu-
tants, or rifampicin resistant mutants. Culture was grown from three colonies and the
plasmid DNA was isolated. The plasmid DNA was cleaved with EcoRI and BamHI.
The size of the plasmids was too small to contain the cosmid clone, but the restriction
pattern was different than that of pJH121. pJH121 gives bands of 6.6 kb, 1 kb, 0.7 kb,
and 0.4 kb. The plasmids isolated from the Gateway recombination all gave 0.1 kb,
2 kb, and 8 kb. The proper clone was not isolated but the a recombination did occur.
134
4.3. Results
Figure 4.6: Gateway IMCE donor vector. The map of pJH121 is shown. It contains a Gateway
destination flanked byΦC31 attB sites. A gentamicin resistance gene is also included in the attB flanked
cassette.
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4.3.4 Test IMCE with pJH145
The fosmid vector pJH145 was constructed to allow for integration, via IMCE, of cos-
mid library inserts. The vector was tested to make sure the attB sites were functional.
To test pJH145 an IMCE mating was done. The gentamicin resistance gene cloned in
the Eco72I site occurs in between the two attB sites, the location of an insert had a
library been made with the vector. Therefore, a gentamicin selection could be used
for the IMCE. The IMCE was carried out with the identical procedure to the IMCE
with pJH110 into SmUW227, except the donor was pJH145 instead of pJH110. IMCE
also requires the donor vector to be mobilizable. The IMCE test therefore tested both
the integrity of the attB sites and the functionality of the RK2 oriT. This IMCE worked
with the same efficiency and as previous IMCE procedures. Double recombinants that
were spectinomycin sensitive were isolated at the expected frequency (50%).
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Figure 4.7: IMCE donor cosmid vector. The map of pJH145 is shown. It contains a blunt cloning site
(Eco72I sites flanking GmR) flanked by attB sites. The vector is single copy, but is copy-up inducible in
the EPI300 strain using L-arabinose
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4.4 Discussion
To increase the utility of the IMCE system, the reverse IMCE system (RIMCE) was
developed and it was used to create a new landing pad strain that increases the utility
of IMCE by allowing for the integration of marker-less cassettes more easily, through
the use of sacB counterselection. This SacB LP-strain is suited to be used as a recipient
screening host in a functional screen. To accomplish this in the future, the vector
pJH145 was created to allow for the creation of cosmid libraries that are compatible
with IMCE. The vectors pJH121, pJH123, and pJH124 allow for Gateway entry clones
to be integrated into IMCE attB donor vectors, further expanding the compatibility of
the IMCE system with other systems.
RIMCE
In the beginning of this work the ΦC31 RDF had not yet been discovered. The RDFs
for a number of other large serine recombinases had been discovered (Breuner et al.,
1999; Bibb and Hatfull, 2002; Ghosh et al., 2006). The RDFs of the different phage
systems were not related to each other in sequence, so each had to be isolated through
a functional study. The ΦC31 RDF was isolated midway through the project (Khaleel
et al., 2011). The discovery of the RDF allowed me to take this work in several new
directions.
The discovery of the ΦC31 RDF allowed for RIMCE to be accomplished. RIMCE
was used to integrate a new landing pad marker cassette into SmUW246 to create the
SacB LP-strain. This demonstrated that the landing pad sequence could be altered
without having to make a new LP-strain from scratch. RIMCE was particularly useful
when creating the SacB LP-strain because it circumvented the problem that creating a
SacB LP-strain using homologous recombination posed. Creating a SacB LP-strain us-
ing homologous recombination would eliminate the utility of the SacB selection when
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integrating the landing pad sequence into the chromosome. RIMCE has the potential
to allow for the recovery of integrated inserts back onto plasmids. It seems the fre-
quncy of attL-attR recombination is too low to accomplish recovery of the integrated
clones back into Escherichia coli. The integrase-RDF expression plasmid (pJH141) was
transferred into SmUW246 so that step would be eliminated in the clone recovery con-
jugation, but this did not boost the frequency enough to obtain a clone of the recovered
pJH110 cassette in E. coli. For now, recovery of the integrated cassettes has not been
accomplished. Because the frequency of the attP-attB reaction is higher, the conjuga-
tion conditions for clone recovery could be explored using IMCE through an attB-attP
reaction. The landing pad markers could be recovered on a plasmid into an E. coli
background. Another potential way to improve the chances of RIMCE clone recovery
is to address the expression of the RDF. Increasing RDF expression could increase the
frequency of the attL-attR reaction.
The lower frequency of the attL-attR reaction relative to the attB-attP reaction is
evident in the lower frequency of transintegrants given by RIMCE relative to IMCE.
That lower frequency can also explain the lower proportion of double recombinants in
RIMCE. It stands to reason that the limiting step in IMCE is the conjugation because
around 50% of transintegrants are double recombinants. If the overall frequency was
limited by recombination you would expect to see that the frequency of double re-
combination was the square of the frequency of single-recombination. For IMCE, the
frequency of double transintegrants is much higher than 10−6. Using this logic, it
is probable that the the reduction of the recombination frequency would reduce the
proportion of double recombinants relative to transintegrants. This is what is seen in
RIMCE.
A dimer of the RDF gene (gp3) in pJH141 could be contributing to the lower attL-
attR reaction frequency. It is very strange that a monomeric clone could not be ob-
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tained. For the purposes of creating the SacB LP-strain, pJH141 performed well. An
earlier version of pJH141 was constructed using a synthesized clone of gp3, however
the DNA sequence of gp3, that the synthesized clone was based on, turned out to be
incorrect. Paul Reginato, an undergraduate thesis student, discovered this mistake
when a BLAST search turned up a new revision of the gp3 sequence. It was safe to
assume that the synthetic gp3 sequence was correct as it was specified by me, but it
was not safe to assume it was correct as specified by nature. Interestingly the incor-
rect gp3 clone that changed a number of amino acids, still yielded a few colonies. No
double recombinants were ever found, but this was later found out to be because of
a mutation in one of the attL sites on the earlier version of pJH143 (pJH129). Because
of the low frequency of recombination with the incorrect gp3, double recombinants
would be hard to find. Though the incorrect gp3 is not useful for RIMCE, it may be
worth noting its partial activity for the study of the RDF’s activity.
SacB selection
The SacB selection in IMCE allows for more backgroud growth than the antibiotic
selections, but it still provides a good positive-selection for double-recombination.
When the first experiments were done, they were discounted because of the growth
of the SacB LP-strain (SmUW574) on plates containing sucrose. Because there was far
less growth on the sucrose plates when compared with the streptomycin only plates
that SmUW574 grew on (data not shown), it became apparent that SmUW574 did not
form isolated colonies on media containing sucrose, but only confluent growth when
the cell density initially plated was extremely high. For this reason, if the frequency of
the recombination were to drop too low, then it would be difficult to isolate colonies
from background growth on sucrose containing media. It is conceivable that a larger
attB donor cassette could cause the recombination frequency to drop. If that effect
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turns out to be strong, the SacB selection may be insufficient for very large donor cas-
settes. However, that limitation remains to be seen, and to date the SacB selection has
performed sufficiently.
Gateway ΦC31 Vectors
The Gateway vectors provide another tool to make IMCE compatible with more exist-
ing clones. Gateway cloning and Gateway entry clones are common in research labs.
For a lab that uses in vitro Gateway cloning, the use of the Gateway ΦC31 attB vectors
would be simplified compared to their use in the pentaparental in vivo Gateway re-
combination mating described in this chapter. One potential problem with the vectors
(pJH121, pJH123, pJH124) is that they are high copy number. A large insert could be
unstable in these vectors. In the test Gateway recombination, a large cosmid insert
was used in the in vivo Gateway recombination. The resultant isolated plasmid was
not pJH121, although it had the backbone of pJH121. Therefore, Gateway recombina-
tion is likely to have occurred. It could have been that the large insert that was stored
on the pJC8 cosmid (a low copy number plasmid) was unstable in the high copy num-
ber plasmid. In this event, the only stable Gateway recombined clones were ones hav-
ing undergone internal recombinations that resulted in a lessening of the insert size.
A recombination event is not very likely in the E. coli strains used, because they are
recA mutants. However, there are RecA independent pathways in E. coli that are usu-
ally repressed by single-strand exonucleases, by elimination of the ssDNA required
for strand invasion (Dutra et al., 2007; Lovett et al., 2002). The in vivo Gateway recom-
bination procedure is based on conjugation. Conjugation does increase the level of
transient ssDNA in the E. coli cell (Baharoglu et al., 2010; Bialowska-Hobrzanska and
Kunicki-Goldfinger, 1977). This could cause the competitive inhibition of the afore-
mentioned ssDNA exonucleaes. Therefore, the level of recombination through RecA
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independent pathways could increase during conjugation. It is also worth noting that
the number of Gateway clones recovered was quite low. The amount of Gateway re-
combinants reported by House et al. (2004) was hundreds to thousands of colonies for
a 5 mm diameter mating spot. THE mating spots in this research were approximately
20 mm in diameter with less than 10 colonies isolated. For larger sized inserts, a low
copy number Gateway IMCE vector would be preferable to the high copy number
vectors that were constructed.
ΦC31 attB Fosmid
The IMCE donor vector fosmid, pJH145, is a single-copy (inducible to medium copy)
cosmid vector that only replicates in E. coli. It is mobilizable for use in IMCE. A higher
copy number can be induced when pJH145 is in the E. coli EPI300 host when grown
on media containing 10 mM L-arabinose. The IMCE test worked as expected, and the
blunt cloning site (for cosmid library construction) restricts as expected. The gentam-
icin resistance gene was cloned into the blunt site because it had been noted that the
efficiency of the restriction was improved relative to having the single restriction site
(J. Cheng, personal communication). The pJH145 vector can also function as a bac-
terial artificial chromosome (BAC). The vector is much better suited for maintaining
large fragments of DNA in E. coli for integration into the chromosome of other strains
by IMCE.
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5.1 Introduction
To increase the utility of the overall chromosome engineering system, a homologous
recombination based system, called recombination synthesis was devised. Recombi-
nation synthesis (RS) is designed to allow overlapping IMCE clones to be combined
so that the resulting construct is present in the IMCE locus. This combination of the
two IMCE inserts is based on a specific homologous recombination event that is se-
lected by two antibiotic resistance genes flanking the entire goal construct (Figure 5.1).
The design of RS allows for either the assembly of smaller overlapping IMCE inserts
into a larger construct, or the combinatorial assembly of a library of IMCE inserts with
common overlaps.
With the goal of developing strains for polyhydroxyalkanoate (PHA) synthesis,
the application and proof of concept of RS was to make medium chain length (mcl)
PHA synthesis operons. Mcl-PHAs have quite different physical properties from
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short chain length (scl) PHAs. The most common scl PHA, PHB, has properties close
to isotactic polypropylene (crystalline polypropylene with the side chains all in the
same orientation) (Griffin, 1994). PHB does have some limitations when compared to
polypropylene. It is more fragile than polypropylene and is thermally unstable at tem-
peratures above its melting temperature. This can be mitigated by mixing PHB with
other polymers (Pachekoski et al., 2009). Creating various co-polymers comprised of
mcl-scl mixes, or different mcls, has the potential to produce a material that overcomes
some of the limitations of scl-PHAs and opens up new applications of PHAs. Cur-
rently, mcl PHAs are most commonly produced in Pseudomonas. Producing mcl-PHAs
in natural scl producers has the potential to open the door to the aforementioned new
materials. I hypothesized that co-expressing phaG and phaC originating from mcl pro-
ducers in Sinorhizobium meliloti, which does not naturally produce mcl-PHA, would
confer on S. meliloti the ability to produce mcl-PHA.
The operons for the proof of concept contain both a phaG gene and a phaC gene.
The phaG gene encodes (R)-3-hydroxydecanol-ACP:CoA transacylase (PhaG). PhaG is
responsible for removing the acyl carrier protein (ACP) from 3-hydroxyacyl interme-
diates of fatty acid synthesis and replacing ACP with a coenzyme-A (CoA) molecule
(Fiedler et al., 2000). These fatty acid CoA thioesters are then imbued with the chemical
energy to power PHA synthase (PhaC). The nature of the PHA produced may depend
on the substrate specificity of the PhaC, the substrate specificity of the PhaG, which
would affect what PhaC substrates are available, and the background metabolism of
the cell (various rates of metabolic steps). The construction of PHA synthesis oper-
ons containing orthologues of phaG and phaC was undertaken. The egfp (Cormack
et al., 1996) gene was used as the common overlap, and a xylE reporter (Ingram et al.,
1989) was placed after phaC. To produce these operons, half operons were designed so
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that when inserted by IMCE, RS would fall into place (Figure 5.3). The DNA transfer
method chosen was first transduction, and was later changed to conjugation.
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Figure 5.1: Recombination synthesis: DNA from one IMCE clone is transferred into another IMCE
clone. There is overlapping sequence (C) that is a substrate for homologous recombination cross-over.
On the left end there is a gentamicin resistance gene, and on the right end a hygromycin resistance
gene. The desired homologous recombination event will yield cells resistant to both antibiotics. The
DNA transfer method suggested in this figure is transduction. The use of another DNA transfer method
may be necessary
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Figure 5.2: PHA pathways. For PHB production, a short chain length (scl) PHA, acetyl-CoA enters
the PHB pathway. For medium chain length (mcl) PHA production, acetyl-CoA is transformed into
malonyl-ACP were it enters the de novo fatty acid biosynthesis cycle. From there, the 3-hydroxyacyl
intermediate is shunted by PhaG into PHA synthesis through PhaC (class II synthase), shown on the
left. Adapted from Fiedler et al. (2000)
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Figure 5.3: Above the arrow, the transfer of the phaG construct by conjugation into the phaC construct
IMCE clone brings the two segments of DNA into proximity. The recombination that is drawn will
result in the assembled operon shown below the arrow. This recombination event is selected using
gentamicin and hygromycin. The oriT is recombined out in the bottom panel.
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5.2 Materials and Methods
5.2.1 Construction of pJRT8
The plasmid pJRT8 was used to integrate, via IMCE, the upstream half operon con-
taining phaG from Pseudomonas putida KT2440.
The primers GFPstart-F-PmeI-XbaI and GFPstart-R-SphI-EcoRI (Table 2.2) were
used with the template pTH1703 (Table 2.1) to amplify a 5‘ truncated segment of gfp,
including its ribosome binding site (RBS). A PmeI site was added for the future cloning
of phaG. An SphI site was added for the future subcloning of the construct into pJH110.
The PCR product was ligated into pK19mobSacB as an XbaI-EcoRI fragment to create
pk19gfpstart. The primers lactac-F-PstI-SphI and lactac-R-PacI-XbaI were used with
the template pTH1227 to amplify the lacIq Plac construct from pTH1227. An SphI site
was added for future subcloning of the entire construct into pJH110, and the PacI site
was added for cloning of phaG. The PCR product was cloned as a PstI-XbaI fragment
into pk19gfpstart to create pJRT1 (Table 2.1). The pJRT1 construct was subcloned into
pJH110 as an SphI fragment to create pJRT13. The desired orientation was verified by
restriction mapping with HindIII. pJRT13 gave HindIII fragments of 2.5 kb and 6 kb
as opposed to the plasmid with the opposite insert orientation that gave HindIII frag-
ments of 0.5 kb and 8 kb. The primers phaG-F-PacI and phaG-R-PmeI-HIS were used
to amplify phaG using P. putida KT2440 genomic DNA as the template. A C-terminal
his-tag was added to phaG. The phaG PCR product was cloned as a PacI-PmeI fragment
into pJRT13 to create pJRT8. Ricardo Nordeste and Tam Tran aided in the construction
of this vector, by contributing to the cloning strategy and cloning in the phaG gene.
149
Chapter 5. Recombination Synthesis of PHA Genes
5.2.2 Construction of pJRT9
The plasmid pJRT9 was used to integrate, via IMCE, the upstream half operon con-
taining phaG from P. putida UW4.
The primers phaGUW4-F-PacI and phaGuW4-R-PmeI-HIS were used to amplify
phaG using P. putida UW4 genomic DNA as a template. The PCR product was cloned
into pJRT13 as a PacI-PmeI fragment to create pJRT9.
5.2.3 Construction of pJRT10
The plasmid pJRT10 was used to integrate, via IMCE, the downstream half operon
containing Sinorhizobium meliloti codon optimized phaC from P. putida GPo1.
The primers GFPend-F-PstI-SphI and GFPend-R-PacI-XbaI were used to amplify
a 3′ gfp using pTH1703 as a template. The PacI site was added for the future cloning
of phaC. The SphI site was added for the future subcloning of the marker construct
into pJH122. The PCR product was cloned as a PstI-XbaI fragment into pK19mobSacB
to create pK19gfpend. The primers XylE/T-F-PmeI-XbaI and XylE/T-R-SphI-EcoRI
were used to amplify the overlapping xylE and xylT open reading frames (ORF) in-
cluding their RBSs, using mini-Tn5-XylE (de Lorenzo et al., 1990) as the template. The
PCR product was cloned as an XbaI-EcoRI fragment into pk19gfpend to create pJRT2.
The SphI fragment from pJRT2 was subcloned into pJH122 to create pJRT14. The ori-
entation of the SphI fragment in pJRT14 was verified with with a HindIII digest, that
yielded HindII fragments of 4 kb and 5.5 kb. The primers GPO1-F-PacI and GPO1-R-
PmeI were used to amplify phaC, adding a C-terminal his-tag, using a synthetic gene
codon optimized for S. meliloti (optimizer program) as the template (Puigbò et al.,
2007). This PCR product was cloned into pJRT14 as a PacI-PmeI fragment to create
pJRT10.
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5.2.4 Construction of pJRT12
The plasmid pJRT12 was used to integrate, via IMCE, the downstream half operon
containing S. meliloti codon optimized phaC from P. putida pTAM (phaC1400) (Tran,
2015).
The primers phaC1400-F-PacI(2) and phaC1400-R-PmeI(2) were used to amplify
the phaC1400 ORF using the codon optimized synthetic DNA construct containing
phaC1400 (designed by Tam Tran, contained on pTAM) as the template (Tran, 2015).
The PCR product was cloned into pJRT14 as a PacI-PmeI fragment to create pJRT12.
5.2.5 Construction of pJRT15
The plasmid pJRT15 was used in the same way as pJRT8, except it contained the R388
oriT in the IMCE cassette, allowing for the resultant IMCE strain’s use as a donor in
conjugative RS.
The primers R388-F-attB-XbaI and R388-SalI-R were used to amplify the R388 oriT,
with the ΦC31 attB site included. The template used was pSU711. The PCR product
was cloned into pJRT8 as an XbaI-SalI fragment, replacing attB and a small segment
of the already truncated gfp with the R388 oriT-attB construct. This created pJRT15.
5.2.6 Construction of pJRT16
The plasmid pJRT16 was used in the same way as pJRT9, except it contained the R388
oriT in the IMCE cassette, allowing for the resultant IMCE strain’s use as a donor in
conjugative RS.
pJRT16 was created in the same way as pJRT15 except the XbaI-SalI fragment was
cloned into pJRT9 to create pJRT16.
151
Chapter 5. Recombination Synthesis of PHA Genes
5.2.7 Construction of pJH146
The plasmid pJH146 is a pJET clone of one of the in vitro PCR assembled PHA operons.
To construct the plasmid, the primers phaG-gfp-F-SphI and phaG-gfpR-XO (Table 2.2)
were used to amplify the P. putida KT2440 phaG, including the lacIq, Ptac and truncated
gfp, using pJRT8 (Table 2.1) as a template. The primers phaC-gfpF-XO and phaC-gfpR-
SphI (Table 2.2) were used to amplify the P. putida GPo1 phaC including the truncated
gfp and xylE, xylT genes (note xylE reporter is in overlapping ORF with xylT), using
pJRT10 (Table 2.1) as a template. These two PCR products were gel purified and used
as a template in a following PCR reaction using the primers phaG-gfp-F-SphI and
phaC-gfpR-SphI. This second PCR step allows the overlap between the truncated gfps
on both templates to act as the internal primers thereby, assembling the two templates
into one amplicon and assembling the operon. This large assembled PCR product
was gel purified and ligated into the pJET vector using the cloneJET PCR cloning kit
(Fisher Scientific Inc.) to create pJH146
5.2.8 Construction of pJH147
The plasmid pJH147 is a pJET clone of one of the in vitro PCR assembled PHA oper-
ons. The same strategy and primers were used to create pJH147 as was used to create
pJH146 except that the initial templates in the first round of PCR were pJRT8 and
pJRT12, to give the assembly containing P. putida KT2440 phaG and phaC 1400.
5.2.9 Construction of pJH148, pJH149, and pJH150
The plasmids pJH148, pJH149, and pJH150 are pJET clones of one of the in vitro PCR
assembled PHA operons. Again the same strategy and primers were used as in the
construction of pJH146. The templates used for the initial round of PCR were pJRT9
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and pJRT10, to give the assembly containing P. putida UW4 phaG and P. putida GPo1
phaC. From the initial screen a few clones that had the correct restriction pattern were
saved. pJH148 and pJH149 were ostensibly equivalent. pJH150 colonies fluoresced
under GFP excitation conditions.
5.2.10 Construction of pJH151
The plasmid pJH151 is a subclone of the operon from pJH148 that could be integrated
into a LP-strain with IMCE. To construct pJH151, the insert from pJH148 was sub-
cloned into pJH110 as an SphI fragment (replacing rfp), so that the completely assem-
bled operon could be integrated into LP-strains with IMCE.
5.2.11 SmUW235 φ SmUW227
Ricardo Nordeste helped construct this strain. Using transduction (section 2.4), a
ΦM12 lysate of SmUW227 was used to infect SmUW235 and transductants were se-
lected with spectinomycin at 100 µg/ml. The strain is a phbC deletion strain that con-
tains the landing pad sequence. phbC is the S. meliloti PHA synthase. The deletion was
made using the standard techniques involving cloning homologous DNA flanking the
gene into pK19mobSacB (Schafer et al., 1994), and using a two step selection method.
This selection method was described in Section 3.2.1.
5.2.12 SmUW497 φ SmUW227
As with SmUW235 φ SmUW227, the landing pad sequence was added to SmUW497
by transduction. Ricardo Nordeste constructed the strain. SmUW497 has all 3 PHB
synthesis genes deleted (phbC, phbA, phbB), and has the PHA depolymerase gene
deleted (phaZ). Deletions were made using the standard techniques involving cloning
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homologous DNA flanking the gene into pK19mobSacB (Schafer et al., 1994), and us-
ing a two step selection method. This selection method was described in Section 3.2.1.
5.2.13 IMCE
IMCE (section 3.2.8) was used to integrate into S. meliloti SmUW235 φ SmUW227, the
PHA half operon contained between the two attB sites in the donor vectors: pJRT8,
pJRT9, pJRT10, pJRT12, pJRT15, pJRT16. The orientation and presence of the half
operons was verified by colony PCR (sections 2.7.9 and 3.2.9). The same was done
for Ochrobactrum anthropi Ow0013 and Agrobacterium tumefaciens At11142. The colony
PCR was used to verify the orientation of Ow0013 IMCE inserts.
IMCE was also used to integrate the in vitro cloned operon from pJH151 into S.
meliloti SmUW235 φ SmUW227, and SmUW497 φ SmUW227.
5.2.14 RS Triparental Mating
These matings were carried out with both the S. meliloti and O. anthropi IMCE clones.
The matings were done between clones of the same species. IMCE clones in the S.
meliloti background were paired with the other IMCE clones of the same background.
The same procedure was carried out for the IMCE clones in the O. anthropi back-
ground.
Preparation of Culture
Cultures of the donor (JRT15 IMCE or JRT16 IMCE), recipient (JRT10 IMCE or JRT12
IMCE), and mobilizer strain (pSU711 in Escherichia coli DH5α) were prepared by inoc-
ulating a single colony in 5 ml of LB media. Kanamycin was added to the mobilizer
culture at 12.5 µg/ml for plasmid maintenance. The S. meliloti landing pad strain was
incubated at 30◦C with constant shaking at 180 RPM for 2-3 days, until the culture was
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saturated. The mobilizer strain, in E. coli was incubated at 37◦C for 16-20 hours with
constant shaking at 180 RPM.
Mating
Once cultures were grown, the procedure stated in section 2.5 was followed. The cul-
tures were combined so that the following combinations were present: JRT15-JRT10,
JRT15-JRT12, JRT16-JRT10, JRT16-JRT12. Those combinations contained Kt2440 phaG
and GpO1 phaC, Kt2440 phaG and 1400 phaC, UW4 phaG and GpO1 phaC, UW4 phaG
and 1400 phaC, respectively.
Selection
After the incubation the control spots were streaked on selective media containing hy-
gromycin at 50 µg/ml and gentamicin at 25 µg/ml, that was counterselective against
donor and recipient, therefore selective for transconjugants. The triparental mating
spot was also streaked on the same media. One quarter to one half of the triparental
mating spot was resuspended in 0.85% NaCl and a 10 fold dilution series to 10−7.
Typically this was done by diluting 10 µl of culture into 90 µl of 0.85% NaCl. 40 µl
of each dilution, 10−1-10−4, was spread plated on media selective for transconjugants;
40 µl of each dilution 10−4-10−7 on media selective for recipients and transconjugants.
Plates were then incubated at 30◦C for three days in the case of S. meliloti background
strains, and 2 days for O. anthropi background strains. O. anthropi backgrounds re-
quired a higher amount of hygromycin for selection: 100-200 µg/ml.
5.2.15 RS Transduction
For the S. meliloti IMCE clones, transductions were carried out as described in sec-
tion 2.4. Lysates of each IMCE strain (JRT8, JRT9, JRT10, JRT12) were made. The
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same IMCE strains were used as recipients. JRT8 and JRT9 lysates were used to infect
JRT10 and JRT12 cultures, and RS transductants were selected on LB agar containing
50 µg/ml gentamicin and 50 µg/ml hygromycin. As a positive control general trans-
ductants were selected on LB agar containing 50 µg/ml gentamicin. Conversely, JRT10
and JRT12 lysates were used to infect JRT8 and JRT9 cultures. RS transductants were
selected on LB agar containing 50 µg/ml gentamicin and 50 µg/ml hygromycin. As a
positive control general transductants were selected on LB agar containing 50 µg/ml
of hygromycin.
5.2.16 Reporter, and Fluorescent Dye Visualization
XylE
An aqueous solution of 0.5 M catechol was sprayed directly onto the colonies. Colonies
turned yellow in 5 to 60 seconds (Ingram et al., 1989).
GFP fluorescence
Colonies containing GFP on agar Petri plates were visualized by shining white light
(from a white phosphor plate on a UV transilluminator) through a LEE Filters 120
deep blue filter, onto the plate, and then placing a LEE Filters 139 primary green filter
on the plate. This assembly was inside a dark box with a camera mounted on top.
Before the camera there was also a UV filter that was used for DNA gel imaging.
This generic filter was of a yellow colour and helped cut the background green in
the images, increasing contrast. This method was derived from the RFP visualization
method for plates that I developed (Heil et al., 2011).
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Nile Red Fluorescence
Colonies suspected to make PHAs were grown on yeast mannitol agar (YMA) contain-
ing 0.5 µg/ml Nile Red (Spiekermann et al., 1999), with and without 0.5 mM IPTG. The
fluorescence was visualized in the same was as above, with the excitation filter being
Lee Filters 139 Primary Green and the emission filter being Lee Filters 128 Bright Pink
(Heil et al., 2011).
5.2.17 Colony PCR and Sequencing
Colony PCR was done using the protocol from section 2.7.9. The left border of the
hypothetical construct was targeted with the primers: L-fwd-EcoRI and Gm-rev. The
right border was targeted with: Hy-Fwd and R-rev-HindIII. The central gfp region
was targeted with: GFPstart-F-PmeI-XbaI and GFPend-R-PacI-XbaI. These primer sets
were used on colonies of each RS combination.
5.2.18 Direct Genomic Sanger Sequencing
Direct genomic Sanger sequencing was carried out at the McMaster Mobix Lab (Hamil-
ton ON). Samples of S. meliloti genomic DNA were sent at a concentration of 2 µg/µl.
5 µl of DNA was used for each read. The primers were sent at a concentration of
20 µM. To obtain large amounts of concentrated DNA, a large scale genomic DNA
preparation protocol was used (section 2.8.4)
The genomic DNA template for the JRT15-JRT12 combination was sequenced with
the primers: gfpXO-41-F, gfpXO-313-F, gfpXO-162-R, gfpXO-691-R, gfpXO-755-R. The
other three combinations were sequenced with the primers: gfpXO-755-R, and gfp-
junction-R (Table 2.2).
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5.2.19 Transduction Linkage Mapping
Lysates of the JRT15-JRT12 RS strain, and the JRT16-JRT10 RS strain were made ac-
cording to the method described in section 2.4. The lysates were used to infect S.
meliloti Rm1021. Transductants were selected on LB plates containing 50 µg/ml hy-
gromycin. The plates were incubated for three days at 30◦C. The transductants that
arose were checked for gentamicin resistance on LB plates containing 50 µg/ml gen-
tamicin. Transductants that were also gentamicin resistant were co-transductants. A
graph of a linkage distance as a function of cotransductant frequency based on Wu’s
formula was used to estimate the linkage distance (Charles, 1990).
5.2.20 Cell PHA Content Analysis Gas Chromatography and Mass
Spectrometry (CG-MS)
GC-MS analysis was used to detect PHAs present in the bacterial strains reported in
this thesis. The GC-MS method was first reported by Braunegg et al. (1978).
For the GC-MS analysis of cultures 50 ml of culture was prepared using the meth-
ods in section 2.3. For S. meliloti the 50 ml culture was grown for 3 days at 30◦C with
constant shaking. 0.5 mM IPTG, for induction of the putative PHA operon, was in-
cluded in the media.
The clones used were: JRT15-JRT10, JRT15-JRT12, JRT16-JRT10, JRT16-JRT12, SmUW235
φ SmUW227, Rm1021, JRT15 IMCE, JRT16 IMCE, JRT10 IMCE, and JRT12 IMCE. Pure
polymer standards were run by Ricardo Nordeste previously using the same protocol,
on the same instrument.
158
5.2. Materials and Methods
Derivatization of Samples for Lipid Analysis
The culture was decanted into a 50 ml centrifuge tube and the cells were pelleted by
centrifugation at 7500 x g for 5 minutes. The supernatant was discarded. The cells
were resuspended in 45 ml of deionized water and centrifuged again with the same
settings. The supernatant was discarded. This wash was repeated three more times.
It was important to note that once the pellet was suspended in water it did not reform
a very strong pellet, so care was taken not to lose the pellet.The pellet was dried in a
60◦C incubator over a period of 1-2 days.
Next the pellet was carefully placed into a pre-weighed KIMAX 5 ml screw cap
test tube. The dry weight of the pellet was recorded. Then 2 ml of chloroform was
added to the tube. Then 1 ml of 15 % 18 M sulphuric acid in methanol was added. The
tube was tightly capped. The tube was placed on a 100◦C heat block for 6 hours. The
tube was allowed to cool to room temperature and then 1 ml of deionized water was
added. The tube was vortexed for 30 seconds. The phases were allowed to separate
and then approximately 1 ml of the organic layer (bottom layer) was removed with a
pasteur pipette and placed in a GC-vial.
GC-MS protocol
An Agilent GC-MS system with a 6890N GC, 5975B mass spectrometer and a 7693
autosampler was used (Agilent Technologies, Santa Clara, California). The column
used was a capillary HP–5MS 5% phenyl methyl siloxane column (30 m x 0.25 mm,
film thickness 0.25 µm, Agilent 19091S-433). Injector syringe wash vials were washed
and filled with chloroform. A 10 µl syringe was used. The injection volume was 1 µl.
Activation of the electron ionization filament was delayed by 3 minutes after injection
to protect the filament from the solvent front. The solvent front came through at 1.9
minutes. After injection the oven temperature was held at 50◦C for 5 minutes. Then
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the oven temperature was increased at 20◦C per minute for 11.5 minutes to reach a
temperature of 280◦C. 280◦C was held for 10 minutes.
5.3 Results
5.3.1 RS Transduction
To assemble PHA operons on the Sinorhizobium meliloti chromosome, the half oper-
ons were assembled on plasmids and integrated by IMCE for a subsequent genetic
cross that would accomplish RS. The half-operon plasmids: pJRT8, pJRT9, pJRT10,
and pJRT12 were constructed such that, after IMCE (Figure 5.4), the resultant strains
could be crossed, achieving a crossover event as seen in Figure 5.1. A sequence align-
ment of the two homologues of each PHA gene included in these constructs was done
to highlight their similarities and differences (Figures 5.5, 5.6). The first method tried
for achieving this genetic cross to assemble the half operons was transduction (Fi-
nan et al., 1986). The IMCE strains of S. meliloti were used in the transductions. The
crossover event was selected with the two antibiotics, gentamicin and hygromycin.
No colonies grew in these selections. The titer of the phage in the lysates was ade-
quate, ranging from 7× 109 to 5× 1010 PFU per ml. The control transductions used a
less stringent selection, only selecting for the resistance contained on the DNA in the
transducing particle. For pJRT8 and pJRT9 lysates, that was gentamicin; for pJRT10
and pJRT12 lysates, that was hygromycin. These control transductions yielded 5-10
colonies consistently. With that frequency of successful transductants, it was unlikely
that transductants would be present that satisfied the more specific double selection.
No RS transductants were isolated.
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Figure 5.4: PHA half operons. In the left column are the IMCE JRT variants that contain a phaG
gene; phaGKt2440 is from P. putida Kt2440; phaG UW4 is from P. putida UW4. In the right column are the
phaC containing variants; phaC GPo1 is from P. putida GPo1; phaC 1400 is a phaC isolated by in through
mutation experiments (Yang et al., 2010)
Figure 5.5: PhaC sequence alignment. A global pairwise sequence alignment of the amino acid
sequence of phaC1400 and phaC from GPo1 is shown. Mismatches are highlighted.
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Figure 5.6: PhaG sequence alignment. A global pairwise sequence alignment of the amino acid
sequence of phaG from KT2440 and phaG from UW4 is shown. Mismatches are highlighted.
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5.3.2 RS Conjugation
After the failure of transduction as an RS genetic cross method, conjugation was cho-
sen. It was hypothesized that a more specific region of DNA (i.e. the target region)
could would be transferred, leading to a higher likelihood of successful RS
Because the IMCE protocol already made use of the RK2 conjugation system, the
R388 conjugation system was chosen for use with RS. If the RK2 system had been used
the donor plasmids would have carried two RK2 oriTs. One in the attB flanked cassette
and one on the vector backbone. This may have caused conjugation of a truncated
vector segment between the two oriTs (Chain, 1998). The R388 conjugation system
was chosen because it was another broad host range conjugation system that had been
used successfully (Demarre et al., 2005). If the R388 oriT was recognized by the RK2
transfer proteins IMCE may have yielded only single-recombinants. IMCE worked as
it did before, indicating that there was no problem caused to the addition of the R388
oriT.
For RS using the R388 conjugation system the IMCE strains containing pJRT15 and
pJRT16 (Figure 5.3) were used as donors. These strains are similar to JRT8 and JRT9
IMCE strains, except that they contain an R388 oriT. Transconjugants were isolated at
a frequency of 10−4. The isolated colonies did not show any GFP fluorescence, nor did
they show any xylE yellow colour. Escherichia coli, carrying pJRT14, did turn yellow
when sprayed with catechol (Figure 5.8). E. coli carrying the same vector but with
phaC cloned before xylE (pJRT10) did not turn yellow. IMCE was done with pJRT14
and RS was done with JRT14 IMCE as a recipient. The resultant colonies still did not
turn yellow when sprayed with catechol. No GFP was detected either. The same was
done for the Ochrobactrum anthropi LP-strain, Ow0013. The frequency of colonies for
O. anthropi Ow0013 RS was lower at 10−5. The Ow0013 RS colonies did not display
the reporter phenotypes either. The Ow0013 IMCE transintegrant clones used for RS
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were added to the strain collection. The resultant RS clones were not added.
The S. meliloti RS clones were examined more closely. The clones did have the gen-
tamicin resistance phenotype of the donor and the hygromycin resistance phenotype
of the recipient. The IMCE strains containing phaG (JRT15 and JRT16) fluoresced on
media containing Nile red dye. The fluorescence was stronger on plates containing
IPTG and Nile red, indicating that the induction of the Ptac promoter is working (Fig-
ure 5.9). The RS strains also have this phenotype, where the IMCE JRT10 and JRT12
strains (recipients in RS conjugation) do not have this phenotype. It is apparent from
the transfer of the Nile red phenotype that the genes in the landing pad locus of the
donor have been transferred and integrated into the recipient somewhere.
The phenotype of the cells was not as expected; expression of the reporter genes
could not be detected. Because of the possibility of poor expression of the reporter
genes due to a variety of factors, I chose to physically verify that the operons were in-
deed properly assembled. This was done with the S. meliloti RS variants only. Colony
PCR to amplify the actual point of crossing over (the gfp gene) and the two borders of
the landing pad sequence (Figure 5.7). Colony PCR successfully amplified the correct
size amplicon for all but RS JRT16-JRT10 with the left border primer set (Figure 5.10).
Each PCR product derived from the gfp primer set was sequenced. The sequence for
each PCR product indicated a fully intact gfp ORF. Since before the RS conjugation
the IMCE strains had contained truncated gfp ORFs, this was indicative of a success-
ful recombination. The fact that the left and right borders were amplified (except for
one case) was also indicative of a properly assembled operon. However, due to the
fact that the gfp halves overlapped, even separated gfp halves could produce the am-
plified PCR product that was observed. Direct Sanger sequencing using a genomic
template was used to give the definitive answer. This technique is not vulnerable to in
vitro assembly of two actually separated overlapping segments of DNA. The genomic
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Sanger sequencing revealed that the gfp segments were not actually assembled, and
that the downstream half operon (containing phaC) was actually in the landing pad
locus independently. The sequence of the ΦC31 attL site appears directly upstream of
the point of 5′ truncation of the downstream gfp segment. Further upstream of the attL
site, the S. meliloti genomic sequence is found. This was the case for all four RS strains
sequenced. Given the positive PCR results for the left and right borders, where there
should be no overlapping sequence, it is reasonable to hypothesize that the landing
pad locus of the donor had inserted somewhere randomly, thereby duplicating the
some sequence surrounding the locus. This would be enough sequence to provide the
template for the left border of the intended operon while the operon was not actually
assembled.
Transduction experiments were done to determine the genetic linkage of the gen-
tamicin resistance gene, near the left border, and the hygromycin resistance gene, near
the left border. The experiments were done with the JRT16-JRT10 and JRT15-JRT12 RS
clones. The JRT15-JRT12 experiment yielded no cotransductants for the 33 colonies
that were transductants. The JRT16-JRT10 clone yielded 2 cotransductants of 34 trans-
ductants, giving a cotransduction frequency of less than 10 %. This cotransduction
frequency corresponds to a distance of around 85-95 kb between the two markers
(Charles, 1990). It is clear from these transduction experiments that the PHA operon
was not assembled as intended by RS. The expected distance between the two markers
is approximately 7 kb, which would give a cotransduction frequency of approximately
90 %. The transduction experiments supported the hypothesis of random integration
post-conjugation.
Because the PCR results implied the correct assembly of the PHA operons, despite
the absence of any reporter gene phenotypes, GC-MS analysis was done on the RS
clones. In one clone (RS JRT16-JRT10) some polyhydroxyoctanoate (PHO), an mcl-
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PHA, was detected (Figure 5.11). This result needs to be replicated (technical issues
with the instrument arose) to make certain that the detected peak was not merely con-
tamination from previous experiments. Though, it is unlikely that this result is due to
contamination from other samples, because the peak in question did not appear in the
control samples (data not shown), and the smaller peak, present in the pure polymer
sample, was not present in the RS JRT16-JRT10 sample. However, it is curious that
there should be any polymer made, because it is unknown how the phaC is expressed.
Although, it is plausible that phaC would be expressed through transcription read-
through from adjacent genes. The same experiment was tried with no IPTG in the
media, and clones containing JRT12 (phaC1400) did show a small PHB peak (data not
shown). It is unclear why this small PHB peak was not present in the experiment with
IPTG media. The Rm1021 control gave a very large PHB peak (data not shown). The
PHO peak was not present in the experiment that excluded IPTG (data not shown).
Because of the Nile red fluorescence phenotype of the phaG-containing strains, the
GC-MS chromatograms of the empty LP-strain and JRT15 and JRT16 IMCE were com-
pared. There were no peaks that appeared in the two IMCE strains’ chromatograms
that did not appear in the empty LP-strain chromatogram. There was some difference
in the intensity of certain peaks between strains, but there was no discernible pattern.
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Figure 5.7: PCR evaluation of RS strains. The location of the amplicons that were targeted in colony
PCR experiments to ascertain the genotype of the colony. The map is not to scale. A blue box indicates
the amplicon. The amplicon is named below the blue box.
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Figure 5.8: XylE reporter test. The colonies on the streak plates were sprayed with 0.5 mM catechol.
The expected yellow colour developed on the pJRT14 colonies. It did not develop on pJRT10 and pJRT12
which are derivatives of pJRT14. The pictures were taken on a blue backgroud to accentuate the yellow
colour.
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Figure 5.9: Nile red fluorescence in RS strains. The IMCE and select RS strains streaked on YMA Nile
Red plates, with and without IPTG. The plate on the top panel shows that the fluorescent phenotype
is transferred into the RS strain by the donor, since the recipient did not display the phenotype. The
bottom two plates show the increase in fluorescence intensity when IPTG is added versus when it is
not added.
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Figure 5.10: RS PCR results. The labels refer to the top row on the top right gel photograph. The
other gels contain 1 row which the lane labels refer to. The expected size of the left border is 600 bp, the
right border is 650 bp and the gfp XO region is 700 bp. The molecular weight standard used was the
Fisher GeneRuler 1 kb ladder. The band sizes are from the bottom up in bp: 250, 500, 750, 1000, 1500,
2000, 2500, 3000, 3500, 4000, 5000, 6000, 8000, 10000. The PCR produced all amplicons successfully for
all clones except for 15-12 template with the right border primers. Primer dimers can be seen in all
lanes as the smallest band.
170
5.3. Results
Figure 5.11: GC-MS results. The red trace line is the chromatogram. The black vertical line is
the cursor. The empty LP-strain shows no peak at 10.8 minutes, while the RS strain does show a 10.8
minute peak at a height of 120 000 (partially overlapped by black cursor line). The peak in the RS strain
matches PHO from pure polymer. The IMCE strains did not contain the 10.8 minute peak either (data
not shown).
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5.3.3 In vitro Assembly of PHA Operons
After it was apparent that RS had not assembled the operons correctly, another strat-
egy was used to assemble the operons prior to IMCE. Because there was already an
overlapping section of gfp contained on both the phaG and phaC half operon clones,
a two step assembly PCR method was chosen. The PCR products were the proper
length. The products were blunt end cloned into pJET. A clone for three of four oper-
ons was isolated. For one of the configurations three clones were saved. The configu-
ration of a single operon was the primary focus because others were more difficult to
subclone due to internal SphI sites. The chosen operon contained the UW4 phaG and
GPo1 phaC genes. One of the three clones displayed GFP fluorescence. A first round
of Sanger sequencing was done using vector primers and primers internal to gfp the
read outwards in both directions. This sequencing revealed that all three clones con-
tained all the expected genes in the correct order. Therefore, the PCR to assemble the
PHA operon did completely assemble the operon as intended. These results rule out
that there was a flaw in the sequence of the half operons that caused the RS strains to
not be properly assembled. The green fluorescent colony that was isolated was called
pJH150, the other two were called pJH148 and pJH149. The clone that was eventu-
ally subcloned was pJH148. Only pJH150 displayed green fluorescence (Figure 5.12),
regardless of the addition of IPTG. More sequencing reads were acquired for pJH149
that showed a mutation in pJH149, which changed a single amino acid in the gfp se-
quence. Not enough sequencing coverage was gained to rule out the possibility of
mutations in all of the genes. The pJH148 insert was subcloned. The pJH148 clone
insert was subcloned into pJH110. This subclone (pJH151) was used in IMCE to inte-
grate the assembled operon into two deletion mutant LP-strains: a phbC mutant and
phbC, phbA, phbB, phaZ mutant. These IMCE strains did gain some slight Nile red flu-
orescence when compared to the empty LP-strain backgrounds, although it was not
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Figure 5.12: Colony displaying GFP fluorescence. This is the original selection plate for the cloning
of the assembled PHA operon PCR product. A single colony displaying GFP fluorescence was detected.
This clone was saved as pJH150.
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as strong as the fluorescence observed with the previous clones containing phaG. Both
IMCE clones were run on GC-MS and there were no fatty acid compounds present
that were not present in the empty LP-strains. No GFP fluorescence was seen in these
IMCE strains. It would be worthwhile to isolate and verify a mutation free clone, and
look for PHA production again.
5.3.4 IMCE strains Containing Plasmids
The expression and function of phaG was apparent from the Nile red fluorescence
phenotype of the phaG IMCE strains. Therefore, the addition of the phaC genes on
plasmids was completed. The plasmids had already been constructed by Ricardo
Nordeste and Jiujun Cheng. Ricardo had seen some promising GC-MS results us-
ing the IMCE strain containing KT2440 phaG and a KT2440 phaC clone on pRK7813
(constructed by Jiujun Cheng)(personal communication). The GPo1 phaC had been
subloned into pTH1227 by Ricardo. I moved that plasmid into the JRT16 IMCE strain
containing UW4 phaG. There are many more phaC clones that have been isolated by
Jiujun Cheng that have been moved into the phaG containing IMCE clones.
5.4 Discussion
Nile Red Phenotype of phaG IMCE Clones
It was intriguing that the strains containing phaG displayed fluorescence when plated
on YM agar containing Nile red. This phenotype was intensified by the addition of
IPTG, making it clear that the integrated phaG construct was responsible. Nile red
is a fluorescent dye that binds to lipids in general. It is used as a dye to visualize
intracellular lipid droplets (Greenspan et al., 1985). PHA granules are in a sense lipid
droplets. That makes Nile red a good choice for visualizing PHA. However, there can
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be no PHA granules, in the case of the IMCE strains containing only phaG that lack a
polymerase gene (phaC).
When the native PHA polymerase gene of Sinorhizobium meliloti (phbC: a more spe-
cific name for phaC) is deleted, the Nile red fluorescence of the wild type strain is abol-
ished. The wild type pathway for short-chain PHA production produces PHB through
the polymerization of 3-hydroxybutyryl-CoA. This monomer substrate is produced
starting from acetyl-CoA, by the activity of β-ketothiolase (PhbA) and acetoacetyl-
CoA reductase (PhbB) (Tombolini et al., 1995). In the case of a phbC deletion mutant,
the monomer substrate is likely still produced. It is likely broken down back into
acetyl-CoA through β-oxidation. In the mcl-PHA pathway, that this work aimed to
reconstruct, the monomers are 3-hydroxyacyl-CoAs derived from de novo fatty acid
synthesis through the activity of PhaG. These 3-hydroxyacyl-CoAs are of a longer
chain length, and they are also intermediates in the β-oxidation pathway. These 3-
hydroxyacyl-CoAs may enter the β-oxidation cycle midway through, and would be
catabolized into a shorter acyl-CoA, and one acetyl-CoA. The shortened acyl-CoA
would re-enter the pathway and be shortened once more. Longer chain fatty acids
would require more cycles to be fully catabolized. It is therefore plausible that, by the
addition of phaG, fatty acids are being shunted into β-oxidation causing the cells to
accumulate lipid droplets in the form of acyl-CoAs.
The β-oxidation build up hypothesis is also supported by the fact that there was
no difference seen between the empty LP-strain and the phaG containing strain when
GC-MS was used to analyse fatty acid methyl esters (FAMEs). Yet the difference in
Nile red fluorescence was apparent. The chemical reaction used to derivatize lipids
in the cell pellet is essentially the same reaction used to make biodiesel: an acid cat-
alyzed transesterification reaction, using methanol. It breaks the ester linkage and
leaves a methyl group, producing methyl-esters.This reaction works well for detecting
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PHAs, because PHAs are polyesters. The GC-MS is detecting FAMEs, and anything
not derivatized will not be detected. In Acyl-CoAs the carbon chain is linked to the
CoA molecule through a thioester linkage. There are derivatization methods for the
anlysis of acyl-CoA thioesters (Tamvakopoulos and Anderson, 1992), but the method
used in this work will not allow them to be detected.
RS Transfer
In the case of the transduction mediated genetic cross there is a limited but large
amount of DNA contained in the transducing particle, approximately 160 kb (Finan
et al., 1984). There is a large amount of homologous DNA that can recombine into the
recipient genome. In RS, a recombination event at the gfp crossover region was re-
quired. This region is only a small portion of all the homologous DNA available. It is
therefore very likely that the recombination will happen elsewhere, which would give
rise to a transductant cell resistant to the single antibiotic corresponding to the gene
carried by the transducing particle. Only the recombination event that occurred at the
gfp region would yield a transductant resistant to both antibiotics. Because the fre-
quencey of transduction was low, it was unlikely an RS transductant would be among
the transductants. After the failure of the RS transductions, conjugation was chosen
as a method to accomplish the genetic cross that the RS method depended on.
I thought that placing an oriT right next to the gfp crossover region and using con-
jugation to specifically transfer that DNA would increase the likelihood of a cross-over
event occurring within the gfp region. Colonies that were resistant to both antibiotics
were successfully obtained. The Nile red fluorescence phenotype of phaG, from the
donor strain, was transferred. Moreover, there was evidence of the integration of the
donor DNA from PCRs, and it seemed to be in the right place. It was revealed by
the direct genomic Sanger sequencing that the donor DNA was not integrated in the
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correct place. To find out exactly where it was integrated was not trivial, so it was not
attempted. The PCR results taken together with the direct genomic sequencing results
suggest that the donor DNA integrated randomly. The donor DNA also included a
segment of the adjacent chromosomal DNA, as one would expect, some sequence ad-
jacent to the landing pad locus was duplicated. It would seem that integration of the
donor DNA at the intended location would have been more likely than a random in-
tegration of the donor DNA, but there could be some mechanisms in place that may
explain the outcome. It has been shown that conjugation causes the induction of the
SOS response in Escherichia coli and Vibrio cholerae (Baharoglu et al., 2010). The SOS
response causes the activation of a host of genes involved in recombination and DNA
replication and repair. Error prone DNA polymerases are expressed, so the replica-
tion fork may pass through damaged DNA regions. It has been shown that the SOS
response can cause an increase in duplication of sequence (Dimpfl and Echols, 1989).
In relation to this issue, horizontal gene transfer has been associated with an increase
in rearrangements of the transferred genes (Hao and Golding, 2009). Perhaps some of
these effects were significant enough in S. meliloti to cause the donor DNA to integrate
the way it did, instead of the, ostensibly more likely, intended location.
PHO production in RS strain
Even though RS did not accomplish the integration of the donor DNA in the correct lo-
cation, the phaG Nile red phenotype was transferred, indicationg that the donor DNA
was indeed functioning. The recipients contained the phaC gene already integrated at
the landing pad locus. The phaC is promoterless, but it is possible that a small amount
of transcription could be happening. To make a detectable amount of PHA, a large
amount of PhaC enzyme should not be required. It is possible that the result show-
ing the PHO production was due to contamination of the sample with the standard
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pure polymer, though the accompanying peak present in the standard is not present
in the RS sample. In any case the strain itself is not easily described, because the lo-
cation of the phaG insertion is unknown. More work is needed to construct a strain
where the PHA genes are surely expressed, and the detection of PHO is repeatable.
The detection of PHO in the RS strain does offer some promise of success.
PCR False Positive
PCR is now commonly used as a method to detect physical changes in genomes. When
compared with Southern blot analysis, PCR is much more rapid and easily accom-
plished. One potential problem of using PCR analysis is the amplification of non-
specific products. However, this problem is easily circumvented by sequencing of
PCR products, and also simple verification that the PCR products are the correct size.
In the case of the RS strains, initially PCR was used to evaluate the physical makeup
of the chromosome at the locus of the putative assembly. The PCR product for the gfp
junction, where the amplicon straddled the truncation in the initial gfp pieces, was of
the correct size for full-length gfp. Sequencing of the gfp amplicon gave the full intact
sequence of un-truncated gfp. At the time this result seemed like very strong evidence
for the correct assembly of the PHA half operons by RS. Later it was revealed by direct
genomic Sanger sequencing that this was not the case. The direct genomic sequenc-
ing was done because the expected GFP fluorescence was absent in the RS strains,
yet the sequence of the PCR product showed full length gfp without one mutation.
I was aware that the PCR product may have assembled in vitro if the overlapping
truncated templates were available. The overlapping DNA would serve as a primer
for its overlapping counterpart. Direct genomic sequencing was chosen, because it
was not susceptible to being confounded by the presence of overlapping sequence.
The sequencing revealed that the truncated gfp remained truncated. The successful
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PCR amplification must have been successfully amplified due to in vitroassembly of
the overlapping parts. It is important to take this possibility into consideration when
designing PCR experiments to evaluate the physical arrangement of the chromosome.
PHA Metabolic Engineering Future Work
RS was successful in transferring the genes of the donor into the recipient despite the
fact that they did not integrate in the precise location to cause the desired assembly of
the full operon. Though the RS strains were not the desired strains, the GC-MS results
showing the detection of PHO in the JRT16-JRT10 RS strain are encouraging. When
phaC is supplied on a plasmid the need for RS is circumvented, and further analysis
of the strains containing phaC on a plasmid is needed.
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Chapter 6
General Discussion
Brief Summary of This Work
This work is centered on the development of chromosome engineering tools for gen-
eral use in a wide range of bacteria. In this thesis, the work has been confined to three
members of the Rhizobiales: S. meliloti, Agrobacterium tumefaciens, and Ochrobactrum
anthropi. Because of the demonstrated functionality of ΦC31 integrase in vitro and
across kingdoms of life, (Groth et al., 2000; Thomason et al., 2001; Bateman and Wu,
2008; Kushtoss and Rao, 1991), and the broad host range of RK2 conjugation (Thomas,
1981), the methods developed here are broadly applicable to many diverse bacterial
species. The work is also focused on the more specific goal of expanding the types of
PHAs that S. meliloti and other members of the Rhizobiales can make.
The integrase mediated cassette exchange (IMCE) system and its variations (rIMCE,
SacB IMCE) were successfully developed and they have been shown to be very reli-
able. However, the recombination synthesis (RS) system to assemble already inte-
grated overlapping DNA segments proved to be more challenging. Alternatives to RS
that have been developed in recent years will be discussed in this context. The PHA
operons were successfully assembled through more conventional means, because they
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were not quite big enough to preclude the use of traditional cloning techniques. With
one of these operons, S. meliloti did make medium chain length polyhydroxy alka-
noates (mcl-PHA).
More specific discussions of the content of the previous chapters: 3, 4, and 5 are
present at the end of those chapters. This discussion aims to integrate the results of
the chapters to inform the future application of the contributions made by this thesis.
The Chromosome Engineering Strategy: Comparison to Other Strategies
The overall goal of the chromosome engineering system was to allow for the assembly
of large synthetic DNA constructs on the chromosome. The end result being a heavily
modified strain of the host bacteria with a large volume of integrated DNA. As a proof
of concept of the methods that were conceived to do this, a smaller amount of DNA
that would be functional was to be assembled. In the end, it is irrelevant whether the
DNA is assembled after it is introduced into the chromosome or whether it is assem-
bled first and integrated later. The rationale behind the design of the system in this
thesis is that it is difficult to manipulate and clone large pieces of DNA before integra-
tion. Therefore, the system described in this thesis first uses IMCE to reliably integrate
the DNA into a common locus, and then uses RS to take the already integrated over-
lapping fragments and assemble them through a genetic cross. The DNA pieces have
to be designed carefully before IMCE to ensure proper conditions for RS to take place.
Around the time this work was started, there had been the announcement by the
Venter Institute of a synthetic genome (Gibson et al., 2008a) where most of the assem-
bly was done in vitro but the final assembly was done by homologous recombination in
the yeast Saccharomyces cerevisiae. Later the S. cerevisiae assembly method was pushed
to its full potential (Gibson et al., 2008b), so that the whole genome of Mycoplasma geni-
talium was assembled in yeast in one step. Though what was coming out of the Venter
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Institute was certainly impressive, for DNA constructs significantly shorter than a
fully synthetic cell, it seemed that the RS-based method had a niche to fill. In the end
we desired bacterial strains containing the engineered DNA: not a fully synthetic cell.
Members of the George Church group developed conjugation methods similar to RS
to do chromosome engineering (Isaacs et al., 2011), a method called MAGE/CAGE.
In MAGE/CAGE the stop codons of every gene in E. coli were changed by first mak-
ing the mutations with λ-Red recombination, and then combining all those mutants
into one strain by conjugating overlapping segments of the genome into another mu-
tant. The underlying theory of the conjugation step is very similar to RS. The main
difference between them was that, MAGE/CAGE was used to combine many point
mutations into a single strain, whereas RS would be used to combine many medium
to large insertions at a single locus.
In theory, the advantage of a method similar to RS, is that the assembly is done in
the desired host, therefore the transfer to a new host and the establishment of a large
piece of DNA in that host is not necessary. The Gibson yeast methods do require the
transfer of the finally constructed DNA to its desired host. The DNA transfer method
was developed using natural DNA (Lartigue et al., 2007) and then applied to a syn-
thetic Mycoplasma mycoides genome some time later (Gibson et al., 2010). This method
is similar in concept to a CaCl2 transformation but with specialized gentle methods
for handling the large DNA. It was developed specifically for Mycoplasma capricolum.
If RS had worked well, it would have maintained the advantage of the DNA transfer
happening during the assembly process itself, and the underlying methods of RS are
already developed for most proteobacteria. Unlike the transformation based method
for installing the synthetic DNA into the intended host, a conjugation based method
does not require a host that is, restriction enzyme deficient and recombination de-
ficient. The underlying methods used by the Venter Institute were new and being
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developed for M. capricolum and M. mycoides, and they had to solve the restriction and
recombination problems.
In the years since the invention of the yeast based assembly, other genomes have
been assembled and cloned in yeast (Karas et al., 2013b,a; Noskov et al., 2012). The
technical problems that were solved concern the toxicity of certain genes to yeast, and
replication problems due to high GC content causing there to be a reduced frequency
of randomly occurring yeast origins of replication. Still the focus has been mostly
on assembling and cloning the genomes in yeast, not the installation of the synthetic
DNA into the intended host. However, the yeast assembly method is proving to be
very powerful indeed. It is conceivable that an assembly could be made in yeast that
could be a substrate for IMCE. It would be transferred into the landing pad strain (LP-
strain) from yeast, probably through a transformation based method similar to the
method described by Lartigue et al. (2007). The disadvantage being that in addition to
developing an LP-strain, a transformation method would also have to be developed.
Conjugation is a much more general method for a variety of reasons. One reason is
that during conjugation a single strand of DNA is used as a template for DNA syn-
thesis in the recipient strain during transfer. In many cases this reduces the barrier
posed by restriction modification systems, because the incoming DNA is sufficiently
modified to avoid restriction (Langella and Chopin, 1989). This protection is not af-
forded to the naked DNA taken up during transformation. To address this problem
in the context of transformation, strains devoid of restriction modification systems
must be developed, or the donor DNA must be incubated with appropriate modi-
fication enzymes (Gibson et al., 2010). The development of transformation methods
is therefore non-trivial. To circumvent the need to develop transformation methods,
the yeast assembly could be transformed into E. coli and then conjugated into the LP-
strain through a regular IMCE protocol. For sub-genome sized assemblies this may
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work, and the in vitro DNA handling requirements would be less stringent, than for
full genomes.
Although I have established the RS methodology, it still requires some refinement
for reliable and routine use. With future investigation, RS could possibly be improved
so that it works reliably. Given the acceleration of the development of the yeast based
assembly methods, and the apparent power of those methods (assembly of tens or
hundreds of fragments at once), it would probably be a better investment to develop
the link between the yeast based assembly and IMCE. That way sub-genome sized
constructs could quickly be assembled and integrated. That type of system would
allow for quick prototyping or screening of constructs for the intended metabolic en-
gineering, or synthetic biology application, when a whole new synthetic genome is
more than what is needed.
A method that could be used for chromosome engineering in the intended host
is inchworm elongation (Itaya et al., 2008). Essentially this method relies on homol-
ogous recombination to sequentially assemble a chromosomal insert. At the end of
every insert is inserted homologous DNA to act as a substrate for the next insertion
by homologous recombination. In this respect it is somewhat similar in concept to RS.
RS, in its original conception, would be an iterative process as well. At each iteration
the antibiotic resistance gene at the growing end of the construct that selects for the
RS transconjugants would be alternated. Three markers would be required, one at the
stationary end, and two for alternate use at the growing end. It is conceivable that the
RS process could be used in a construction tree arrangement where with each itera-
tion the construct grows exponentially larger. However, with the limitations of the RS
system, even if it had proved reliable, this would be impractical. A large number of
selectable markers would be needed to avoid conflicts in the construction tree, unless
a very careful design, avoided the pairing of growing constructs flanked by the same
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markers. In any case, during this project, only enough markers were available for the
pure iterative process, and this thesis describes the attempt at the first assembly iter-
ation. The advantage of combining IMCE coupled with yeast DNA assembly is that
the whole construct could be made at once and integrated into the intended host. The
assembly in yeast works well enough that multiple iterations are not necessary. The
all-at-once yeast approach may turn out to be more rapid than an iterative approach.
The application of RS that was the focus of this thesis is its ability to create con-
structs in a combinatorial way. Such was the case with the various PHA operons,
each containing a different combination of phaG, and phaC orthologues, with the same
overlapping homology between them. In this thesis, the number of possible combina-
tions was small, so the different combinations were made deliberately. If the number
of combinations was large, such as combining two libraries of hundreds of phaC and
phaG genes, the combinations would not be deliberate, but random. Sufficient num-
bers of colonies would have to be screened to ensure a reasonable probability that
the combinatorial space was adequately covered. It would be important to have an
efficient system to be able to deliver the number of colonies required. In this exam-
ple (PHA production), it would also be important to employ an efficient phenotypic
screen, since using GC-MS on that number of colonies would be impractical. How-
ever, that is a separate issue. The yeast system has the potential for use in combinato-
rial assembly in this way (Gibson et al., 2008b). Judging from its ability to take up and
assemble many DNA fragments. Since the assembly principle in yeast is also based on
DNA homology, like in RS, a slight modification of the existing RS constructs to add
homology to a yeast vector on the outside ends would be all that is needed to adapt
the system. This would be all that is needed after getting all the other pieces working,
and successfully linking the yeast assembly system to IMCE.
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PHA Production: Why Try Different Combinations of Genes?
The plastics industry produces a staggering array of different materials with various
physical properties. There are myriad physical properties that can be measured: ten-
sile strength, stiffness, Young’s modulus (a measure of the force needed to stretch
or compress a material), deformation before breaking, glass transition temperature,
melting temperature, density, and more. A material with certain properties makes
it well suited for a certain application. In the case of bioplastics, expanding the di-
versity of the materials available will serve to increase the diversity of applications
suited to their use. These physical properties are influenced by the molecular structure
of the polymer and packing of that molecular structure in crystalline or amorphous
ways (van Krevelen and te Nijenhuis, 2009). Even two polymers with the exact same
monomer composition can vary in physical properties. For example, polypropylene
may be isotactic, syndiotactic, or are atactic. Tacticity refers to the orientation of the
methyl side groups on the polymer. An isotactic polymer has all the methyl groups
in the same orientation, syndiotactic alternates the orientation. Atactic polymers have
random orientations of side-chains. The tacticity of the polymer affects its physical
properties (Jones et al., 2002). Natural PHB is exclusively isotactic, having all of its
monomers in the R stereochemical orientation (Timmins et al., 1996). So this is not a
factor in the structure of natural PHAs, but perhaps there is a novel PHA synthase
out there in the world that would incorporate S-3-hydroxyalkanoates as well as the
R-3-hydroxyalkanoates. Even though, this point does not concern as yet discovered
natural PHAs it does illustrate how the finer aspects of polymer structure can affect
the physical properties of the material. PHAs are a polyester with 3 carbons between
linkages, the rest of the carbons make up the side chain. PHB is a 4 carbon monomer
so has a methyl group as the side chain. Mcl-PHAs have longer side chains. Any
polymer containing monomers longer than 5 carbons is considered an mcl-PHA. Var-
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ious homopolymers and co-polymers containing scl monomers, mcl monomers, or
a mixture of scl and mcl monomers would cover a range of physical properties. The
arrangement of the monomers in a co-polymer also matters. There are random copoly-
mers and block copolymers. Many examples of PHA copolymers in the literature are
random copolymers (Kato et al., 1996).
This thesis discussed the engineering of S. meliloti to produce mcl-PHA (6-12 car-
bons long), where S. meliloti naturally produces scl-PHA (3-5 carbons long). To my
knowledge, mcl-PHAs have not been produced in bacteria other than Pseudomonas.
The activity of the phaG should provide mcl substrates for polymerization. The chain
length of the monomer substrate should depend on the underlying metabolism of the
cell and the substrate specificity of the phaG. On top of that, the substrate specificity
of the phaC would determine which of the available monomers get incorporated into
the polymer. There have been examples of PHAs that are mcl-scl copolymers reported
(Kato et al., 1996). In this case, the phaC had a broad substrate specificity and the strain
in which it was operating was producing a broad range of monomers appropriate for
incorporation. It could even be possible that a block copolymer would be made given
the right constellation of substrate selectivity of either enzyme, where it would ex-
haust one substrate before moving onto the other substrate of a different chain length.
Given all of the interacting factors that would affect the final physical properties of
the bioplastic, it makes sense that a combinatorial approach would be worthwhile. A
rapid screening method to differentiate between colonies containing PHAs varying
in chain length would be a great complement to the genetic engineering techniques
that allow for the generation of a combinatorial library. The Nile red screen method
published by Wu et al. (2003) does allow the differentiation of mcl and scl PHA by
identifying a shift in the Nile red fluorescence emission wavelength. A refinement of
this screening method or something similar, the ability to create the combinatorial li-
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brary of PHA producing strains, and the discovery of new PHA metabolism genes all
taken together could provide a powerful system for novel PHA discovery.
Concluding Statement
The focus of this thesis work was on developing the chromosome engineering systems
of IMCE and RS. The secondary focus was applying these systems to metabolic engi-
neering to produce mcl-PHAs in S. meliloti. The IMCE system worked very well and
turned out to be very robust. The RS system was implemented, yet the donor DNA
did not integrate in the intended location. In the future, it makes sense to integrate
IMCE into other emerging and proven chromosome engineering methods, such as as-
sembly in yeast, rather than troubleshooting RS. The IMCE system provides a very
robust way of creating a marker free strain with stably integrated genes.
Some promising yet preliminary results were obtained showing mcl-PHA produc-
tion in S. meliloti. Using plasmids to express the phaC genes for the purpose of screen-
ing and prototyping in IMCE strains containing phaG should be more productive than
attempting to troubleshoot RS. In the future the IMCE strains containing phaG will
provide a useful test-bed for any plasmids expressing phaC. The use of the phaG IMCE
strains to test phaC clones isolated from the environment may prove fruitful in the
search for interesting PHAs.
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Figure A.1: At1142 blot measurement: shown is the blot ECL bitmap superimposed on the regular
photograph of the blot with a ruler included
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Figure A.2: Ow0013 blot measurement: shown is the blot ECL bitmap superimposed on the regular
photograph of the blot with a ruler included
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Figure A.3: Standard for Ow0013 and At11142 Southern blot. The standard curve for DNA mi-
gration as a function of size is shown. The equation y = 10784e−0.622x was used to determine DNA
fragment size (y) from the distance migrated on the agarose gel (x).
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Figure A.4: Standard for SmUW227 Southern blot. The standard curve for DNA migration as a
function of size is shown. The equation y = 10374e−0.595x was used to determine DNA fragment size
(y) from the distance migrated on the agarose gel (x).
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Appendix B
Hyaluronic Acid Project
B.1 Introduction
This project that I worked on was a collaboration with a company who wanted to
make high molecular weight hyaluronic acid in Bacillus subtilus. Hyaluronic acid pro-
duction had been shown in B. subtilus before (Widner et al., 2005). The company rep-
resentative thought it would make the difference to use a hyaluronic acid synthase
from Rattus norvegicus instead of the synthase from Streptococcus equisimilis. Some
genes (tuaD, gtaB, gcaD) from B. subtilus were also cloned such that their copy num-
ber would be increased, as Widner et al. (2005) has shown that increases production.
The S. equisimilis synthase was also cloned to serve as a positive control. The clones
were given to the company and another lab who received subsequent funding. They
are also stored in the Charles lab collection. We did not have access to the B. subtilus
strains used by Widner et al. (2005) due to their protection by patents.
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B.2 Materials and Methods
B.2.1 Construction of Hyaluronic Acid Operon
What follows is a step by step description of the strain construction for the Hylauronic
Acid Bacillus project: (All PCR used B. Subtilis 168 genomic DNA as a template). PCR
primers also added a ribosome binding site to the 5’ end of the product. The native
ribosome binding site (RBS) was used for gtaB, gcaD, and tuaD. The ribosome binding
site used in rnHAS2 and spHAS was the native ribosome binding site from gcaD.
This RBS turned out to be unnecessary for the use in pHT01 (MoBiTec), since pHT01
contains an RBS.
The gene gtaB was amplified adding a His tag and adding SmaI-EcoRI sites to the
end using the primers: gtaB F SmaI, gtaB R EcoRI his. The gene gtaB was cloned
into pK19mob (Schafer et al., 1994) using SmaI EcoRI restriction sites, creating pJH131.
This step was verified with sequencing. The gcaD gene was amplified adding a His tag
and adding SphI-XbaI sites using the primers: gcaD F SphI, gcaD R XbaI his. Cut sites
(PacI,SalI, XhoI) for future cloning steps were also added in forward primer (gcaD
F).The gcaD gene was cloned into pJH131 using SphI-XbaI restriction sites to create
pJH132. This step was verified by restriction mapping. The tuaD gene was ampli-
fied adding a His tag and adding XbaI-BamHI sites to the ends using the primers:
tuaD F XbaI, tuaD R BamHI his. A stuffer (2 kb long Sp resistance gene) was cloned
into the BamHI site of pJH132, to allow for better digestion of the vector. The stuffer
was was removed as part of the subsequent cloning steps. Its absence was verified
by restriction mapping. The tuaD gene was cloned, using the XbaI and BamHI re-
striction sites, into pJH132 to create pJH133. Here the construction splits into two
streams (spHAS and rnHAS2). Codon optimized rnHAS2 was synthesized by bioba-
sic (BioBasic Inc.Markham ON) with SalI-XhoI ends.The codons were optimized with
212
B.2. Materials and Methods
Optimizer (Puigbò et al., 2007) for expression in Bacillus subtilus.The restriction en-
zymes SalI-XhoI produce compatible ends, so the SalI-XhoI cut insert was cloned into
SalI cut pJH133 to create pJH136. The orientation and presence of the insert was veri-
fied by two independent restriction maps. Codon optimized spHAS was synthesized
in the same way but with PacI-SalI ends. PacI SalI cut SpHAS was cloned into PacI-SalI
cut pJH136 to replace rnHAS2 thereby creating pJH135. At this stage a HindIII digest
was done on both pJH136 and pJH135 to verify the proper banding pattern (4 bands
with 2 differing ).The spectinomycin resistance stuffer was used again, but this time to
carry new restriction sites (PacI-PmeI) into the Bacillus vectors (pHT01 and pSWEET).
pSWEET (Bhavsar et al., 2001) required the addition of just a PmeI site, where pHT01
(MoBiTec) required the addition of PacI and PmeI sites. The full length construct from
pJH135 was cloned into both pSWEET and pHT01 (modified versions) using PacI-
PmeI. This step created pJH137 (pHT01 based) and pJH139 (pSWEET based). The full
length construct from pJH136 was subcloned into both pSWEET and pHT01 (modi-
fied versions) using PacI-PmeI. This step created pJH138 (pHT01 based) and pJH140
(pSWEET based).The pHT01 based vectors were transformed into B. subtilus 168 us-
ing electroporation (Meddeb-Mouelhi et al., 2012). The resultant colonies had the cor-
rect resistance and they are stored in the Charles Lab Bacillus strain collection. The
pSWEET based vectors were transformed into B. subtilus 168 using Bacillus induced
natural competence (Yasbin et al., 1975). A clone potentially containing the construct
from pJH140 was isolated. It displayed the correct antibiotic resistance phenotype:
chloramphenicol resistance. The pSWEET vector has recombination sites for homol-
ogous recombination into the amyE gene by double homologous recombination. A
screen for the inability to use starch can be done to verify integration.
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B.2.2 Oligonucleotides
• gtaB F SmaI: CATCCCGGGAAGGAAGGTGCCTTTTAAATGAAAAAAGTACG-
TAAAGCCATAATTC
• gtaB R EcoRI his: CATGAATTCGTTTAAACTTAGTGATGGTGATGGTGTGGATTTCTTC-
TTTGTTTAGTAAACC
• gcaD F SphI: CATGCATGCTTAATTAAGTCGACCTCGAGATATTGGAGGCCAATAAATG-
GATAAGCGGTTTGCAGTTG
• gcaD R XbaI his: CATTCTAGATTAGTGATGGTGATGGTGATGTTTTTTATGAATATTTTTCA-
CATAATCGTC
• TuaD F XbaI: CATTCTAGATACAGGAGAGGGTTGAGCGCATGAAAAAAATAGCT-
GTCATTGGAAC
• TuaD R BamHI his: CATGGATCCTTAGTGATGGTGATGGTGATGTAAATTGACGCTTC-
CCAAGTCTTTAGC
• PmePacF pHT01 Bam: GATCCTTAATTAAATCGGCTACTGTTTAAAC
• PmePacR pHT01 blunt: GTTTAAACAGTAGCCGATTTAATTAAG
• PmeF pSweet Bam: GATCCATCGGCTACTGTTTAAACG
• PmeR pSweetBam HI: GATCCGTTTAAACAGTAGCCGATG
B.2.3 Conclusion
The clones were made as specified in the project proposal in the time that was allowed.
The integrated strain may have the plasmid integrated in one of the cloned B. subtilus
genes (tuaD, gtaB, gcaD) instead of the targeted amyE locus.
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